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Regional anesthesia and study of pain 
The Croatian Society of Regional Anaesthesia and analgesia is pleased to announce The 6th Croatian Congress of Regional Anaesthesia and 
analgesia with international participation  in collaboration with the Eu-
ropean Society of Regional Anaesthesia& Pain Therapy under auspices 
Croatian Academy Scientific and Arts in Zagreb, 12.–13. June 2015. 
Tremendous changes have affected the practice of pain management 
and regional anesthesia, not just in relation to advances in pharmaco-
logic and intervention aspects, but particularly in the manner by which 
these growing subspecialties are accepted in the delivery of health care. 
We have created this symposium to promote a better understanding of 
the pathophysiology of acute and chronic pain and to enhance the knowl-
edge regarding various chronic neuropathic pain conditions as well as the 
novel state-of the-art  interventional and non-interventional techniques 
in diagnosis and management of chronic pain, cancer pain and headache. 
We have assembled nationally and internationally renowned faculty to 
address current topics in acute, chronic, cancer pain management, and 
regional anesthesia.
Modern concept explicitly assumes that pain perception always has 
an underlying physical cause-injury, infection, or some disease process. 
Pain in the absence of such a cause is usually attributed to psychological 
illness or malingering. By recognizing the dominant role of the brain, 
which generates our subjective experiences and activates our defense sys-
tems, we are now able to appreciate the intimate relationship between 
pain and stress. These relationships among stress, gender, the immune 
system, and chronic pain syndromes reveal the need to study pain in a 
biological context far broader than a pain pathway. 
The ultrasound and ultrasound guidance are the hottest fields in Re-
gional Anaesthesia today. A lot of research still has to be done in order to 
prove that ultrasound really does improve our practice. Other  hot topic 
is how Regional Anaesthesia can assist in improving the peri-operative 
outcome of patients. Not only the acute intra and immediately post-
operation pain relief, but long term pain relief in addition to other pa-
rameters of outcome; inflammation, cancer recurrence, and speed of 
discharge from the hospital.  Discusses how Regional Anaesthesia can be 
used as part of an integrated peri-operative approach to the patient. An 
additional topic  is chronic pain management. This topic is an important 
aspect of Regional Anaesthesia and it is getting a lot of attention in Eu-
rope and the European commission as well.
We have a mission-all of us-to rectify the existing situation, for cancer 
pain as well as postsurgical pain, for pain in adults and in children, and 
for any kind of severe pain that can be helped by sensible administration 
of drugs and other pain therapies. In addition to educating one another 
in current pain research and therapy, as we do in journals and congresses, 
we must promote education on the management of pain for medical 
students and all health professionals. We must also teach patients to co-
mmunicate better about their pain, and inform them that they have a 
right to freedom from pain, that each suffering human being deserves 
the best that the health professions have to offer.
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Functional neuroanatomy of nociception and pain
Abstract
Pain is a complex sensory state based on the integration of a variety of 
nociceptive inputs processed centrally through many parallel and overlapping 
neural systems. The traditional anatomical concept implies that nociceptive 
information is dominantly used to generate and regulate perception of pain 
through one major sensory pathway. It becomes recognized that experiencing 
the affective component of the pain is at least as important as perception. 
Also, nociceptive information is strongly influencing brain centers for regu-
lating homeostasis. So, understanding neuroanatomical organization of 
central processing of nociceptive information is of great clinical importance. 
There is an attempt to simplify this complex set of interacting networks to a 
core set of brain regions or a generalizable pain signature. Herewith we wish 
to give a short overview of recent advances by presenting principles about 
neuroanatomical organization for processing various aspects of nociceptive 
inputs.
GenerAl neuroAnAtomicAl principles in 
nociceptive processinG
Pain is the most distinctive of all the sensory modalities (1) but can be simply defined as the subjective experience associated with actual or 
potential tissue damage (2–5). It serves an important protective function 
and warns to avoid or treat injury. The perception of pain is subjective 
and can vary greatly among individuals. Moreover, in the same individ-
ual an identical sensory stimulus can elicit quite distinct conscious re-
sponses under different conditions. This includes also psychological con-
ditions, such as fear or anxiety that can significantly influence the 
experience of pain. So, more than most sensory modalities, the perception 
of pain is influenced by emotional state and environmental contingency, 
is dependent on experience, and varies so markedly from person to person 
(6–16), and consequently remains notoriously difficult to treat .
Noxious stimuli, including tissue injury, activate nociceptors (from 
the Latin, noceo = to injure, hurt) which are present in peripheral struc-
tures and transmit information to the CNS: from the body to the spinal 
cord dorsal grey column, from the skin of the head to the spinal and 
principal trigeminal nucleus, and from the neck mucosa to the lower 
2/3rd of solitary tract nucleus (17–19). To generate perception of pain 
the information should continue ultimately to the cerebral cortex. From 
anatomical point of view it should be noted that nociception refers to 
the process through which information about peripheral stimuli is trans-
mitted by primary afferent nociceptors to the spinal cord, brainstem, 
thalamus, and subcortical structures. For the experience of pain, activ-
ity of thalamocortical networks that process the information conveyed 
by pathways of nociception is needed (20–26) (Figure 1).
ANA HLADNIK  
IVANA BIČANIĆ  
ZDRAVKO PETANJEK*
University of Zagreb, School of Medicine,  
Department of Anatomy and Clinical Anatomy,  
Croatian Institute for Brain Research 
[alata 11, Zagreb, Croatia
*Correspondence: 
Zdravko Petanjek 
University of Zagreb, School of Medicine  
Department of Anatomy and Clinical Anatomy  
Croatian Institute for Brain Research 
[alata 11, Zagreb, Croatia 
E-mail: zdravko.petanjek@mef.hr
 
Received May 5, 2015.
Leading article
Ana Hladnik et al. Neuroanatomy of pain
196 Period biol, Vol 117, No 2, 2015.
Pain sensation is not the direct expression of a sensory 
event. It has strong urgent and primitive quality with af-
fective and emotional components (7; 26–32), and has 
also influence on homeostatic functioning (33; 34). By 
classical neuroanatomical description pain processing is 
dominantly related to spino- and trigemino-thalamic 
pathway (17–19), still this pathway is evolutionary newest 
in conducing nociceptive information (35). Pain is actu-
ally a complex sensory state that reflects the integration 
of many sensory signals and is the product of elaborate 
brain processing. Particularly complex processing is need-
ed for experiencing the affective component of the pain 
and for the influencing on homeostasis. Numerous paral-
lel and overlapping neural systems processing nociceptive 
information allow such a complex impact on the brain 
functioning (22; 36–40). Among the ascending pathways 
arising from the spinal cord and its trigeminal homologue 
are the spinothalamic and spinoreticulothalamic tracts, 
as well as the spinoparabrachial-amygdala pathway, which 
provides more direct access to limbic emotional circuits 
in the brain. There is an attempt to simplify this complex 
set of interacting networks to a core set of brain regions 
or a generalizable pain signature. Such approaches iden-
tify the following areas as key to experiencing pain: the 
thalamus, the posterior and anterior insula, the postcen-
tral gyrus, the anterior cingulate cortex, and the periaq-
ueductal gray matter. Functional specificity of this com-
plex pattern is still unresolved.
Altogether, understanding neuroanatomical organi-
zation of central processing of nociceptive information 
is of great clinical importance (41-45). Herewith we wish 
to give a short overview of recent advances in under-
Figure 1. Structures containing neurons processing nociception and pain.
Neuroanatomy of pain Ana Hladnik et al.
Period biol, Vol 117, No 2, 2015. 197
standing neuroanatomical organization for various as-
pects of nociceptive processing and to relate neural struc-
tures and pathways to various submodalities of 
nociceptive processing.
moleculAr AnAtomy of 
peripherAl nociceptive 
processinG
Nociceptors, structures that respond selectively to 
stimuli that can damage tissue are widely distributed in 
the skin and deep tissues and include thermal, mechani-
cal, and polymodal sensory receptors (46-49). They re-
spond directly to mechanical and thermal stimuli, and 
indirectly to other stimuli by means of chemicals released 
from cells in the traumatized tissue. Fourth class, so called 
“silent” nociceptors are found in the viscera. The nocicep-
tors are free nerve endings of the peripheral axonal 
branches originating from primary sensory neurons. The 
cell bodies of nociceptors that convey information from 
the body are located in the dorsal root ganglia. Trigeminal 
ganglia and superior ganglia of glossopharyngeus and 
vagus contain somatic neurons processing nociceptive 
stimuli from skin, cranial periost and dura, the mucosa 
of eye, nasal sinuses, oral and nasal cavity and possibly 
part of tympanic tube and cavity. For the rest of tym-
panic tube and cavity, and the whole mucosa of pharynx 
and larynx primary visceral neurons are located in the 
inferior ganglia of glossopharyngeus and vagus (17). The 
central branches of these primary neurons enter the cen-
tral nervous system through spinal or cranial nerves where 
they make synaptic connections with a complex array of 
neurons that play different roles in nociceptive processing 
and pain. Trigeminal, glossopharyngeal and vagal nerve 
convey somatic information into the trigeminal nuclei, 
and visceral information into the nucleus of the solitary 
tract. The spinal nerve conveys nociceptive information 
from the body and viscera and terminates on neurons in 
the dorsal horn of the spinal cord. Afferent fibers innervat-
ing viscera project to the CNS through autonomic nerves; 
some spinal afferents travel along hypogastric, lumbar 
colonic and splanchnic nerves to terminate in thoraco-
lumbar regions as part of sympathetic innervation, while 
vagal and pelvic afferents respectively terminate in the 
brainstem and lumbosacral cord and contribute to para-
sympathetic innervation. Thoracic branches of vagus also 
contain afferent fibers, but the nature to conduct pain 
information from thoracic and abdominal viscera is not 
clarified.
Based on the myelination of their afferent fibers noci-
ceptors in the skin, muscle, joints, and visceral receptors 
fall into two broad classes (2; 50-52). The first class are 
small diameter, thin myelinated Ad fibers that innervate 
nociceptors producing short-latency pain described as 
sharp and pricking. The majority are mechanoreceptors 
because they are activated by sharp objects that penetrate, 
squeeze, or pinch the skin. In addition, many of these Ad 
fibers also respond to noxious heat that can burn the skin. 
Electrophysiological studies have subdivided Ad nocicep-
tors into two main classes: type I and type II. Type I re-
spond to both mechanical and chemical stimuli, but have 
relatively high heat thresholds (>50°C). These fibers medi-
ate the first pain provoked by pinprick and other intense 
mechanical stimuli. Type II Ad nociceptors have a much 
lower heat threshold, but a very high mechanical thresh-
old; these fibers mediate the “first” acute pain response to 
noxious heat. The second class are nociceptors innervated 
by small diameter, unmyelinated C fibers producing dif-
fusely distributed and poorly tolerated dull, burning pain. 
Under this heterogeneous class the most common type 
are polymodal nociceptors activated by a variety of nox-
ious mechanical, thermal, and chemical stimuli, such as 
Table 1





sharp cutting pain mechanical nociceptors Ad fibers
dull burning pain polymodal nociceptors C fibers 
deep aching pain from viscera visceral nociceptors Ad, C fibers
burning pain thermal-mechanical (hot) Ad fibers
freezing pain thermal-mechanical (cold) C fibers
Non-Nociceptive Pain
(neurophatic or symphatetic)
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pinch or puncture, noxious heat and cold, and irritant 
chemicals applied to the skin. Electrical stimulation of 
these fibers in humans evokes prolonged sensations of 
burning pain. Of particular interest are the heat respon-
sive, but mechanically insensitive unmyelinated afferents 
(so-called silent nociceptors) that develop sensitivity when 
the chemical milieu of inflammation alters their proper-
ties (53).
Visceral fibers can serve sensory function and evoke 
conscious sensations and also afferent function and regu-
late autonomic flow. Visceral sensory afferents are almost 
exclusively thinly myelinated Ad-fibres and unmyelinated 
C-fibres. However, the distinction between nociceptive 
afferents and non-nociceptive afferents in the viscera is 
not clear. Nociceptors in the viscera that produce sensa-
tions of intense pain are activated by distension or swell-
ing. Silent nociceptors found in the viscera are not nor-
mally activated by noxious stimulation. However, after 
tissue insult these nociceptors “wake up” in response to 
endogenous chemical mediators associated with tissue 
injury. Silent nociceptors are typically associated with in-
creased spontaneous activity and responsiveness to nox-
ious and even innocuous stimulus intensities. Their acti-
vation is thought to contribute to the development of 
secondary hyperalgesia and central sensitization, two 
prominent pain syndromes.
The membrane of the nociceptor contains protein 
complexes forming receptors and channels that transduce 
thermal, mechanical, or chemical energy of noxious stim-
uli into electrical impulses, which are propagated along 
the peripheral and central axon of the nociceptor into the 
central nervous system. Biochemical and molecular anal-
ysis of the nociceptor has identified multiple nociceptor 
subclasses, each expressing a distinctive repertoire of 
membrane ion channels, receptors and intracellular sig-
naling proteins that are attractive targets for the develop-
ment of drugs for therapeutic intervention in clinical pain 
conditions (54-56). This includes voltage-gated sodium, 
potassium and calcium channels, leak channels, and li-
gand-gated channels such as acid-sensing ion channels 
and transient receptor potential (TRP) channels (57). The 
role of transient receptor potential ion channels in ther-
mal sensation was originally discovered by analyses of 
natural substances such as capsaicin and menthol that 
produce burning or cooling sensations when applied to 
the skin or injected subcutaneously. Capsaicin, the active 
ingredient in chili peppers, has been used extensively to 
activate nociceptive afferents that mediate sensations of 
burning pain (58). The varieties of TRP channels in no-
ciceptors underlie the perception of a wide range of tem-
peratures from extreme cold to intense heat. Some classes 
of TRP receptors are activated by cold temperatures and 
inactivated by warming (TRPM8 and TRPA1receptors) 
while some types of TRP receptors are activated by warm 
or hot temperatures and inactivated by cooling (TRPV3, 
TRPV1, TRPV2  and TRPV4 receptors) (59-61). A key 
role in the perception of pain in humans plays the voltage-
gated sodium channel NaV1.7, found exclusively in the 
periphery and its mutation can lead to the inability to 
experience pain (62). An ionotropic purinergic receptor, 
PTX3, that is activated by adenosine triphosphate (ATP) 
released from peripheral cells after tissue damage is also 
expressed by nociceptors (63-65). In addition, nociceptors 
express members of the Mas-related G protein-coupled 
receptor (Mrg) family, which are activated by peptide li-
gands. They serve to sensitize nociceptors to other chem-
icals released in their local environment (66-68). 
Neuroanatomical and molecular characterization of 
nociceptors demonstrated their heterogeneity; various 
functionally and molecularly heterogeneous classes of 
nociceptors associate with specific function in the detec-
tion of distinct pain submodalities (69).
mechAnisms modulAtinG 
nociceptive processinG
The proper function of the nociceptive system enables 
and enforces protective behavioral responses such as with-
drawal or avoidance to acutely painful stimuli. In case of 
an injury the vulnerability of the affected tissue is going 
to increase (70-75). The nociceptive system adapts to this 
enhanced vulnerability by locally lowering the nocicep-
tive thresholds and by facilitation of nocifensive respons-
es. The behavioral correlates of these adaptations are al-
lodynia (condition in which non-noxious events are 
perceived as noxious) and hyperalgesia (mildly noxious 
events are perceived as highly noxious). However, hyper-
algesia and allodynia may persist long after the initial 
cause for pain or may occur due to dysfunction of parts 
of the peripheral or central nervous system and become 
maladaptive rather than protective.
Two types of hyperalgesia, primary and secondary, are 
associated with different mechanisms. Primary hyperal-
gesia develops at the site of tissue injury associated with 
an increased sensitivity of the peripheral nerve fibers in-
volved in pain. Secondary hyperalgesia develops in unin-
jured tissue surrounding the site of injury. This form of 
hyperalgesia is not caused by sensitization of nociceptive 
nerve endings but due to changes in the excitability of 
neurons in the central nervous system, including the spi-
nal cord and supra-spinal sites in the brain. Recent evi-
dence suggests, however, that altered processing in the 
central nervous system is equally important in the induc-
tion of primary hyperalgesia (70).
Numerous mediators in the peripheral and central ner-
vous systems contribute to the processes of sensitization. 
The sensitization of nociceptors is triggered by chemical 
mediators released from distinct cell types that accumu-
late at the site of tissue injury and act together to decrease 
the threshold of nociceptor activation, such as histamine, 
anandamide, acetylcholine, serotonin, norepinephrine, 
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prostaglandin, bradykinin, substance P and calcitonin 
gene-related peptide. Central sensitization is a consider-
ably more complicated process that can result from in-
creased release of excitatory neurotransmitter (e.g., gluta-
mate, substance P) and/or enhanced synaptic efficacy. 
These changes relate to several cellular mechanisms (a) 
presynaptic changes, (b) postsynaptic changes, (c) inter-
neuron changes, (d) changes in descending modulation, 
and (e) immune/microglial mechanisms (76; 77).
The understanding of pain mechanisms and pain con-
trol has focused on the properties of primary afferent and 
dorsal horn nociceptive neurons and ascending pathways. 
However, there is an active regulation of sensory transmis-
sion at the level of the dorsal horn by descending projec-
tions arising from a number of brain sites (78-89). De-
scending control plays a critical role in determining the 
experience of pain and can be facilitatory as well as in-
hibitory. The balance between inhibition and facilitation 
is dynamic, and can be altered in different behavioral, 
emotional and pathological states. For example, intense 
stress and fear are associated with decreased responsive-
ness to noxious stimuli that reflects a shift towards de-
scending inhibition. By contrast, inflammation and nerve 
injury, sickness, and chronic opioid administration are 
associated with hyperalgesia that in part reflects a shift 
towards descending facilitation. There is much evidence 
to suggest that descending facilitation of spinal nocicep-
tion is a major contributor to central sensitization and the 
development of secondary hyperalgesia.
Descending control arises from a number of supraspi-
nal sites, including the midline periaqueductal gray-ros-
tral ventromedial medulla (PAG-RVM) system, and the 
more lateral and caudal dorsal reticular nucleus (DRt) and 
ventrolateral medulla (VLM). Serotonergic neurons set-
tled in the raphe nuclei and neorepinephrine neurons 
settled in the locus coerlues play the major role in de-
scending control. Inhibitory control from the PAG-RVM 
system preferentially suppresses nociceptive inputs medi-
ated by C-fibers, preserving sensory-discriminative infor-
mation conveyed by more rapidly conducting A-fibers. 
Analysis of the circuitry within the RVM reveals that the 
neural basis for bidirectional control from the midline 
system is two populations of neurons, ON-cells and OFF-
cells that are differentially recruited by higher structures 
important in fear, illness and psychological stress to en-
hance or inhibit pain.
functionAl neuroAnAtomy of 
centrAl nociceptive processinG
The pain-related circuitry extends over both the cogni-
tive and the emotional-motivational domains of the brain. 
It includes the spinothalamic component of the antero-
lateral fasciculus, the trigeminothalamic tract and path-
ways that connect the spinal cord and the sensory nuclei 
of the trigeminal nerve with the brain stem, the hypo-
thalamus and the basal forebrain (17).
The central branches of primary neurons enter the cen-
tral nervous system and make synaptic connections with 
a complex array of neurons. This triggers the release of 
neurotransmitters such as glutamate and substance P, 
which activate second-order neurons that project to the 
brain. The spinal gray dorsal horn-column (and its equiv-
alent, the caudal part of trigeminal nerve nucleus) consti-
tutes one of the main relay stations for primary afferents 
of the dorsal roots. 
Besides nociceptive-specific neurons, the spinal dorsal 
horn (especially deeper laminae) also contains wide dy-
namic range (WDR) neurons that respond to both in-
nocuous and noxious stimuli. After entering the spinal 
cord (through lateral division of peripheral nerve) small 
myelinated Ad and unmyelinated C fibers terminate in 
the dorsal horn. The spinal gray matter in the dorsal horn 
is divided into six layers of cells (90-93). Nociception spe-
cific neurons in the lamina I respond selectively to nox-
ious inputs from Ad or C fibers and project to higher brain 
structures. Other classes of lamina I responed to both 
innocuous and noxious mechanical stimulation and thus 
are termed wide-dynamic-range neurons. Neurons in 
laminae II and III are interneurons that receive inputs 
from Ad and C fibers, and make excitatory or inhibitory 
connections to neurons in lamina I, IV, and V that project 
to higher brain centers. Wide-dynamic-range neurons in 
lamina V typically respond to a wide variety of noxious 
stimuli and project to the brain stem and thalamus. Neu-
rons in lamina V also receive input from nociceptors in 
visceral tissues. 
Many neurons located in laminae VII and VIII, build-
ing the intermediate grey and deep part of ventral gray 
column, have complex response properties to noxious 
stimuli because the inputs from nociceptors to these neu-
rons are conveyed through many intervening synapses. 
Whereas most dorsal horn neurons receive unilateral in-
put, neurons in lamina VII often respond to stimulation 
of both side of the body and therefore contribute to the 
diffuse quality of many pain conditions. Visceral C fibers 
terminate ipsilaterally in laminae I, II, V, and X and also 
in lamina V and X of the contralateral gray matter. 
Finally, fibers from lamina I and the nucleus of the 
solitary tract convey information about impending and 
actual tissue damage, and a wide range of visceral stim-
uli; the responses of neurons in lamina V correlate close-
ly with reports of pain intensity, while the lamina VII 
plays a significant role in emotional responses to sensory 
stimuli.
Five major ascending pathways contribute to the cen-
tral processing of nociceptive information: the spinotha-
lamic, spinoreticular, spinomesencephalic, cervicotha-
lamic, and spinohypothalamic tracts.
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From neurons in laminae I, V, and VII, the main tar-
gets of the small-diameter fibers with sensory information 
destined for conscious perception, originates the spino-
thalamic tract that is the principal pathway transmitting 
noxious, thermal, and visceral information to the thala-
mus and cerebral cortex (94). The axons of most neurons 
in lamina I cross the midline, just ventral to the central 
canal, and ascend in the contralateral lateral spinotha-
lamic tract located in the lateral funiculus. Axons of 
lamina V neurons cross the spinal cord and ascend in the 
contralateral ventral spinothalamic tract. Axons from the 
caudal part of spinal trigeminal nucleus form tractus tri-
geminothalamicus lateralis that crosses the midline and 
joins the spinothalamic tract. As a result of the decussa-
tion of spinothalamic fibers in the spinal cord, noxious 
information from each dermatome is transmitted contra-
laterally in the anterolateral column. The importance in 
pain processing through the sphinothalamic tract is dem-
onstrated by experimental and clinical evidence. Electri-
cal stimulation is sufficient to elicit the sensation of pain 
and anterolateral cordotomy results in a marked reduction 
in pain sensation on the side of the body contralateral to 
that of the lesion. As mentioned, information carried by 
small-diameter sensory fibers also reaches the cerebral 
cortex through several polysynaptic routes other than the 
spinothalamic tract (38-40; 95). Although many of these 
pathways originate from neurons in lamina I and V, they 
arise from a different group of neurons and project to 
brain stem nuclei which in turn project to the thalamus 
and to other sites, such as the hypothalamus and amyg-
dala. Neurons that project to sites other than the thala-
mus are involved in homeostatic control, by regulating 
endocrine release and autonomic activity. The spinore-
ticular tract ascends in the anterolateral quadrant of the 
spinal cord and terminates in both the reticular formation 
and the thalamus. It contains the axons of projection neu-
rons in laminae VII and VIII and do not cross the mid-
line. The spinomesencephalic (spinoparabrachial) tract 
projects in the anterolateral quadrant of the spinal cord 
to the mesencephalic reticular formation and periaque-
ductal gray matter. It contains the axons of projection 
neurons in laminae I and V. Information transmitted 
along this tract are thought to contribute to the affective 
component of pain. They also course through the dorsal 
part of the lateral funiculus and project to the parabra-
chial nucleus. Neurons of the parabrachial nucleus project 
to the amygdala, a key nucleus of the limbic system that 
regulates emotional states.  The spinohypothalamic tract 
projects to hypothalamic nuclei that serve as autonomic 
control centers involved in the regulation of the neuroen-
docrine and cardiovascular responses that accompany 
pain syndromes. It contains the axons of neurons in lam-
inae I, V, and VIII. The cervicothalamic tract runs in the 
lateral white matter of the upper two cervical segments of 
the spinal cord and contains the axons of neurons of the 
lateral cervical nucleus, which receives input from neu-
rons in laminae III and IV of the dorsal horn. Most axo-
ns in the cervicothalamic tract cross the midline and as-
cend in the medial lemniscus of the brain stem, 
terminating in midbrain nuclei and in the ventroposte-
rior nuclei of the thalamus. The signals from nociceptors 
in the pelvic and abdominal viscera are relayed through 
other neurons in laminae III and IV of the sacral and 
midthoracic spinal cord which project axon through the 
most medial part of the white dorsal column terminating 
in the gracile nucleus. 
The thalamus represents a key integrative structure for 
the processing of pain and thus contains several relay nu-
clei that participate in the central processing of nocicep-
tive information. 
The lateral nuclear group comprises the ventroposte-
rior medial nucleus, the ventroposterior lateral nucleus, 
and the dorsal posterior nucleus that receive inputs from 
nociception-specific and wide-dynamic-range neurons in 
laminae I and V of the dorsal horn through the spinotha-
lamic tract. The lateral thalamus is thought to be con-
cerned with the processing of information about the pre-
cise location of an injury, information usually conveyed 
to consciousness as acute pain. The medial nuclear group 
of the thalamus comprises the central lateral nucleus of 
the thalamus and the intralaminar complex and receives 
major input from neurons in laminae VII and VIII of the 
spinal cord. Many neurons in the medial thalamus re-
spond optimally to noxious stimuli and project widely to 
the basal ganglia and different cortical areas. The pathway 
to the medial thalamus was the first spinothalamic projec-
tion evident in the evolution of mammals and is therefore 
known as the paleospinothalamic tract. It is also some-
times referred to as the spinoreticulothalamic tract be-
cause it includes indirect connections through the reticu-
lar formation of the brain stem. The projection from the 
lateral thalamus to the ventroposterior nuclei is most de-
veloped in primates, and is termed the neospinothalamic 
tract.
Regarding cortical processing it should be emphasized 
that pain is a complex perception that involves many ar-
eas. Spatial, temporal and intensity aspects of pain percep-
tion are processed in the primary and secondary somato-
sensory cortex (S1 and S2, respectively). The anterior 
cingulate cortex and insular cortex are involved in pro-
cessing emotional states associated with pain, while the 
dorsal posterior insula contributes to the autonomic com-
ponent of pain responses. Moreover, the prefrontal cortex 
with corresponding mediodorsal thalamic nucleus and 
premotor areas in connection with cerebellum are also 
commonly activated by painful stimulation.
functionAl neuroAnAtomy of pAin 
submodAlities
The sense of pain includes a response to external events 
that damage or harm the body and therefore belongs to 
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extroceptive sensation. Although the sense of the function 
of the major organ systems of the body and its internal 
state (interoception) do not become conscious sensation, 
abnormal function in major organ systems resulting from 
disease or trauma can evoke conscious sensations of pain.
When pain is experienced it can be acute, persistent or 
chronic (76). Persistent pain characterizes many clinical 
conditions and is usually the major reason why patients 
seek medical attention. In contrast, chronic pain does not 
serve a useful biological function; it only makes patients 
miserable (7; 31; 32; 96-101). Persistent pain can be sub-
divided into two broad classes, nociceptive and neuro-
pathic (Table 1). Nociceptive pains result from the direct 
activation of nociceptors in the skin or soft tissue in re-
sponse to tissue injury and usually arise from accompany-
ing inflammation. Sprains and strains produce mild forms 
of nociceptive pain, whereas arthritis or a tumor that in-
vades soft tissue produces a much more severe nociceptive 
pain. Pain may also result from injury to sensory fibers or 
from damage to the central nervous system. These types 
of pain are designated as non-nociceptive or neuropathic 
pain (77; 102-105). Neuropathic pains include the syn-
dromes of reflex sympathetic dystrophy, also called com-
plex regional pain syndrome, and post-herpetic neuralgia, 
the severe pain experienced by patients after a bout of 
shingles. Other neuropathic pains include phantom limb 
pain (106-109), the pain that occurs after limb amputa-
tion. In some instances pain can even occur without a 
peripheral stimulus, a phenomenon termed anesthesia 
dolorosa. This syndrome can be triggered following at-
tempts to block chronic pain, for example after therapeu-
tic transection of sensory afferent fibers in the dorsal roots.
Sharp, pricking pain is produced by nociceptors in-
nervated by Ad fibers and activated by sharp objects that 
penetrate, squeeze, or pinch the skin (mechanical noci-
ceptors). Dull, burning pain that is diffusely localized and 
poorly tolerated is produced by nociceptors innervated by 
C fiber (polymodal nociceptors). When a stone hits your 
elbow, you initially feel a sharp, fast, momentary pain, 
called first pain and conveyed by Ad fibers followed by a 
more prolonged aching and sometimes burning pain 
(“second pain”) which is transmitted by the C fibers.
There is a clear demarcation between the perception of 
innocuous warmth and noxious heat. This enables us to 
avoid temperatures capable of causing tissue damage. If 
skin temperature changes slowly, we are unaware of 
changes in the range 31° to 36°C. Below 31°C the sensa-
tion progresses from cool to cold and finally, beginning 
at 10° to 15°C, to pain. Above 36°C the sensation pro-
gresses from warm to hot and then, beginning at 45°C, 
to pain. The freezing pain is produced by cold nociceptors 
innervated by C fibers, while the burning pain is pro-
duced by heat nociceptors innervated by Ad fibers. Ther-
mal stimuli activate specific classes of TRP ion channels 
in the membrane (60). Two classes of TRP receptors are 
activated by cold temperatures and inactivated by warm-
ing; TRPM8 receptors respond to temperatures below 
25°C (such temperatures are perceived as cool or cold), 
while TRPA1 receptors have thresholds below 17°C (this 
range is described as cold or frigid). Four types of TRP 
receptors are activated by warm or hot temperatures and 
inactivated by cooling; TRPV3 receptors are expressed in 
warm type fibers and they respond to warming of the skin 
above 35°C (generate sensations ranging from warm to 
hot). TRPV1 and TRPV2 receptors are expressed in heat 
nociceptors and respond to temperatures exceeding 45°C 
(mediate sensations of burning pain). TRPV4 receptors 
are activated by temperatures above 27°C and respond to 
normal skin temperatures.
Visceral pain (deep aching pain) is sensations of in-
tense, diffuse, often poorly localized pain. Diffuse nature 
and difficulty in locating visceral pain is due to a low 
density of visceral sensory innervation and extensive spi-
nal distribution of visceral C fibers. Visceral pain is often 
associated with marked autonomic phenomena: nausea, 
gastrointestinal disturbances, pallor, profuse sweating, 
and changes in blood pressure, heart rate and body tem-
perature. In addition, visceral pain frequently produces 
referred pain, a condition in which pain from injury to a 
visceral tissue is perceived as originating from a region of 
the body surface. Referred pain is sharper, better localized 
and less likely to be accompanied by autonomic signs, and 
therefore difficult to differentiate from pain of somatic 
origin. Convergence of visceral and somatic afferent fibers 
may account for referred pain phenomenon. Nociceptive 
afferent fibers from the viscera and fibers from specific 
areas of the skin converge on the same projection neurons 
in the dorsal horn (lamina V neurons). Thus, a signal from 
this neuron does not inform higher brain centers about 
the source of the input and the brain incorrectly attributes 
the pain to the skin. Another anatomical explanation for 
instances of referred pain is that the axons of nociceptive 
sensory neurons branch in the periphery, innervating 
both skin and visceral targets (110; 111). 
There is one unpleasant sensation showing consider-
able apparent overlap in the neuronal cells and circuits 
that transmit pain, the itch. It is characterized by a strong 
innate urge to scratch and is confined to the skin, the 
ocular conjunctiva, and the mucosa. Itch was considered 
to be related to pain, because painful stimuli such as 
scratching inhibits while some analgesics (e.g. opioids) 
can cause itch. In addition, some itch-causing compounds 
(pruritogens) induce inflammatory pain, and under cer-
tain circumstances some pain-causing compounds (algo-
gens) induce itch. Finally, there is a broad overlap between 
relevant mediator systems in pain and itch. Parallels be-
tween pain and itch processing are even more evident in 
the pattern of central sensitization. Touch- and pin prick-
induced pain (allodynia and punctate hyperalgesia) cor-
relate to touch- and pin prick induced itch (alloknesis and 
punctate hyperknesis). However, recent discoveries about 
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molecular and cellular basis of itch cover diverse aspects 
of itch sensation, from the identification of new receptors 
to the characterization of spinal cord itch circuits. These 
studies demonstrate that itch sensory signals are clearly 
demarcated from input of other somatosensory modalities 
(pain, touch, temperature) that is achieved by the expres-
sion of dedicated receptors and transmitters in a select 
population of sensory neurons which detect pruritogens. 
Also, itch specificity is maintained in a spinal cord circuit 
by the utilization of specific neurotransmitters and cog-
nate receptors to convey input along a distinct cellular 
pathway (112-116).
recent advances in molecular and 
anatomical processing of pain: clinical 
implications 
Impressive insights into the molecular mechanisms of 
peripheral pain transduction has been recently developed 
opening the way for more effective pain therapies. Hu-
man genetics and molecular biology have revealed spe-
cific channels expressed selectively by nociceptive sensory 
neurons, such as TRP and Na channels, what has led to 
the development of many small-molecule channel an-
tagonists some of which may prove to be effective as selec-
tive peripheral analgesics. The use of transcutaneous and 
dorsal-column electrical stimulation in the control of cer-
tain types of peripheral pain was encouraged by the find-
ing that the balance of activity in small- and large-diam-
eter sensory fibers modulates the perception of pain. Also, 
an observation that stimulation of specific sites in the 
brain stem produces deep analgesia has encouraged efforts 
to control pain by activating endogenous modulatory sys-
tems. In certain clinical conditions intrathecal and epi-
dural administration of opiates induces a potent analgesia. 
However, understanding of the organization of central 
pain circuits under normal and pathological conditions 
remains relatively incomplete and thereby for most central 
pain syndromes there are still no effective pain therapies. 
It is expected that the future progress in pain therapy will 
depend on the research finding about brain circuits that 
transmit nociceptive signals (2; 117-120).
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What is new in education and teaching in regional  
anaesthesia?
introduction
Training of some procedures on live patients is no longer ethically justified or acceptable to the patient. Patients expect that health 
professionals have fully mastered a procedure before using it on them. 
Procedures performed on a patient simulator can be interrupted, im-
proved and repeated and, unlike in real life, no harm is done when a 
mistake is made (1).
simulAtion teAchinG And leArninG in 
reGionAl AnAesthesiA
Various types of simulators are used to train and assess different 
levels of learners. These include human cadaver, mannequin simulators 
or animal models, computer-based simulation, haptic and or virtual 
simulation, as well as simulation using standardized patients (2). One 
of the prerequisites for physician, who wish to take the European Di-
ploma in Regional Anaesthesia and Pain therapy (EDRA) Part I, is to 
attend a minimum of 1 ESRA workshop or CME/CDP approved work-
shop. The following are considered ESRA workshops: ESRA Congress 
WS, ESRA Cadaver WS in Innsbruck or Ljubljana, ESRA Winter Week 
in Grindelwald (http://esraeurope.org/education/esra-diploma/). Evalu-
ation of cadaver workshops for education in regional anaesthesia dem-
onstrated that the practice of peripheral nerve blocks on cadavers repre-
sents the most important part of the course (3).
Although cadavers are used to teach anatomy and technical skills for 
regional anaesthesia, utilisation of ultrasound-guided simulator for tech-
nical skill training has become a trend in recent years. The observation 
of novice’s behaviour, associated with learning ultrasound-guided pe-
ripheral regional anaesthesia, demonstrated that two main mistakes wre 
failure to visualize the needle before advancement and unintentional 
probe movement. They concluded that this technical part of block can 
be improved with preclinical simulation training (4). Recent study also 
showed that simulation would still be applicable to all peripheral nerve 
blocks with respect to localization of target and placement of needle to 
the target (5). There is commercially available ultrasound training block 
model for acquisition and interpretation of sonographic images of nerves 
and vessels and for developing the psychomotor skills of guiding needles 
to simulated nerves and vessels. Sonoanatomically based part-task sim-
ulators for learning ultrasound guided regional anaesthesia are also com-
mercially available: an upper body torso manikin for learning intersca-
lene and infraclavicular nerve blocks, a femoral model for learning 
femoral nerve blocks, and leg model for learning sciatic nerve blocks in 
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the subgluteal and popliteal areas (Blue Phantom Ultra-
sound Training Models). These simulators were developed 
to anatomically mimic both surface anatomy and the so-
noanatomy present on ultrasound visualization (6). Epi-
dural and spinal anaesthesia simulators consist of a torso 
with synthetic spinal column that includes a ligamentum 
flavum and a spinal cord within a fluid-filled thecal sac. 
These trainers can reasonably recreate the touch, feel and 
consistency of a normal human back and the structures 
involved in neuroaxial regional techniques. Some models 
allow ultrasound imaging (7). Recommendations for 
education and training in ultrasound-guided regional 
anaesthesia by the American Society of Regional Anaes-
thesia and Pain Medicine as well as the European Society 
of Regional Anaesthesia and Pain Therapy suggest one 
method for education is to practice needle insertion tech-
niques using simulators and phantoms (8). Increasingly 
sophisticated regional anaesthesia simulators continue to 
be developed although the contribution for such models 
to attainment regional anaesthesia skills remains to be 
seen (7).
For teaching and practicing how to manage critical 
events associated with peripheral neuroaxial and nerve 
blocks such as phrenic nerve paralysis with respiratory 
failure, stellate ganglion block with Horner’ s syndrome, 
tension pneumothorax with cardiovascular collapse, re-
current laryngeal nerve block with hoarseness, central 
neuroaxial blockade with cardiovascular and respiratory 
collapse and intravascular injection of local anaesthetic, 
can be simulated with the high-tech computer controlled 
manikin. That manikin is specifically designed for train-
ing in anaesthesia, respiratory and critical care provides 
respiratory gas exchange, anaesthesia delivery and patient 
monitoring with real physiological clinical monitoring. 
The trainee can: “talk” to the mannequin and get answers 
from the operator through a speaker in the mannequin’s 
head. The trainee can check the pupils, which react to 
light, feel arterial pulses, listen to cardiac and lung sounds, 
and collect information on heart rate, blood pressure, re-
spiratory rate and oxygen saturation. Medications and 
fluids can be administered to the simulator, which re-
sponds appropriately based on an interaction between the 
mannequin’s current underlying physiology and the dose, 
pharmacokinetics and pharmacodynamics of the medica-
tion. In addition, a number of procedures such as airway 
management, cricothyroideotomy and chest drain inser-
tion can be performed on the mannequin (HPS Human 
Patient Simulator, CEA Healthcare).
In the University Medical Centre Ljubljana, Medical 
Simulation Unit was officially opened on 29th June 2011. 
It is multidisciplinary skills centre which can deliver a 
diverse number of training activities to national and in-
ternational medical practitioners and healthcare workers. 
The centre has one operating theatre with associated con-
trol room, one intensive care unit with associated control 
room, two briefing – debriefing rooms with e-learning 
pods, storing space, wardrobe and external training area. 
Out trainees have the opportunity to train the regional 
anaesthesia using part-task trainers and management of 
critical events associated with regional anaesthesia with 
high-tech computer controlled manikin.
conclusion
Simulation based clinical training is a supplement, not 
a replacement for traditional training and maintenance 
of competence. Learning on mistakes is done with no 
harm for the patients. It has been identified that simula-
tion based clinical training can shorten the learning 
curve, permit manual skills development before patient 
Figure 1. Trainee is performing spinal anaesthesia on the part-task 
trainer. Medical Simulation Unit, University Medical Center 
Ljubljana.
Figure 2. Operation theatre in Medical Simulation Unit, Univer-
sity Medical Center Ljubljana.
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exposure, improve performance under stress, improve 
team work and optimise communication. It is more than 
just a novel education strategy. Over the next decade it 
should mature into a key tool for error mitigation (9).
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Perioperative analgesia for thoracic surgery
Abstract
Pain after thoracic surgery can be severe and it contribute to perioperative 
morbidity and mortality. After thoracotomy, pain can be result of many 
factors, including the skin incision and deeper tissue injuries and trauma, 
thoracostomy tubes, costovertebral joint disruption, rib and sternum frac-
tures. The role of well planned pain management has been crucial in decreas-
ing morbidity after major thoracic for lung resection. Many methods of 
analgesia have been described to surgery the posttoracotomy pain and prevent 
the development of the postthoracotomy pain syndrome: modification of sur-
gical technique, intercostal nerve block, intrapleural analgesia, lumbar and 
thoracic epidural, paravertebral block, intravenous narcotics together or 
without the use of nonsteroidal antiinflammatory drugs. Multimodal pain 
management strategies can improve postoperative pain management while 
contributing other outcome benefits to our high-risk patient population.
introduction
The alleviation of postoperative pain is primary provided for hu-manitarian reasons, but also to reduce nociception-induced re-
sponses, which may adversely influence organ functioning and contrib-
ute to morbidity. Major surgery elicits profounding physiologoical 
changes including hormonal, metabolic and immunological responses. 
Surgical injury, trauma and infection of a tissue induce an acute inflam-
matory reaction with excessive mediator release. The response to injury 
is initiated by somatic and autonomic nerve impulses and the release of 
cytokines and other inflammatotory mediators (1, 2).
A local inflammatory response always occurs in relation to surgical 
trauma. Severe injury or multiple trauma evoke a systemic inflamma-
tory response. This systemic inflammatory response to major injury is 
caused by hormonal, metabolic and immunological mediators, and is 
associated with a haemodynamic response (3). Surgical  trauma is also 
associated with ischemia, ischemia/reperfusion (I/R) injury, hypovole-
mia and the immunological reactions secondary to blood transfusion 
(3). The systemic inflammatory response is required for tissue repair and 
has evolved in all mammals to optimise the healing potential of an or-
ganism. In uncomplicated surgical patients the systemic inflammatory 
response is temporary, predictable and well balanced between pro- and 
anti-inflammatory mediators (3). If the patient is exposed to severe ma-
jor surgical trauma an initial exaggerated proinflammatory response 
may be observed (3).
After a major surgery a pulsatile release of stress hormons occures. 
The net effect of the neuroendocrine response to surgery is an increased 
secretion of the catabolic hormones, with increased catabolism.  Hor-
monal, metabolic and immune stress response can result in increased 
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perioperative morbidity and mortality. Knowledge of the 
normal inflammatory and hormonal response to trauma 
makes it possible for the anaesthetist or surgeon to react 
if an abnormal response is observed. Undesirable aspects 
of the surgery can be decreased by the use of  appropriate 
surgical (minimal invasive surgery) and anaesthesiological 
techniques (use of volatile anaesthetics, protective ventila-
tion, appropriate fluid resusscitation,…). It can be mini-
mised also by certain analgesic techniques (1, 2, 3).
In the following discussion, we briefly review the cur-
rent literature surrounding pain management after tho-
racic surgical procedures and propose an approach.
mechAnism of pAin
Pain can be defined as an unpleasant sensory and emo-
tional experience associated with actual or potential tissue 
damage, as described in terms of such damage.  Visceral 
pain is the most common form of pain produced by surgi-
cal injury (2). Local tissue damage results in inflammation 
and propagation of stimuli to the central nervous system. 
Nocioceptors may be associated with small myelinated A 
delta group fibres or unmyelinated C fibers afferents. Pain-
ful stimuli ascend through the the spinal cord in to the 
spinothalamic trackts and are modulated by excitatory 
(N-methyl-Daspartate [NMDA]) and inhibitory (opiate) 
pathways (4). Clinical and laboratory observations suggest 
that pain can result in hyperexcitability in the spinal cord, 
resulting in increasing levels of perceived pain. This pro-
cess, also known as central sensitization or “wind-up,” 
involves conduction of impulses along afferent C-fibers, 
and release of excitatory neurotransmitters such as gluta-
mate and aspartate through the NMDA receptor (4). In 
the perception of the pain stimuli also psychological fac-
tors play an important role (2).
The existence of chronic pain after surgery is well 
known and described through out the years (5). To evalu-
ate pain after surgery following criteria must be met: the 
development of pain after surgical procedure; pain, which 
persist for at least 2 months; malignant lesions and/or 
inflammation must be excluded and no previous chronic 
pain syndrome encountered (5, 6).
pAin mAnAGement for 
thorAcotomy
Pain after thoracic surgery can be severe and it contrib-
ute to perioperative morbidity and mortality.
Beside acute pain this patients also incur a significant 
risk of chronic pain. Although there are guidelines for 
postoperative pain management in these patients, there is 
no widespread surgical or anesthetic “best practice” (7).
After thoracotomy, pain can be result of many factors, 
including the skin incision and deeper tissue injuries and 
trauma, thoracostomy tubes, costovertebral joint disrup-
tion, and rarely rib- or sternum- fractures. Pain from a 
thoracotomy incision is considered to be severe and in-
tense as a consequence of tissue damage to the ribs, mus-
cles, and peripheral nerves (4, 7)
The typical patient undergoing thoracic surgery has 
little reserve to tolerate adverse effects from the complica-
tions of poor pain management. Common comorbid 
conditions beyond lung disease include advanced age, 
heart disease, renal dysfunction, and obesity (4, 7). Pa-
tients undergoing thoracotomy are often deconditioned 
secondary to their poor pulmonary function or treatment 
of their respiratory condition, including chemotherapy, 
radiation, immune compromise, malnutrition, and re-
lated anemia (7).
The role of well-planned pain management has been 
crucial in decreasing morbidity after major thoracic sur-
gery for lung resection. Pain is a key component in the 
alteration of lung function after thoracic surgery, high-
lighting the importance of providing effective postopera-
tive analgesia to reduce pulmonary complications and 
attenuate the stress response (7). Various analgesic tech-
niques have been developed to treat postoperative thora-
cotomy pain; however, acute and chronic pain conditions 
associated with thoracotomy continue to present a prob-
lem to clinicians (4, 7).
Strategies have been created to minimize pain and cre-
ate a “best practice” for patients undergoing thoracotomy. 
A primary surgical shift in using minimally invasive, 
video-assisted thorascopic surgery (VATS) whenever pos-
sible has been supported in part by studies reporting re-
duced incisional pain in the acute period when compared 
to thoracotomy (8). In the cardiac surgery realm, when 
compared to sternotomy, minimally invasive port-access 
cardiac surgery has not resulted in less pain. Unfortu-
nately, patients undergoing thoracotomy and VATS alike 
continue to experience chronic pain at an alarmingly high 
incidence, 4–8 with about one third developing a neuro-
pathic component (7, 9). 
Uncontrolled acute perioperative pain and related sur-
gical stress responses are associated with higher periop-
erative morbidity, longer hospitalization, lower patient 
satisfaction, and higher costs(10). Unalleviated pain in the 
perioperative period also predicts the development of 
chronic pain- postthoracotomy pain syndrome (7). 
Postthoracotomy pain syndrome is defined as pain that 
recurs or persists along a thoracotomy incision at least two 
months following the surgical procedure. Chronic pain 
after thoracic surgery has the prevalence of 9–80% for 
thoracotomy and 5–33% for video-assisted thoracoscop-
ic surgery (11). Such a difference in the prevalence of post-
thoracotomy pain can be attributed to several factors, 
including the intraoperative technique, anaesthesia and 
postoperative analgesia (11). The exact cause of the devel-
opment of post-thoracotomy pain syndrome has not been 
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established, possible causes include the damage of inter-
costal nerve (rib retraction, troacar insertion, suture place-
ment), type of incision, personality traits (preoperative 
anxiety) and pain due to extensive rib retraction (disar-
ticulation of costochondral/costovertebral junctions, in-
juries to the muscles) (12, 13). Some authors also include 
suboptimal management of acute post-thoracotomy pain 
as one of the major causes in developement of this syn-
drome. The patient, suffering from post-thoracotomy pain 
syndrome typically describes his pain as stabbing or burn-
ing in nature, dysaesthesias are almost obligate. Pain 
worsens on deep inspiration or during cough (12–15). 
Many methods of analgesia have been described to 
alleviate the postthoractomy pain and  prevent the devel-
opment of  the postthoracotomy pain syndrome: modifi-
cation of surgical technique, intercostal nerve block, in-
trapleural analgesia, lumbar and thoracic epidural, 
paravertebral block, intravenous narcotics together or 
without the use of nonsteroidal anti-inflammatory drugs 
(NSAIDS) (5).  A multimodal analgesic strategy that in-
cludes regional anesthesia is considered by some to be a 
gold standard for patients undergoing thoracotomy, and 
evidence suggests this may convey a morbidity benefit, 
although a clear improvement in outcomes after thora-
cotomy related to specific analgesic techniques has been 
difficult to prove (7, 16).
systemic treAtment of pAin
A multimodal approach to analgesia embraces the con-
cept that intercepting signaling at numerous locations is 
more effective than targeting one site along the pain path-
way (7).
Opioids have been the mainstay of postoperative pain 
management for decades. Unfortunately, systemic opi-
oids can be associated with significant side effects, which 
has prompted the search for alternative systemic medica-
tions (4).
Nowdays, following systemic drugs can be used: opi-
oids, NSAIDS, paracetamol, a2- adrenergic agonists 
(clonidine, dexmedetomidine), ketamine, local anaes-
thetics, gabapentin, pregabalin, magnesium, and anxio-
lytics (4, 7).
epidurAl AnAesthesiA And 
AnAlGesiA
The epidural administration of various anaesthetic and 
analgetic drugs gained increased popularity following the 
discovery of opioid receptors in the spinal cord capable of 
producing analgesia. The ability to produce neuroaxial 
anaesthesia and analgesia without dural puncture pro-
vides an attractive option. Epidural analgesia is defined 
as the intraoperative use of local anaesthetics, opioids and 
other drugs with analgetic properities. 
Epidural analgesia has emerged as the analgesic tech-
nique of choice for postoperative thoracotomy pain man-
agement. Not only does the technique provide excellent 
pain control, but it also avoids much of the sedation as-
sociated with systemic opiates. Furthermore, the epidural 
catheter allows for continued dosing postoperatively, and 
avoids much of the motor blockade associated with intra-
thecal drug administration (4). Continuous thoracic epi-
dural catheter techniques have been widely studied and 
are currently considered the standard for analgesia in pa-
tients undergoing thoracic surgery (4, 17).
Epidural analgesia is associated with a zone of differntial 
block.  Epidural effect is not only analgesia, but also many 
other effects- cardiovascular, coagulation, pulmonary func-
tion, gastrointestinal system and stress response (2). Epidu-
ral technique effectively blunt the stress response to surgery 
and provide superior pain relief compared to systemic opi-
oids for patients undergoing thoracic surgery (7). 
Whereas there is evidence that suggests that epidural 
analgesia offers superior pain relief, not all studies have 
shown that epidural analgesia improves pulmonary func-
tion and reduces pulmonary complications (18,19). Meta-
analyses have also demonstrated reductions in bleeding, 
infections, respiratory depression, renal failure, and vas-
cular complications (7).
The risks of epidural placement should not be over-
looked in evaluating the value of postoperative neuraxial 
analgesia, and such risks need to be discussed before un-
dergoing any procedure. These include local anesthetic 
allergy, concentration-dependent neurotoxicity , inadver-
tent entry into the intrathecal space, nerve root injury and 
the  risk of an epidural hematoma (2, 7).
Major contraindication for epidural analgesia are: pa-
tient refusal, active infection at the site of needle insertion, 
presence of systhemic infection and sepsis and coagula-
tion disorders. Other contraindication, like  pre-existant 
neurologic deficit,  respiratory failure, severe cardiac de-
sease, increased intracranial pressure, lack of cooperation, 
are relative (2).
Both lumbar and thoracic epidural catheters can be 
used for postoperative thoracotomy pain management. 
The superiority of thoracic epidural analgesia over lumbar 
epidural analgesia has been called into question. As a re-
sult of limited evidence confirming the benefits of tho-
racic versus lumbar epidural analgesia, some authors have 
expressed caution in using thoracic epidural analgesia on 
a routine basis (4).
pArAvertebrAl blocK
Paravertebral blocks (PVB) produce unilateral trunk 
anaesthesia by blocking the segmental nerves of the spinal 
cord. PVB decrease cardiovascular and respiratory effects 
of epidural block. The paravertebral space is bounded by 
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the vertebral body medially, the transverse process and 
costotransverse ligament superficially and parietal pleura 
laterally. The lumbal paravertebral space is not countinous 
with thoracic. It contains the dorsal and ventral rami of the 
spinal roots as well as sympathetic fibres of the ventral rami. 
Thus anaesthetisc introduced into this space provide an 
unilateral motor, anaesthetics and sympathetic block (2).
Paravertebral blocks can be placed via a single injection 
or catheter-based continuous nerve blockade to achieve 
unilateral thoracic analgesia (2, 4, 7).
Over the past decade enthusiasm for a thoracic para-
vertebral blocks (TPB) in patients undergoing thoracic 
surgery has increased (13).
Several recent studies have suggested that paravertebral 
analgesia can be an effective alternative to epidural anal-
gesia in thoracotomy patients (4). According to published 
studies paravertebral analgesia provide simular or better 
analgesia, the patient provide less postoperative morphine 
consumption and better preservation of pulmonary func-
tion. In addition, side effects such as nausea, vomiting, 
hypotension and urine retention were more problematic in 
the epidural group (2, 4). Paravertebral analgesia with le-
vobupivacaine is very efficient in treatment of postoperative 
pain after thoracic surgery (20). The patients with paraver-
tebral analgesia had better perioperative hemodynamic 
stability with less need for intravenous colloid therapy and 
vasopressor administration during open lung surgery (21).
The absolute and relative contraindications are the 
same as for epidural block (2). Compared to the other 
available regional techniques such as intercostals and in-
terpleurals TPB offers better quality, longer duration of 
analgesia and less side effects (13). 
intercostAl nerve blocK
Blockade of intercostal nerves interrupts C-fiber affer-
ent transmission of impulses to the spinal cord. A single 
intercostal injection of a long-acting local anesthetic can 
provide pain relief and improve pulmonary function for 
up to 6 hours (4, 22). Percutaneous intercostal blocks can 
be performed before surgery, or the surgeon can conduct 
intrathoracic intercostal blockade under direct vision be-
fore chest closure. To achieve longer durations of analgesia, 
a continuous extrapleural intercostal nerve block technique 
can be performed. Often, patients receiving intercostal 
blocks for analgesia after thoracotomy will require addi-
tional interventions to achieve adequate pain control. In-
tercostal analgesia should be instituted in patients who do 
not qualify for thoracic epidural analgesia (4,7).
intrApleurAl AnAlGesiA
Local anesthetic agents can also be administered 
through a catheter positioned inside the pleural cavity as 
another modality to anesthetize intercostal nerves. The 
mechanism of action appears to be diffusion across the 
parietal pleura (23).
Intrapleural analgesia is not as effective as epidural and 
paravertebral analgesia (4).
video-Assisted thorAcic surGery 
(vAts)
VATS is a type of thoracic surgery performed using a 
small video camera that is introduced into the patient's 
chest via a scope. It has been introduced in early 90s.
VATS has emerged as a minimal invasive technique for 
lung biopsy and resection of peripheral lung cancer. Ben-
efits of the technique when compared with thoracotomy 
in lung cancer patients include improvement in postop-
erative pulmonary function, more rapid return to activity, 
shorter postoperative stay, shorter intraoperative time, and 
improved patient satisfaction (4).
The implications seem to be that VATS is associated 
with less postoperative pain and postoperative morbidity 
when compared with operations with a significantly great-
er level of surgical stimulation and tissue damage than in 
those with limited dissection (4).
Typically three incisions are used. Although periop-
erative pain may be lessened, chronic neuralgia is not 
uncommon for many patients, three incisions may not be 
necessary. Recent ly the single incision videoscopic lung 
resection method (UNIVATS)  for performing lung re-
sections was introduced (24, 25).
phrenic nerve infiltrAtion
Patients undergoing thoracic surgery frequently com-
plain of ipsilateral shoulder pain due to diaphragmatic 
irritation. This pain is often not covered with the band of 
analgesia achieved with epidural pain management. 
Patients receiving phrenic nerve block with lidocaine 
had a significantly decreased incidence of ipsilateral shoul-
der pain and an overall reduction in pain score when 
compared with placebo infiltration (26). 
incisionAl AdministrAtion of 
locAl AnAesthetics
The catheter in surgical incision and aplications of lo-
cal anaesthetics to it provide an efficient analgesia follow-
ing port access heart surgery and does not increase the 
risk for wound infection and does not interfere with 
wound healing (27).
conclusion
Multimodal pain management strategies can improve 
postoperative pain management while contributing other 
outcome benefits to our high-risk patient population. 
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Realistic expectations should be set with the patient 
preoperatively and patient education should include a 
discussion of the risks and benefits of epidural or paraver-
tebral catheters, peripheral nerve blocks, and other anal-
gesic medications.
Proper patient preparation and a comprehensive team 
approach to pain management, involving the surgeon and 
anesthesiologist, are vital for minimizing postoperative 
pain and morbidity and improving patient satisfaction.
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Regional anesthesia in children: indications  
and limitations 
Abstract
The goal of regional anesthesia in infants and children is perioperative and 
postoperative pain relief. The use of regional anesthesia and analgesia provide 
improvement in patient outcomes, and may be helpful in special situations, 
such as premature babies, patients with neuromuscular disorders or non-fast-
ing children presenting for urgent surgery. Application of ilioinguinal and 
rectus sheath blocks, transverses abdominal plane blocks and wound infiltra-
tion with local anesthetics is commonly performed in combination with gen-
eral anesthesia. Continuous central and perineural infusion of local anesthet-
ics remains the technique of choice for prolonged major surgery or intense 
postoperative pain. Caudal block still remains the most important and safe 
technique. Introduction of nerve stimulators and lastly ultrasound guided 
regional anesthesia techniques reduced the risks and increase the benefits of this 
kind of anesthesia. The safety profile of regional anesthesia presented in surveys 
is superior with the very low incidence of serious complications. The aim is to 
find the safest technique for realizing the anesthesia and analgesia in children 
where a benefit overcomes the risk.
history of pediAtric reGionAl AnesthesiA
Regional anesthesia becomes very popular in pediatric population. Central nerve blocks, like spinal and caudal (epidural) blocks are 
widely used not only in modern European centers, but also in develop-
ing countries.
Regional techniques in children started more than 100 years ago, by 
August Bier in 1899, reported first spinal anesthesia applied in child (1). 
Few years later (1909) Gray published the first large scale series with spinal 
anesthesia in children undergoing various surgical interventions (2).
The second renaissance of regional anesthesia in children was in 
1980s, in which period the concerns about risks of regional anesthesia 
were raised. However, performed scientific studies improve the beneficial 
effects of these techniques in infants and children (3–5).
The third period of regional anesthesia in children is his growing with 
technology developments. Introduction of nerve stimulators and lastly 
ultrasound guided regional anesthesia techniques reduced the risks and 
increase the benefits of this kind of anesthesia.
indicAtions for reGionAl AnesthesiA in 
children
Indications for regional anesthesia depend on the type of interven-
tion, the age of child and the anesthetist’s experience. This kind of an-
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esthesia is widely used in urologic, orthopedic and lower 
abdominal surgery, and also in cardiac surgery. The other 
indications for this kind of anesthesia are the all cases in 
which is general anesthesia contraindicated, like full 
stomach and risk of aspiration, difficult intubation, al-
lergy to general anesthesia, pseudocholynesterase defi-
ciency or history of malignant hyperthermia. Regional 
anesthesia can be used in patients with upper airway or 
pulmonary infections.
The block selection is depended on age. In neonates 
and infants, two kinds of blocks are mostly used: spinal 
and caudal epidural. Peripheral nerve blocks are used in 
older children, mostly, below 6 years old.
When we talk about indications and benefits of re-
gional anesthesia in pediatric population, we must com-
pare it with general anesthesia.
Risk of morbidity and mortality is highest in children 
under 1 year of age during general anesthesia. However, 
most operations are avoided during this period; surgery 
performed on neonates is often emergency surgery. Anes-
thetic concerns relate mostly to the airway and cardiovas-
cular systems, but some of the metabolic and neuromus-
cular disorders may have life-threatening reactions with 
anesthetic agents. The morbidity related to regional anes-
thesia in children, based on retrospective and prospective 
studies, is low, 1: 1000 overall (6–9). 
Drugs used to generate general anesthesia have been 
used for many decades to patients of all ages without evi-
dence of long-term damage. New evidence from animal 
research is accumulating in the field of anesthetic neuro-
toxicity (10–12). According to their results, possibility of 
long lasting effects on the central nervous system might 
be expected. Infants and neonates are considered to be at 
greater risk due to immature nervous systems. Reaching 
definite information about the effects of anesthetics on 
the developing brain will probably take numerous animal 
and human studies during many years. These further 
studies need to answer many questions regarding the ef-
fects of anesthetics on neurologic development in children 
other than age, the use of specific anesthetic drugs and 
techniques, duration of exposure, doses and other factors. 
Currently there are no alternatives to the anesthetic drugs 
in use, but application of regional anesthesia when pos-
sible may be the best alternative.
Surgical trauma induces a stress response that has en-
docrine, metabolic, hormonal, immunologic and inflam-
matory consequences. All these factors lead to cellular and 
organ dysfunctions with long convalescence period, espe-
cially in children. Regional anesthesia was more effective 
in reducing surgical stress during surgery than systemic 
opioids (13). 
Respiratory complications during and after general 
anesthesia in babies are the other reason to practice re-
gional anesthesia. Alveolar collapse, hypoxemia, apnea 
and bradycardia are significantly lower postoperative 
complications with regional blocks, than those who re-
ceive general anesthesia. Rate of ventilator support after 
anesthesia is also reduced, mostly in large surgeries, like 
thoracic, upper abdominal and cardiac anesthesia (14, 15).
Analgesia is in other issue achieved with regional 
blocks. Acute pain causes chest and abdominal wall mus-
cle splinting and result with decreased tidal volume and 
alveolar ventilation (16). Pain in babies and small children 
has been ignored for many years, and usually was un-
treated. Quality of postoperative pain control possible 
with regional anesthesia and its minimal effect on cogni-
tive function is difficult to realize with other methods. 
Neonates had lower pain scores and overdose with opioids 
could have fatal outcome (17). 
Caudal blocks and dorsal penile blocks are effective for 
circumcision performed in awake neonates. Ilioinguinal 
and rectus sheath blocks, transverses abdominal plane 
blocks and wound infiltration with local anesthetics is 
commonly performed in combination with general anes-
thesia. Spinal, epidural, and caudal routes are applied for 
with general anesthesia or in awake neonates (18). The 
advantages include reduction of general anesthetic and 
opioid requirements, and the need for postoperative me-
chanical ventilation and other postoperative respiratory 
complications.
But still, when compared to adult regional anesthesia, 
regional anesthesia in children is relatively rarely done. 
According to a French survey, regional pediatric anesthe-
sia represents 12% of the total anesthesia cases; infants 
represent 1%, and neonates or preterm babies are extreme-
ly rarely done (19). 
In regards with many studies and meta-analyses (20–
21) is improved that epidural analgesia decrease the length 
of stay in hospital, decrease the complications, like respi-
ratory complications, vascular and gastrointestinal com-
plications, low the rate of nausea and vomiting in postop-
erative period. 
continuAl reGionAl AnesthesiA
Prolonged intraoperative and postoperative analgesia 
with continuous central or peripheral nerve block cathe-
ters (CCT) became the preferred technique in many pe-
diatric centers. Duration of plain long acting local anes-
thetics is only 3–5 h, which is easily solved by this 
technique.
The indications to place a catheter for continuous pe-
ripheral nerve blocks are long and painful intraoperative 
procedures requiring postoperative pain control for many 
days. Postoperative rehabilitation and physiotherapy are 
probably the main indications, because only if pain is 
under control, the successful rehabilitation could be per-
formed. Many published studies underline the efficacy 
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and safety of analgesia via a peripheral catheter, and the 
low rate of complications or side effects. The stress re-
sponse and postoperative complications is visibly de-
creased compared with systemic analgesia. They can af-
fect outcome and the postoperative cost, intensive care 
unit and hospital stay is rapidly increased. The incidence 
of PONV is very low, but the bowel function is not im-
paired (22). 
In neonates, epidural catheters inserted through the 
sacral hiatus can be advanced to a lumbar or thoracic 
level. This catheter allows the neonate to benefit from 
epidural analgesia without the worry of spinal cord injury 
(23). In the series of 15,013 central blocks; 29 of them was 
neuraxial catheters, the complication rate for 0±30-day-
old term and preterm neonates was 0% (19). 
The conduct of continual regional blocks in children 
by pediatric anesthesiologist carries only a small risk for 
neural damage (19). 
limitAtions of reGionAl 
AnesthesiA in children
The anatomy of children differs from that of adults in 
the size and position of the spinal cord. At birth, the cord 
ends at L3 and the dura at S3; therefore, an injury to the 
spinal cord can occur when a lumbar epidural block is 
performed even at low levels. By the end of the first year 
of life, the cord and the dural sac rise to reach their adult 
levels, L1, L2 and S2. The loose epidural fat increases a 
spread of local anesthetics, up to the thoracic region. Up 
to the age of 6–8 years central nerve blocks, spinal and 
epidural, causes only minimal cardiovascular changes.
Myelination is not complete until 12 years of age. In-
complete myelination allows for better penetration of lo-
cal anesthetic into the nerve fibers. Also, the loose of 
fascial attachments around the nerves increase the spread 
of local anesthetic. Furthermore, because the local anes-
thetic spreads easily in children, the duration of the block 
may be shortened compared to an adult. As the patient’s 
age increases, local anesthetic latency of onset and dura-
tion of action increases as well (24).
Martin Jöhr (25), in his article presented at ESRA 
Winter Week 2010, described three phenomena which 
characterized the pharmacokinetics in neonates and small 
infants: firstly, a larger volume of distribution leading to 
lower plasma levels; secondly, an increased free non-pro-
tein bound fraction enhances toxicity and, thirdly, a di-
minished metabolic clearance. Low levels of a-1 acid 
glycoprotein lead to higher serum levels of unbound local 
anesthetic, and this free drug is responsible for toxicity. 
Infants also have decreased clearance and a longer elimi-
nation half-life of local anesthetic compared to adults. All 
these factors contribute to the increased general risk of 
local anesthetic toxicity resulting from a predominance 
of free drug circulating in the pediatric patient’s plasma 
during regional anesthesia.
Absolute contraindications for spinal anesthesia in 
children include refusal of the parents, coagulation de-
fects, and infection at the site of insertion, true allergy to 
local anesthetics, severe hypovolemia, progressive neuro-
logic disease and uncontrolled convulsions (26).
The French-Language Society of Pediatric Anesthesi-
ologists (19) reports the results during the one year period. 
From 85,412 procedures; 61,003 were realized with gen-
eral anesthesia and only in 24,409 cases were performed 
regional anesthesia. Most of the blocks were caudal 
(15,013 or more than 60%), and the other part included 
different regional techniques. Most of the blocks were 
performed under light anesthesia. Complications were 
rare and minor, without any sequel. The overall complica-
tions rate of regional anesthesia was 0.9 in 1000, but com-
plications occurred with central blocks were 1.5 in 1000. 
The incidence of complications during regional anes-
thesia is relatively low.
conclusions
Regional anesthesia could not replace the general an-
esthesia in children. But, the high benefits and extremely 
low incidence of complications during regional anesthesia 
must support anesthesiologists to use them more fre-
quently.
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Regional anaesthesia in cancer surgery:  
an  update
Abstract
Anaesthetic techniques can influence the cellular immune system and 
affect long term outcome. Cancer surgery itself and general anaesthetics, 
especially opioids, suppress immunity and therefore promote metastases. Re-
gional anaesthesia attenuates the immunosuppressive effect of surgery. Local 
anaesthetics, contrary to opioids, stimulate the activity of natural killer (NK) 
cells during the perioperative period. All techniques of regional anaesthesia 
are very useful and applicable in cancer surgery, either for the anaesthesia 
itself or for the treatment of postoperative pain. The relationship between 
regional anaesthesia and cancer recurrence is one of the most interesting 
topics in anaesthesia today, but we must wait the results of prospective trials 
before definitive conclusions. 
 
introduction
Cancer remains a significant cause of morbidity and mortality inter-nationally. It is the second most common cause of death. The like-
lihood of tumour metastases depends on the balance between the 
metastatic potential of the tumour and the anti-metastatic host defenc-
es. Surgery is the mainstay treatment for solid tumours, but studies on 
humans have demonstrated that surgery itself can promote the develop-
ment of metastases. The potential effect of anaesthesia on long-term 
patient outcome has been increasingly acknowledged (1). The periop-
erative period is a critical time and the suppression of host defence 
mechanisms at that time can have deleterious long-term consequences. 
The perioperative stress response affects the immune system which has 
been developed to protect us from infection but also from cancer. There-
fore, at the same time cancer surgery may initiate migration of cancer 
cells through the body and supress the defence immune system. The 
question that arises is how the choice of anaesthetic technique improves 
ability of body to eliminate cancer cells and upgrade survival.
perioperAtive immune response And 
cAncer
Animal studies indicate that immune response control over the cir-
culation of tumour cells and micrometastasis is carried out mainly 
through cell-mediated immunity (CMI), which includes cytotoxic T 
lymphocytes, NK (natural killer) cells, NK-T cells, dendritic cells and 
macrophages (2). NK cells are important because they can naturally 
recognise and kill malignant cells. B-adrenergic stimulation, which in-
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metastasis (3). Human studies show that low periopera-
tive levels of NK activity are associated with an increased 
cancer related morbidity and mortality (4, 5). 
Cancer surgery supresses immunity and therefore pro-
motes metastasis. Growth of pre-existing micro metasta-
ses and dissemination of malignant cells during postop-
erative period is facilitated (6). Further, surgical stress 
activates angiogenesis which contributes to neoplastic 
growth. 
role of AnAestesiA in the 
peroperAtive immune response 
And cAncer
The choice of anaesthetic technique and drugs pro-
foundly influences the immune response and consequent-
ly cancer metastasis. Melamed et al. demonstrated in rats 
that ketamine, thiopental and halothane reduces NK cell 
activity and increased lung tumour retention or lung me-
tastasis (7). Propofol does not affect metastasis, which 
may be related to its B-adrenergic antagonist properties 
(8). Another study has been looked at propofol conjugates 
(propofol-docosahex-aenoate and propofol-eicosapentae-
noate) as treatment for breast cancer, as they have been 
shown to inhibit cellular adhesion, migration and apop-
tosis in breast cancer cells. Effects of inhalation anaesthet-
ics on tumour growth were studied by Brozovic et al. in 
mice. Their results confirmed the genotoxic and cyto-
toxic activity of halogenated inhalation anaesthetics on 
tumour cells (9). Isoflurane and halothane inhibit inter-
feron stimulation of NK cell cytotoxicity in mice (10). 
Multiple studies have demonstrated in vitro effects that 
may have some relevance in the cancer setting. For in-
stance, sevoflurane alters the release of cytokines (IL-1b 
and TNF-a, but not IL-2) by NK and NK-like cells in 
vitro (11). In humans, one large retrospective analysis 
found that general anaesthesia for excision of primary 
melanoma was associated with a decrease in the survival 
rate compared with local anaesthesia. The difference was 
attributed to use of general anaesthetic agents. General 
anaesthesia decreases circulating NK cells in patients un-
dergoing elective orthopaedic surgery (12). Neutrophil, 
macrophage, dendritic and T-cell function are also im-
paired (13). Nitrous oxide interferes with DNA, purine 
and thymidylate synthesis and depressed neutrophil che-
motaxis (14). Opioid administration has been shown to 
suppress cell-mediated and humoral immunity. This in-
cludes NK cell activity, production of immune-stimulat-
ing cytokines, phagocytic activity and antibody produc-
tion (13, 15). Morphine at clinically relevant doses 
increases angiogenesis and promotes breast tumour 
growth in mice (16). Tramadol, which has noradrenergic 
and serotonergic activity, stimulates NK cell activity, both 
in rodents and humans (17). The differences between 
morphine and tramadol have been shown in humans un-
dergoing hysterectomy for uterine carcinoma. T-lympho-
cyte proliferation was depressed in both groups, but re-
mained depressed only in morphine group. Neither 
surgery nor morphine affected NK cell activity, whereas 
tramadol was shown to enhance NK cell activity. Long 
term outcome was not reported (18).
Non-steroidal anti-inflammatory drugs inhibit prosta-
glandin synthesis via inhibition of the cyclooxygenase 
(COX) enzyme. Tumour cells have been shown to secrete 
prostaglandins, and this may be a mechanism to evade 
host cell-mediated immunity (19).
When we analyse the effects of regional anaesthesia, 
we can find two major retrospective studies. One showed 
a 57% reduction in incidence of biochemical cancer re-
currence when epidural analgesia was used for open pros-
tatectomy when compared with postoperative opioid 
analgesia. The other showed a four-fold reduction in the 
incidence of recurrence or metastasis in patients who re-
ceived general and paravertebral anaesthesia and analgesia 
when compared with general anaesthesia and morphine 
analgesia for breast cancer surgery (20). The effect of re-
gional anaesthesia on human breast cancer cells in vitro 
has also been investigated. Serum from patients who re-
ceived propofol/ paravertebral anaesthesia was found to 
inhibit proliferation but not migration of an oestrogen 
receptor-negative breast cancer cell line when compared 
with a sevoflurane/ opioid group (21).
The potential ability of regional anaesthesia to improve 
long-term outcome after cancer surgery can be attributed 
to at least three different mechanisms. First, regional an-
aesthesia attenuates the immunosuppressive effect of sur-
gery. Secondly, patients who received regional analgesia 
have lower opioid requirements. Opioids may themselves 
inhibit cell-mediated immunity and host anti-tumour 
defences. Finally, when regional anaesthesia is used in 
addition to general anaesthesia, the amount of general 
anaesthetic required during surgery is reduced. Further, 
local anaesthetics contrary to opioids stimulate the activ-
ity of NK cells during the perioperative period. Intrave-
nous infusion of lidocaine reduces surgery-induced im-
mune alterations. The long-term clinical implications of 
these findings are unknown and warrant future investiga-
tions (13). Acute pain suppressed NK cell activity too. 
Optimizing postoperative pain management may attenu-
ate the post-surgical inhibition of host anti-tumour de-
fence mechanism, including NK cells.
Postoperative pain therapy may play a very important 
role in metastasis after cancer surgery. Page et al. demon-
strated in rats that the provision of pain relief attenuates 
the surgery-induced increase in metastatic susceptibility, 
likely because of reduction in the stress response. They 
demonstrated that preoperative intrathecal administra-
tion of bupivacaine plus morphine and the perioperative 
systemic administration of fentanyl significantly en-
hanced the host resistance to surgery-induced increases in 
lung metastasis. They suggested that the pain-alleviating 
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effect of these drugs attenuated the surgery-induced pro-
motion of metastasis rather than having direct effect on 
immunity, tumour cells or other mechanisms (22). 
Opioids likely play a profoundly negative role. Mor-
phine has been repeatedly shown to promote angiogene-
sis. It is well established that opioids inhibit cellular and 
humoral immune function in humans.
Anaesthetic strategies that protect the immune system 
have been suggested to guard against this effect and may 
reduce cancer recurrence and improve length of survival. 
Regional anaesthesia has been shown to minimise im-
munosuppression via its opioid sparing effect and by re-
ducing the response to surgical stress. 
There are many conflicting studies regarding regional 
anaesthesia and its impact on cancer recurrence. It has 
been reported that regional anaesthesia decreases some of 
the risk factors that promote cancer metastasis by attenu-
ating the neuroendocrine stress response to surgery, re-
ducing pain, the need for general anaesthetics, minimiz-
ing opioid use and decreasing pro-inf lammatory 
cytokines. The theory is that regional anaesthesia may 
leave an intact immune system which could potentially 
decrease cancer recurrence via endogenous removal of 
tumour cell microemboli. A large analysis of 42 000 pa-
tients with colon cancer who underwent colon resection 
demonstrated that epidural use was associated with 5-year 
improved overall survival, but not actual cancer recur-
rence (23). 
However, more prospective randomised controlled 
clinical trials are necessary to statistically demonstrate a 
causal relationship between regional anaesthesia and can-
cer recurrence. In general, all techniques of regional an-
aesthesia are very useful and applicable in cancer surgery, 
either for the anaesthesia itself or for the treatment of 
postoperative pain. We previously mentioned the benefits 
of thoracic paravertebral block for breast surgery and its 
influence on the cancer recurrence. However, this tech-
nique has the potential to offer long-lasting pain relief and 
reduce postoperative nausea, vomiting and chronic pain. 
Paravertebral block can uniquely eliminate cortical re-
sponses to thoracic dermatomes stimulation (24).  
The results of studies aimed on application of epidural 
anaesthesia (EA) in large abdominal surgery are contro-
versial. Although EA is theoretically supposed to be a 
favourable immune-modulating intervention, not all 
studies show a consistent beneficial effect from EA in co-
lon cancer patients. There is increasing evidence deriving 
from animal studies thoracic epidural blockade could 
have an important role in modifying tissue microperfu-
sion and protecting microcirculatory weak units from 
ischemic damage, regardless of the effect on macro-hae-
modynamics. Continuous EA is a technique that ensures 
quality analgesia for surgery in the upper abdomen. Its 
advantages are reduction of opioid consumption, lower 
incidence of cardiac and pulmonary complications, short-
er duration of postoperative ileus and early mobilisation 
of patients (25). Christopherson et al. found a better over-
all survival in the first 1.5 post-operative years in 177 
colon cancer patients for stage I-II patients with a mean 
age of 69 years old who received EA. Nevertheless, the 
type of anaesthesia did not appear to affect long-term 
survival (26). A significant better overall survival was 
found by Holler et al. The positive impact of this study 
was the most significant in the high-risk patients (Amer-
ican Society of Anesthesiologists (ASA) score 3-4) (27). 
The Swedish study of Gupta et al. found a reduction in 
all-cause mortality in rectal cancer patients who received 
EA (28). Contrary, the study of Myles et al. suggested that 
the use of epidural block in abdominal surgery for cancer 
is not associated with improved cancer-free survival (29). 
Study of Hiller et al. considered that effective epidural 
analgesia improves cancer outcomes following gastro-
oesophageal cancer surgery in patients with grouped 
pathological staging (30). Continuous EA is a technique 
that ensures quality analgesia for surgery in the upper 
abdomen. The advantages of EA are reduced opioid con-
sumption, lower incidence of cardiac and pulmonary 
complications, and shorter duration of postoperative ileus 
and early mobilisation of patients. However, there are 
some limitations in the use of EA in the liver surgery such 
as postoperative coagulation disorders. 
Contrary to EA continuous wound infiltration (CWI) 
is analgesic technique of application local anaesthetic di-
rectly into surgical wound through multi-holed wound 
catheter placed by surgeon on the end of the surgery. 
CWI enables reduction in opioid consumption and opi-
oid related side effects, earlier recovery of bowel function 
and hospital stay. Continuous wound infusion of local 
anaesthetics has been successfully applied for postopera-
tive pain control in several procedures but, it is underused 
in thoracic surgery. Fiorelli et al. in their paper concluded 
that CWI is an effective, easy and safe procedure. It sig-
nificantly reduces systemic inflammatory markers, pain 
scores and opioid intake; and accelerates the recovery of 
respiratory function (31).
In ovarian cancer patients intraoperative use of epidu-
ral anaesthesia was associated with an increased time to 
tumour recurrence after surgery (32). Quality improve-
ment in colorectal and gynaecological surgery is perform-
ing the transversus abdominis plane (TAP) block. Adding 
TAP block is appropriate tool to improve patient and fi-
nancial outcomes and to achieve better results of treat-
ment. Keller and colleges analysed results of 200 patients 
with colorectal carcinoma and concluded that transverses 
abdominis plane blocks may be an efficient, cost-effective 
method for improving laparoscopic colorectal surgery 
(33). 
Peripheral nerve blocks (PNB) or plexus blocks can be 
used when pain occurs in the area of one or more periph-
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eral nerves. The pain may arise from primary or secondary 
tumor deposits or be the result of treatment or secondary 
complications such as pathological fracture or vascular 
occlusion. PNB are often used to avoid side effects and 
complications of general anaesthesia, particularly respira-
tory-related effects, and to provide analgesia while mini-
mizing opioid use. PNB are widely-used for surgical an-
aesthesia as well as for postoperative pain control, and 
offer distinct benefits over general or central blocks in 
certain clinical situations. Further, PNB provide analgesia 
that may be superior to other techniques for some pa-
tients. Koshy et al. described successful continuous femo-
ral block for pain relief of acute severe cancer related pain 
caused by pathological femur fracture (34). Locoregional 
anaesthesia provides better pain control, eliminating the 
need for opioids in the postoperative period and resulting 
in negative effects on immune function and tumour 
growth; it also reduces the release of endogenous opioids 
(35).
conclusion
Finally, we could conclude that the relationship be-
tween regional anaesthesia and cancer recurrence is one 
of the most interesting topics in anaesthesia today. The 
concept that anaesthesia can influence the outcome of 
cancer would raise our speciality to a new level. We must 
wait the results of prospective trials before definitive con-
clusions. 
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Pain management in  critically ill patients
Abstract 
Pain is a common and distressing symptom in intensive care unit (ICU) 
patients and despite of pain research, guideline development, numerous 
awareness campaigns and intense educational efforts, it remains currently 
under evaluated and undertreated. The pain relief in critically ill patients 
may be difficult to achieve due to complex interplay between mechanisms of 
critical illness, drug interactions, organ dysfunctions and factors involved in 
influencing pain perception. A different medications have been proposed for 
pain control and they have unique considerations when contemplated for 
use in the critically ill patient.
The purpose of this article is to provide an overview of most important 
pharmacologic pain treatment in the critically ill patient.
introduction 
Pain is a common and distressing symptom in intensive care unit (ICU) patients and represents a major clinical, social, and econom-
ic problem. It has been reported that almost 80% of patients experience 
different intensities of pain during their intensive care unit stay and 
identify it as one of the greatest sources of stress (1, 2). 
Such pain is problematic because produces adverse psychological and 
physiological response that includes increased heart rate, blood pressure, 
respiratory rate, neuroendocrine secretion and psychological distress. 
Failure to relieve pain produces a prolonged stress state, which can result 
in harmful multisystem effects and can therefore impair a patients re-
covery and discharge (3). The primary goal of acute pain management 
in ICU patients are pain control and attenuation of the negative physi-
ologic and psychological consequences of unrelieved pain. Although, a 
number of recent surveys, reported that enhanced pain management 
was associated with improved patient outcome in the ICU (4, 5) and 
despite of pain research, guideline development, numerous awareness 
campaigns and intense educational efforts, pain remains currently under 
evaluated and undertreated in patients who are critically ill (6). There-
fore, the importance of quality pain management in the ICU is inher-
ently compelling and highly challenging. 
etiology and pain assessment in icu patients 
Although, adequate pain control is a basic human right (6), a number 
of factors complicate the management of pain in the critically ill patient. 
In particular, critically ill patients may experience pain due to their 
underlying disease or surgery, but also it may be result of various and 
painful medical procedures (procedural pain) such as inserting urinary 
catheter, nasogastric tube, chest tubes, tracheal suctioning, invasive 
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lines, (arterial and central venous catheter) suture remov-
al and routine nursing care. Nursing care procedures such 
as bathing, massage of back and pressure points, sheets 
change and repositioning are the most common painful 
procedures in ICU patients (7) Vazquez M et al. (8) ana-
lyzing pain intensity during 330 turnings in 96 medical-
surgical patients and reported significantly increased pain 
score between rest and turning. The bolus of analgesic was 
used in less than 15% of the turnings. Further, although 
some ICU patients may be able to communicate, many 
critically ill patient with cognitive or communication 
problems due to stroke or brain injury, dementia, confu-
sion, mechanical ventilation and concomitant use of 
sedatives, may have difficulty in reporting pain. Presence 
of the some causes mentioned above increases the likeli-
hood for poor pain management, and worsens a patient’s 
experience of pain. The first step in providing adequate 
pain relief for ICU patients is appropriate assessment. 
Pain should be assessed by self-reporting scales in patients 
able to communicate, or by behavioral pain scores in pa-
tients unable to communicate. Even though various self-
report pain scales and behavioral pain scales specifically 
developed for use in critically ill adults are available, these 
are not always routinely used in the ICU. Patients’self-
reporting of their pain is the gold standard of pain assess-
ment and provides the most valid measurement of pain 
(9).  The most widely used pain intensity scales are the 
Numeric Rating Scale (NRS) and Visual Analogue Scale 
(VAS) while Behavioral Pain Scale (BPS) is considered to 
be an alternative tool for assessing pain in critically ill, 
sedated, and mechanically ventilated patients. The BPS 
assesses pain through evaluation of facial expression, up-
per limb movements, and compliance with mechanical 
ventilation. A similar behavioral scale called the Critical-
Care Pain Observation Tool (CPOT) may also be used.
route of administration
The route of medication administration is an impor-
tant consideration for the pharmacologic management of 
pain in the ICU setting. Intravenous administration is 
more commonly the route of choice in critically ill pa-
tients because of altered GI tract function that could lead 
to unpredictable absorption of medication.
The choice of intermittent vs. continuous infusion IV 
administration depends on factors such as the frequency 
and severity of pain, and the pharmacokinetics of the pain 
medication. The administration in bolus is associated 
with the variation in the peak plasma concentration, since 
the infusion maintains a more stable concentration, but 
can lead to accumulation of medication especially in pa-
tients with renal or liver failure.
Patient-controlled analgesia (PCA) is an effective met-
hod for administering analgesic medication and gives 
patients a sense of control over their pain, expecialiy in 
postoperative settings. Patients can determine when and 
how much medication they receive, regardless of analge-
sic technique. However, this technique requires fully con-
scious and orientated patients which make use of PCA 
limited in ICU patients. 
Intravenous administration is generally preferred over 
subcutaneous or intramuscular routes given potentially 
inadequate absorption due to regional hypoperfusion 
(e.g., shock, subcutaneous edema). Regional or neuraxial 
(spinal or epidural) modalities may also be used in ICU 
following selected patients and selected surgical proce-
dures. Epidural analgesia (EA) is probably the most often 
used regional anaesthetic technique in the ICU. EA 
should be proposed in critically ill patients, such as post-
operative after thoracic, abdominal surgery, major vascu-
lar surgery and orthopedic surgery or trauma patients, 
typically.
The major disadvantages of epidural analgesia are the 
rare but catastrophic complications such as infection, epi-
dural hematoma formation and nerve damage, which can 
occurred in ICU patients who have a high risk of develop-
ing these complications (10). 
pharmacotherapy 
In January 2013, The Society of Critical Care Medi-
cine (SCCM) published the Clinical Practice Guidelines 
for the Management of Pain, Agitation, and Delirium in 
Adult Patients in the Intensive Care Unit (11).  Table 1. 
shows the commonly used pain management drugs and 
recommended doses. There are no data to support the 
preference of analgesic over the other. 
opioids 
Opioids are the primary medications for managing 
pain in critically ill patients because of potency, concom-
itant mild sedative and anxiolytic properties, and their 
ability to be administered by multiple routes. Recom-
mended opioids include fentanyl, remifentanil, morphine, 
and hydromorphone. The choice of opioid and the dosing 
regimen should be individualized based on drug’s po-
tency, pharmacokinetics and pharmacodynamic profiles, 
side effect profile,  patient comorbidities, and function of 
specific organ systems, in particular the liver and kidneys. 
Morphine sulfate is the most frequently used opioid in 
the ICU and has been traditionally a first-line opioid for 
the treatment of severe pain. Morphine has a half-life of 
1.5 to 2h after intravenous administration in normal sub-
jects, but in ICU patient, distribution volume and protein 
binding may be abnormal. Therefore, the patients can 
respond very differently to morphine doses in terms of the 
analgesic effect but also in terms of the side effects. Al-
though, morphine, such as all opioids, may lead to respi-
ratory depression, it is noteworthy to point out that the 
morphine-6-glucuronide metabolite is more potent than 
morphine itself, and that accumulation can occur, espe-
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cially in patients with renal impairment. Therefore, mor-
phine use should be avoided for patients with known renal 
insufficiency or failure. Side effects include histamine re-
lease, sedation, nausea, ileus, constipation, and spasm of 
the sphincter of Oddi. Morphine sulfate should be ad-
ministered intravenously and titrated to effect. The load-
ing dose of 0.05 mg/kg (2–5 mg) should be given over 5 
to 15 min. In most patients, the average maintenance dose 
is 4 to 6 mg/h and should be administered at the dosing 
interval of 1–2 hrs. Continuous IV morphine can be ad-
ministered with an initial 2–5 mg bolus dose followed by 
1 mg/h.
Fentanyl is synthetic opioid roughly 100 times the po-
tency of morphine, which does not cause histamine re-
lease and was preferred analgesic agent for critically ill 
patients with hemodynamic instability. It efficacy is due 
to its lipid solubility (600 times more lipid soluble than 
morphine), so if used > 4 hrs fentanyl must be used in the 
lowest tolerated dose to prevent prolonged effects. With 
prolonged infusion, the half-life increases dramatically 
from 30 – 60 minutes to 9–16 h and care must be taken 
to adjust infusion rate with time.
Fentanyl causes only minor hemodynamic changes 
and does not affect cardiac inotropy. The dose range for 
fentanyl infusions is variable and some patients may re-
quire higher doses. Bolus dose of 25–100 µg, with subse-
quent doses of 0.25–0.5 µg/kg every 15–30 minutes 
might be a good first alternative to morphine in treating 
acute painful conditions. Alternatively, a bolus dose of 
1–2 mcg/kg (25–100 mcg) may be administered followed 
by initiation of the continuous infusion. Most patients 
will be adequately treated with 1 to 2 µg/kg/hr (25–200 
µg/h infusion).
Remifentanil is a fast-acting drug and presents an 
equally fast recovery (11). It is 150 –200 times more potent 
than morphine. Its metabolism does not depend on the 
liver. Analgesia-based sedation with remifentanil is a use-
ful option for mechanically ventilated patients and it can 
be used in patients that need frequent neurological assess-
ment. Studies have shown a shorter duration of mechan-
ical ventilation and quicker ICU discharge with remifen-
tanil compared with other opioids (12, 13). It offers 
precise control of analgesia for painful procedures in ICU 
patients and has a highly predictable onset and offset, 
with a stable context sensitive half-time (3–10 min). No 
need for initial dose adjustment is required for patients 
with impaired renal and hepatic function. Therefore, 
analgesia-based sedation with remifentanil has been in-
troduced as an option in ICU patients. Remifentanil can 
be administrated in higher doses than are normally used 
with other opioids without concerns about accumulation 
and the possibility of unpredictable and/or delayed recov-
ery. Most ICU patients can be managed without bolus 
doses; if required, a bolus of 0.5–1 µg/kg is usually suf-
ficient. It is recommended that remifentanil infusions 
should be started at 6–9 µg/kg/h and than titrated in the 
range dose 0.5–15 µg/kg/h. Some authors recommended 
dose to 60 µg/kg/h (14). Even under these controlled con-
ditions, this practice has not found widespread use be-
cause of the associated incidence of hypotension and bra-
dycardia. 
Hydromorphone is a semisynthetic opioid agonist that, 
like fentanyl, has a more rapid onset of analgesia (within 
30 minutes) and a short half-life (2–4 hours). While the 
duration of action is similar to morphine, it does not 
stimulate histamine release. Hydromorphone is primar-
ily metabolized in the liver to an active metabolite – hi-
dromorphone-3-glucuronide, but it is not clinically sig-
nificant. Hydromorphone is potent respiratory depressant 
and may accumulate in patients with renal failure, result-
ing in neuroexcitation and cognitive impairment. Dosing 
begins at 0.2 to 0.6 mg and titrated by 0.5 mg increments. 
Most patients requiring 1 to 2 mg every 1 to 2 hrs. In 
addition, if given as an intravenous continuous infusion 
the dose should be 0,5 –3 mg/h. 
Tramadol is a centrally acting opioid-like drug, and 
acts by binding to the µ opiate receptor where it is a pure 
agonist like morphine and inhibits adrenaline and sero-
tonin re–uptake. It is used to treat moderate to severe 
pain. The most common adverse effect is typical to other 
opioids and includes nausea, vomiting, dizziness drowsi-
ness, dry mouth and headache. However, tramadol pro-
duces less respiratory and cardiovascular depression than 
morphine, and euphoria and constipation are also less 
common.
Recommended dosage of 100 mg can be administered 
as an initial bolus. During the 90 minutes following the 
initial bolus further doses of 50 mg may be given every 
30 minutes, up to a total dose of 250 mg including the 
initial bolus. Subsequent doses should be 50 mg or 100 
mg 4 to 6 hourly up to a total daily dose of 400 mg.
non-opioid analgesics 
Non-opioid analgesics are indicated for use in manage-
ment of mild to moderate pain and moderate to severe 
pain with adjunctive opioid analgesics. Potential advan-
tages of multimodal analgesia, that involves combination 
of analgesics with different mechanisms of action, include 
improved analgesia, effective analgesia with lower opioid 
doses, and decreased risk of opioid-related adverse effects.
Nonsteroidal anti-inflammatory drugs (NSAIDs) have 
opioid sparing effect but this has not been sufficiently 
investigated in ICU patients. Although the use of NSAIDs 
is still contraversial, they may be used as adjuncts to opi-
oid therapy. The most common side effect include gastro-
intestinal bleeding, renal dysfunction and inhibition of 
platelet function.
All parenteral NSAIDs should be avoided in patients 
with preexisting renal insufficiency, asthma, hypoperfu-
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sion, advanced age, concomitant use of steroids and anti-
coagulants, situations that are frequently observed in ICU 
patients (15). Treatment should be limited to the mini-
mum dosage for the shortest possible time, not to exceed 
five days.
Acetaminophen (paracetamol) was approved for intra-
venous use in 2010 and is commonly administered for the 
short-term treatment of mild to moderate pain and febrile 
critically ill patients with infection. It differs from the 
available opioids and NSAIDs, since paracetamol does 
not increase incidence of nausea, vomiting, and respira-
tory depression that can occur with opioids, or the plate-
let dysfunction, gastritis, and renal toxicity that are as-
sociated with NSAIDs. Although, represents a relatively 
good safety profile, there is limited information regarding 
IV use in critically ill patients. Research to date has des-
cribed that paracetamol can cause transient abnormaliti-
es of liver function and may cause hypotension in criti-
cally ill patients (16). Acute liver failure is the most 
serious potential complication of the use of paracetamol. 
The key criteria for assessing potential hepatotoxicity with 
conventional doses of paracetamol may include hypoxic 
injury, altered pharmacokinetics, relative over-dosage, 
muscle glutathione depletion, malnutrition, dehydration, 
older age and alcoholism which is often seen in critically 
ill patients. The British National Formulary (BNF) sug-
gests to administer a maximum daily infusion dose of 3 g 
in adults in these patient groups (17).
Randomised, placebo-controlled trial that investiga-
ting the safety and efficacy of paracetamol in febrile ICU 
patients with known or suspected infection is currently 
underway study (the HEAT -Permissive HyperthErmiA 
Through Avoidance of Paracetamol in Known or Suspec-
ted Infection in the Intensive Care Unit) (18). The results 
of this trial are expected to publish in early 2015 and 
should provide essential information on efficacy and 
safety of paracetamol in febrile critically ill patients. The 
recommended dose for IV acetaminophen is 1 g every 6 h 
with a maximum allowable dose of 4 g/daily.
Lidocaine is commonly used for regional anesthesia 
and nerve blocks, however, recent clinical studies demon-
strated that intravenous perioperative administration of 
lidocaine can lead to better postoperative analgesia, re-
duced opioid consumption, improved intestinal motility 
and decrease hospital length of stay (19, 20). Although, 
the analgesic effect depend on dose, there is considerable 
individual variability in pharmacokinetic response to li-
docaine infusions. Serum steady state is achieved fo-
llowing a bolus of 1.5–2.0 mg/kg of lidocaine and infu-
sion rates of 0.9–3.6 mg/kg/h. These doses generally result 
in plasma levels of 1.3–3.7 μg/ml, which provide a small 
Table 1





Suggested Dosage Comments 
Morphine 2-4 h 30 min 2-5 mg bolus 
1-10 mg/h infusion
Avoid in hemodynamically unstable patients. Active 
metabolite accumulates in renal dysfunction. May 
cause itching due to histamine release.
Fentanyl 2-5 h 4 min 25-100 μg bolus 
25-200 μg/h infusion
Fastest onset and shortest duration. Accumulation 
with hepatic impairment.  Muscle rigidity.
Remifentanil 3-10 min 1-3 min 0.5-1 mcg/kg IV bolus 
0.5-15 μg/kg/h infusion
No accumulation in hepatic/renal failure. Use IBW if 
body weight >130% IBW
Hydro-
morphone
2-4 h 20 min 0.5-2 mg bolus and 0.2 to  
0.6 mg every 1-2 h intermittent 
0.5-3 mg/h infusion
Therapeutic option in patients tolerant to morphine/
fentanyl. Accumulation with hepatic/renal impairment 
5-10x more potent than morphine.
Tramadol 5-6 h 45 min 100 mg bolus and 50 mg every 
30 min up to 250 mg including 
the initial bolus. 
total daily dose of 400 mg.
The elimination of tramadol may be prolonged in 
hepatic/renal impairment 
Contraindicated in patients on MAOI or epilepsy.
Acetamino-
phen
2-3 h 15 min 1 g every 6 h May cause hypotension when given by infusion and 
may cause liver and kidney damage, when taken at 
higher than recommended doses (overdose).
Lidocaine 1,5-2 h 45-90 s 100 mg or 1.5–2 mg/kg at least 
half an hour before surgical  
incision, followed by an 
infusion of 1.33–3 mg/kg/h 
intraoperatively
Avoid in patients with arrhythmias, heart failure,  
coronary artery disease, Adams-Stokes, or heart blocks. 
Caution should be taken in patients with hepatic 
or renal failure, sinus bradycardia and incomplete 
branch block.
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marigin of safety. Large doses have better analgesic effect 
but induce systemic lidocaine’s toxicity. Lidocaine induces 
analgesia when serum ranges are kept at 1–5 µg/m. Al-
though the half-life of the drug is only 120 minutes, the 
analgesia provided by systemic lidocaine is prolonged, 
over days or even weeks. With regard to analgesia, it has 
been reported that intravenous lidocaine produces three 
different pain relief stages: the first is during infusion and 
30 to 60 minutes after its end; the second is a transient 
stage approximately 6h after infusion; and the third stage 
appears 24 to 48h after infusion and continues for 21 to 
47 days (21). Intravenous lidocaine should not be used in 
patients with arrhythmias, heart failure, coronary artery 
disease, Adams-Stokes, or heart blocks. Caution should 
be taken also when using lidocaine in patients with he-
patic or renal failure, sinus bradycardia, and incomplete 
branch block since possible accumulation of lidocaine or 
its metabolites may lead to toxic phenomena.
Although there is no clear consensus on the dosage 
regimen, many studies have used a bolus dose of 100 mg 
or 1.5 mg/kg at least half an hour before surgical incision, 
followed by an infusion of 1.33–3 mg/kg/h intraopera-
tively and continued after operation variably up to 24 h. 
The application of continuous lidocaine has not been 
documented in the ICU in controlled studies and more 
study is needed to confirm beneficial effects of lidocaine 
in critically ill patients.
regional anesthesia and analgesia
Regional anesthesia and analgesia although, not com-
monly used as a primary modality for analgesia in criti-
cally ill patients, can help to improve respiratory and 
bowel function, mental status and patient comfort second-
ary to its opioid-sparing effects. It minimizes patient dis-
comfort and reduces the physiological and psychological 
stress, as in non-critical patients.  Limitations for the use 
of regional anesthetic techniques are mainly associated 
with bleeding risks, coagulation disorders, hemodynamic 
disturbances and difficulties in neurologic assessment. The 
use of regional analgesia in the ICU settings should evalu-
ate the risk and benefits due to limited cooperation of the 
patient, and the indication for it use should be carefully 
assessed regarding to patients clinical condition. 
As mentioned above, epidural analgesia is probably the 
regional anaesthetic technique most often used in the 
ICU, but nerve blocks and other sophisticated techniques 
started in the operating room may also be used for pain 
relief in critically ill patients and should not be discontin-
ued when the patient is transferred to ICU. 
conclusion
Pain management is an essential component of quality 
care delivery for the critically ill patient. The patients in 
ICU often suffer from undertreated and unrecognized 
pain, with potentially serious physical and psychological 
effects. The availability of a wide range of treatment op-
tions together with the recognized importance of adequ-
ate management enables better understand, evaluate and 
manage pain in the critically ill patient. It’s therefore im-
portant for clinicians to recognize a patient’s pain profile 
and rational choice of pain medication should be based 
upon individual needs and desired effect of analgesic. Ef-
fective pain management is a moral imperative and pro-
fessional responsibility for both doctors and nurses.
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Neuropathic orofacial pain – diagnostic  
and therapeutic challenges
Abstract
Chronic neuropathic orofacial pain (OFP) is the leading symptom for a 
wide range of conditions. It can exist independently of any addition signs, 
symptoms and radiological or laboratory abnormalities. In addition to 
physical suffering, OFP causes emotional, psychological and social distur-
bances and thus significantly influences the quality of life of those affected. 
Several key factors make OFP a complex diagnostic and therapeutic chal-
lenge. These include a lack of diagnostic criteria that are both validated and 
readily applicable in clinical settings and a lack of sufficient education about 
pain in undergraduate medical training programs. There is also a need to 
develop more analgesic therapies offering improved efficacy and side effect 
profiles. Finally, the provision of analgesic therapies by health insurance 
programs need to be harmonized with the most current evidence-based treat-
ment protocols. In addition to offering recommendations in these areas, this 
paper provides an overview of the most common clinical forms of nonodon-
togenic OFP, epidemiological data, and current diagnostic and therapeutic 
options.
introduction
Pain is one of the most unpleasant aspects of many diseases. To under-score the importance of pain as a global health problem, the Interna-
tional Association for the Study of Pain (IASP) launched its first “Global 
Year Against Pain,” in 2004 with the slogan; Pain management should be 
a human right. Each IASP annual campaign is dedicated to the study of 
pain arising from particular conditions or etiologies. For example, 2013 
marked the year against chronic pain, whereas orofacial pain was the 
focus in 2014, which was followed by a year against neuropathic pain in 
2015 (1). Such campaigns help raise awareness for the many ways in which 
various types of pain effect health, ranging from a vital warning sign to 
a debilitating condition. Acute pain, which signals the occurrence of in-
jury or disease, provides an important protective function. Conversely, 
chronic pain provides no real or potential benefits, resulting only in un-
necessary suffering. This is particularly true of neuropathic pain, an im-
portant component of numerous medical conditions (2). Whatever its 
origin, pain is recognized globally as one of the primary reasons for seek-
ing medical attention. The pain suffered by individuals creates not only 
personal but also societal costs. Communities are burdened with both 
the direct costs of healthcare utilization and the indirect costs of reduced 
worker productivity and increased absenteeism due to pain. 
One of the most significant sources of pain in the human body is the 
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The orofacial region also has great psychological signifi-
cance as the center for chewing, swallowing, speech pro-
duction, communication and personal expression (4). 
Therefore, chronic pain is associated with additional emo-
tional, psychological and social disturbances when located 
in the orofacial region. These changes significantly affect 
the quality of life of those living with chronic orofacial pain 
(OFP) (5). The global prevalence of orofacial pain is esti-
mated at 17–26%, with 7–11% of patients experiencing 
chronic OFP (6). It is not known what share of this per-
centage is attributable to neuropathic pain, an important 
causative factor in many OFP conditions. The prevalence 
of orofacial and chronic pain can reasonably be expected 
to increase as demographics shift toward longer life expec-
tancies. An aging population includes an increased number 
of patients living with chronic and painful conditions such 
as diabetes and cancer. Aging also results in increased ex-
posure to therapeutic methods for these and other condi-
tions that can result in neuropathic pain. Such an increas-
ing potential for chronic and orofacial pain creates the need 
to consider a range of likely consequences, not least of 
which is the impact on quality of life (6, 7). 
The causes and mechanisms of chronic pain are not 
entirely clear, although risk and precipitating factors have 
been identified for the majority of conditions. A large 
body of evidence shows that pain is often inadequately 
treated. Over time, continuous pain symptoms alter neu-
roplasticity and may cause hyperexcitability, changes that 
lead to the development of chronic pain (5). Thus, un-
abated neuropathic pain can become a neurological dis-
order or dysfunction of the central nervous system (CNS), 
in much the same way as epilepsy or Parkinson’s disease. 
These changes to the CNS pain signaling pathways hinder 
the effectiveness of therapies aimed at alleviating the 
symptoms of chronic pain.
nonodontogenic neuropathic  
orofacial pain
A diagnosis of nonodontogenic neuropathic orofacial 
pain can only be made after eliminating the teeth as the 
potential source of pain. Odontogenic OFP arises from 
tooth damage or decay and is often localized to the oral 
cavity. It can also occur in the region of the face that is 
above the neck, in front of the ears,  and below the orbi-
tomeatal line. If dental caries, poor fillings, trauma, and 
dental fractures have all been eliminated as the source of 
pain, OFP is considered unrelated to teeth and is therefore 
referred to as nonodontogenic. Additional findings related 
to the distribution and timing of pain may help confirm 
its origin. Nonodontogenic pain is often treatment resis-
tant, even with the use of local anesthetics and is prone to 
developing into a chronic condition (8). Additionally, pain 
that is bilateral or simultaneously encompasses multiple 
teeth is likely to be of a nonodontogenic origin (9). 
Nonodontogenic neuropathic OFP shares many of the 
characteristic features recognized in other forms of neu-
ropathy. Neuropathic pain arises from peripheral and 
central changes in neuronal function that are perceived as 
persistent pain and sensory abnormalities. Permanent loss 
or injury of primary afferent fibers, a process referred to 
as deafferentation, results in peripheral neuropathic pain. 
Central neuropathic pain, however, arises from direct 
damage to the structure of the central nervous system (10). 
The timing and duration of symptoms are characteristic 
of neuropathic pain, which can be both episodic (or par-
oxysmal) and continuous. While some patients experience 
complete relief from pain symptoms between episodes, 
others can experience paroxysms of pain as an acute exac-
erbation of an otherwise continuous pain syndrome (4). 
While some causes of OFP may be difficult to discern, a 
careful history including the duration and nature of symp-
toms can pinpoint a likely etiology. For example, pain 
described as continuous and burning is typical of neuritis 
and post-traumatic neuropathy. Neuropathy most often 
manifests as repeated, episodic attacks of short stabbing 
or shooting pain. The onset of these episodes can be either 
spontaneous (or stimulus independent) or provoked by 
stimuli. Pain is intensified by the stimulation of trigger-
points or individual muscles. Pain can also be increased 
by emotional stress, physical activity, changes in the posi-
tion of the head and so on. Neuropathic pain is often 
accompanied by additional sensory signs and symptoms 
such as allodynia, pain provoked by a stimulus (as a light 
touch of the skin) which would not normally provoke 
pain. Thermal and mechanical stimuli are the types most 
often associated with provoking allodynia. Hyperalgesia, 
an increased sensitivity to painful stimuli, is another char-
acteristic positive sign. Negative signs, such as hypoalgesia 
and hypoesthesia, can also indicate a neuropathic etiology. 
While many of these signs can be elucidated from patient 
history, the full range of sensory changes experience by an 
individual patient is best assessed using quantitative sen-
sory testing. This non-invasive method relies on the selec-
tive response of specific types of nerve fibers to particular 
stimuli. Given that A-beta fibers are selectively stimulated 
by electricity, A-delta fibers respond to cold or punctate 
mechanical stimuli and C-fibers are stimulated by heat, 
these types of stimuli are applied externally to selectively 
stimulate and record a response from each type of nerve 
fiber. The area from which neuropathic pain and sensory 
changes are elicited represents the receptive field of a par-
ticular nerve, allowing identification of the involved nerve 
or nerve root. Pain in the head and neck is mediated by 
the upper cervical spinal roots, the intermediate, glosso-
pharingeal and vagus nerves, along with sensory fibers 
from the trigeminal nerve (11). 
trigeminal neuralgia
The most common orofacial clinical entity involving 
underlying neuropathic pain is trigeminal neuralgia 
(TN). Trigeminal neuralgia; also known as tic doulou-
reux, Fothergill disease and suicide disease; is estimated to 
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affect 4–13 people per 100,000 population (11–13). It 
occurs at a rate of about 15,000 new cases per year in the 
US (14). TN can occur at any age, including childhood, 
but the incidence generally increases with age. Idiopathic 
cases are the most common after the age of 50 (15). Con-
sidered a natural consequence of their longer life expec-
tancies, women are about 1.5 times more likely to experi-
ence TN (14). Although the disease is more common in 
some families, 80–90% of TN is sporadic (16) and at-
tributable to aberrant loop arteries or veins compressing 
the trigeminal root (17–19). This frequent etiology makes 
trigeminal neuralgia due to vascular compression (10) 
considered “classical” idiopathic trigeminal neuralgia. 
Secondary TN arises from compression by other struc-
tures, such as an acoustic neuroma, meningioma, epider-
moid cyst, aneurysm or AV malformation (10, 20–26). 
Although all three branches of the trigeminal nerve may 
be involved, TN is usually limited to one or two branch-
es. The second and third trigeminal branches are those 
most commonly affected by TN. The first branch of the 
trigeminal nerve is affected in only about 5% of TN 
cases, usually due to herpes zoster infection. The pain of 
trigeminal neuralgia is usually unilateral, sudden, severe, 
and sometimes described as lightning–like. Pain may be 
bilateral, but both sides are not usually affected at the 
same time (14). TN is often accompanied by paresthesias, 
such as burning and shock-like sensations. Pain and par-
esthesia symptoms can be provoked by chewing, talking, 
brushing teeth, cold air, laughing, light touch, smiling or 
any other stimulation of trigger-points around the nose 
and mouth. As is typical of allodynia, the pain induced 
by trigger-points is usually disproportionate to the stimu-
lus, such that a mild stimulus causes severe pain. Notably, 
injection of local anesthetic at trigger-points is usually 
effective in providing pain relief. The pain of trigeminal 
neuralgia typically occurs as episodic attacks ranging in 
duration from a few seconds to several minutes. Whereas 
the pain typically subsides completely between episodes, 
some patients with long-standing TN experience pain 
continuously between paroxysms. Although the course of 
the disease is unpredictable, symptomatic periods of fre-
quent TN paroxysms generally occur over the course of 
weeks or months, followed by periods of remission. The 
course of the disease for some patients tends toward un-
remitting pain while others experience a decrease in fre-
quency and intensity of TN symptoms. Patients with 
trigeminal neuralgia are generally able to sleep through 
the night without suffering paroxysms of pain. 
The diagnostic criteria for classical trigeminal neural-
gia described in the Third International Classification of 
Headache Disorders (ICHD-3) of the International 
Headache Society (IHS) (10) are based on the timing, 
characteristics and distribution of OFP. Classic TN pres-
ents as paroxysmal pain that is intense, sharp, superficial, 
stabbing, or was precipitated from stimuli at trigger-
points and lasts up to two minutes. The pain involves one 
or more branches of the trigeminal nerve and is not as-
sociated with any other disease. In addition, attacks are 
stereotyped in individual patients who have no clinically 
evident neurological deficit. 
The ICHD-3 diagnostic criteria for secondary (or 
symptomatic) trigeminal neuralgia require that anything 
other than vascular compression causes the spectrum of 
symptoms associated with TN. One distinctive clinical 
feature of the secondary form is that it lacks a refractory 
period after paroxysms (10). Potential causes of secondary 
TN include acute herpes zoster, postherpetic neuralgia, 
trauma, multiple sclerosis plaques, and other non-vascular 
compressive lesions. Post-traumatic trigeminal neuropa-
thy, or anesthesia dolorosa, is an important cause of sec-
ondary TN that is defined by the ICHD-3 (10) as one-
sided pain of the face or oral cavity in a patient with a 
history of verified mechanical, chemical, thermal or radi-
ation-induced trauma in the same area of  the trigeminal 
nerve associate with symptoms. The pain must appear 
within three to six months after the traumatic event, and 
is not better characterized by another ICHD-3 diagnosis. 
The pain of post-traumatic TN must also be associated 
with clinically apparent positive or negative signs of tri-
geminal nerve dysfunction. Positive signs such as hyper-
algesia and allodynia may coincide with negative signs 
such as hypoesthesia and hypoalgesia. The clinical finding 
of pain in a facial area where the sensation is either miss-
ing or impaired is characteristic of anesthesia dolorosa. 
Patients can find this mix of positive and negative symp-
toms difficult to explain, making a careful clinical his-
tory especially important in identifying causes of central 
pain such as post-traumatic TN.
While the precise mechanism remains to be fully eluci-
dated, the symptoms associated with trigeminal neuralgia 
are likely due to demyelination in the area of  compression 
or damage (27, 28). Demyelination also occurs in multiple 
sclerosis and other structural lesions of the brain stem, mak-
ing these an important part of the differential diagnosis 
(29–32). Demyelinated areas can generate ectopic impuls-
es that contribute to abnormal nerve conduction (17). Such 
alteration of afferent inputs can disinhibit pain pathways 
in the spinal trigeminal core. Evidence supporting involve-
ment of central pain mechanisms includes the occurrence 
of a refractory period after triggered episodes of pain (29). 
During the refractory period, which usually lasts a few 
minutes, a paroxysm of pain is not possible. The complex 
mechanisms involved in the development and presentation 
of trigeminal neuralgia require a range of specialists includ-
ing dentists and neurologists be included in a multidisci-
plinary approach to its diagnosis and treatment. 
herpes zoster and postherpetic 
neuralgia
Herpes zoster may cause pain with neuropathic char-
acteristics in the area innervated by one of the facial 
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nerves. Systemic and topical analgesics may help but are 
usually insufficient for providing complete pain relief. The 
onset of pain from herpes zoster often precedes the occur-
rence of the vesicular rash and can persist even months 
after the lesions are no longer visible. The diagnosis of 
OFP due to herpes zoster is often difficult, particularly 
before the appearance of the characteristic rash. The pri-
mary factor confounding a clear diagnosis is that herpes 
zoster can mimic dental pain. Reliable laboratory tests for 
the unambiguous diagnosis of herpes zoster OFP have not 
yet been developed. Early diagnosis and treatment may 
help prevent the development of postherpetic neuralgia 
(PHN), a condition in which pain endures at least one 
month after the herpes zoster rash has healed. The pain is 
usually a continuation of that experienced before and dur-
ing the acute herpes zoster skin eruption. While it usu-
ally lasts up to six months, PHN can continue for years 
after the rash has healed. 
Atypical odontalgia
Atypical odontalgia is characterized by constant pain 
after removal of a tooth, tooth apex, or dental pulp. Also 
known as idiopathic, or phantom, toothache, this condi-
tion can also be caused by facial trauma. Studies have 
shown that atypical odontalgia appears in 3–6% of pa-
tients after endodontic treatment. In atypical odontalgia, 
a throbbing ache is experienced in the area of a tooth or 
alveolar process over prolonged periods. The sensation 
may be intermittent or constant, and persists despite a 
lack of clinical and radiographic evidence that would in-
dicate a disorder related to the teeth. Patients may have 
difficulty localizing the pain, which is usually more in-
tense on the side where the trauma or dental procedure 
occurred. The pain may spread into adjacent areas unilat-
erally and bilaterally, with the teeth most frequently af-
fected being the upper premolars and molars. Local an-
esthesia can, but does not necessarily, alleviate the pain. 
Unfortunately, the symptoms of atypical odontalgia are 
often untreated as they are mistaken for a normal re-
sponse to the treatment or trauma that precipitated this 
OFP condition.
Glossopharyngeal neuralgia
Glossopharyngeal neuralgia is an infrequent disorder 
that is likely due to compression of the glossopharyngeal 
or upper portions of the vagus nerve. Damage to these 
nerves is suggested by asymmetry in the movement of the 
soft palate and uvula or the absence of the emetic reflex 
(33).  Glossopharyngeal neuralgia manifests as paroxys-
mal pain in the area innervated by the  9th and 10th cra-
nial nerves and is most often experienced as pain in the 
throat, particularly when chewing and swallowing (10, 
34). The pain, which is usually unilateral, can encompass 
the pharynx, base of the tongue, and the area inferior to 
the angle of the mandible and ear. The pain may encom-
pass the receptive field of the auricular and pharyngeal 
branches of the vagus nerve. Bilateral involvement is pos-
sible and occurs in about 12% of patients (35). The ca-
rotid arteries should be examined for pathological chang-
es such as arterial dissection, before considering other 
potential sources of pain in this region. If the teeth, ears 
and carotid arteries have been eliminated as the source of 
pain, glossopharyngeal neuralgia should be considered in 
the differential diagnosis. Trigeminal neuralgia, which is 
70 to 100 times more common than glossopharyngeal 
neuralgia, can occur as a comorbid condition .  
The pain of glossopharingeal neuralgia is usually pro-
jected from the oropharynx to the ear. It is usually parox-
ysmal and intense, but can be superimposed on a con-
stant, less severe pain. Attacks may occur several times 
per day and may even arouse the patient from sleep. The 
ICHD-3 diagnostic criteria for glossopharyngeal neural-
gia requires at least three attacks of unilateral pain, in the 
base of the tongue, tonsillar fossa, pharynx, below the 
angle of the mandible or ear in patients without evident 
neurological deficit (10). Glossopharyngeal neuralgia oc-
curs in paroxysmal attacks of strong, sharp, stabbing, or 
throbbing pain that lasts up to two minutes. Movements 
such as swallowing, coughing, talking or yawning can 
induce paroxysms of pain. Such findings, if not better 
characterized another ICHD-3 diagnosis, confirm a di-
agnosis of glossopharyngeal neuralgia. As with trigeminal 
neuralgia, glossopharyngeal neuralgia exists as either a 
primary or a secondary OFP condition. Secondary glos-
sopharyngeal neuralgia can be caused by demyelinating 
lesions, tumors in the cerebellopontine angle, peritonsillar 
abscess, aneurysm of the carotid artery, Eagle’s syndrome, 
(36–39) and vascular compression of the vertebral artery 
or rear lower cerebellar artery. Similar to trigeminal neu-
ralgia, episodes of glossopharyngeal neuralgia can last for 
weeks or months, punctuating long periods of remission. 
A key diagnostic feature, glossopharyngeal neuralgia is 
the only cranial neuralgia in which painful afferent im-
pulses can precipitate a cardioinhibitory reflex causing 
vagal bradycardia, asystole and syncope (34, 40). This 
symptom must be distinguished from cardiac pain that 
radiates to the orofacial area, such as may occur with 
sickle cell anemia and some neoplasms. It should be not-
ed that pain resembling that of glossopharyngeal neural-
gia can also be of traumatic, postoperative, and psycho-
genic origin. Also included in the differential diagnosis of 
glossopharyngeal neuralgia are several rare disorders such 
as neuralgia of the intermediate nerve, occipital neuralgia, 
optic neuritis, headache due to ipsilateral ischemic lesions 
of the oculomotor nerves (III, IV and VI), Tolosa Hunt 
syndrome, Raeder’s syndrome, recurrent painful ophthal-
moplegic neuropathy, neuralgia of the superior laryngeal 
nerve, burning mouth syndrome, persistent facial pain, 
temporal arteritis and carotidynia. Although uncommon, 
glossopharyngeal neuralgia is an important consideration 
in the differential diagnosis of OFP.
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diagnostic approach to ofp
Multiple factors contribute to the diagnostic and ther-
apeutic challenges related to orofacial pain, making a 
multidisciplinary approach essential to the treatment of 
this disorder.  OFP may arise from a variety of tissues in 
the face and head, including the meninges, cornea, dental 
pulp, oral mucosa, nasal mucosa and temporomandibular 
joint. So, the many pathophysiological mechanisms giv-
ing rise to orofacial pain is reflective of the diverse tissue 
types in which it originates. A lack of validated diagnostic 
criteria is one of several obstacles to improving care for 
patients, but also in translational research. Although ef-
forts have been made in the classification of patients with 
temporomandibular joint disorder (41), headache (42) 
and orofacial pain (43), clinical trials indicate that the 
results of pharmacological, electrophysiological and imag-
ing studies have not yet provided sufficient means for the 
comprehensive diagnosis of orofacial pain (44, 45). 
Screening questionnaires, such as the Leeds Assessment 
of Neuropathic Symptoms and Signs (LANSS), Neuro-
pathic Pain Diagnostic Questionnaire (DN4), Neuro-
pathic Pain Questionnaire (NPQ) and others, can help 
in the identification of neuropathic pain, but conclusive 
results require assessment of questionnaire findings in 
light of the clinical examination and other diagnostic 
methods. Despite its format, the optimal diagnostic tool 
should distinguish neuropathy from other OFP etiologies. 
Another factor potentially contributing to diagnostic and 
therapeutic failure is insufficient education about pain in 
medical education programs. Anecdotal evidence of such 
a shortcoming was recently confirmed in a study of 242 
medical schools from 15 European countries. The authors 
found that 82% of medical programs do not include a 
separate, compulsory course on pain in the curriculum. 
In schools that do dedicate coursework specifically to the 
study of pain, students only receive an average of 12 elec-
tive or mandatory educational hours on pain manage-
ment, equating to only 0.2% of the overall educational 
program (46). A similar proportion of medical education 
in the United States and Canada is dedicated to the man-
agement of pain conditions (5).
The development and management of analgesic thera-
pies presents another area of future improvement. While 
there has been significant progress in the identification of 
pathophysiological mechanisms underlying acute and 
chronic pain, this knowledge has not led to the develop-
ment of new analgesic or coanalgesics which are more 
efficient, safer or have fewer side effects. In the treatment 
of most chronic neuropathic pain conditions, opioid and 
non-steroidal anti-inflammatory drugs (NSAIDs) remain 
the therapies most frequently  prescribed in clinical prac-
tice (47).  The use of these drugs is very often limited 
because of the risk for abuse of opioids and the gastroin-
testinal, renal and cardiovascular side effects associated 
with NSAIDs (48, 49). Other therapies more specifically 
targeting neuropathic pain are included as the accepted 
standard of care in algorithms published by professional 
organizations. These include tricyclic antidepressants, se-
rotonin reuptake inhibitors (SSRIs), selective serotonin 
norepinephrine reuptake inhibitors (SSNRI), anticonvul-
sants, topical lidocaine, topical capsaicin, intrathecal opi-
oids, corticosteroids and ziconotide. This variety of ther-
apies offers clinicians the potential to utilize drugs whose 
mechanisms of action more specifically targets the par-
ticular pathophysiological processes underlying a given 
pain condition. Most of these therapies act on specific 
neurotransmitters involved in pain pathways, providing 
a sound theoretical basis for their use in the treatment of 
neuropathic and nociceptive pain. Tramadol, for example, 
provides opioid-like activity and also modulates seroto-
nergic and noradrenergic systems. Antidepressants also 
provide pain relief through the modulation of select neu-
rotransmitters while also helping to alleviate symptoms 
of depression, a frequent comorbid condition for those 
suffering from chronic pain. Among the oldest drugs in 
this therapeutic group, tricyclic antidepressants (TCAs) 
appear to modulate pain by potentiating the antinocicep-
tive roles of serotonin and norepinephrine. The activity of 
both of these neurotransmitters has been shown to be 
enhanced by the TCA amitriptyline, the drug most com-
monly used when an antidepressant is included in the 
treatment of chronic pain. The efficacy of newer antide-
pressants varies according to class. While SSRIs have been 
shown to be less effective than TCAs in treating neuro-
pathic pain, SSNRIs are more effective being recom-
mended as the drug of choice in some guidelines (50). If 
medication management fails, then surgical procedures 
may be considered, such as a microvascular decompres-
sion to remove pressure from the trigeminal or glossop-
haryngeal nerve, radiofrequency thermocoagulation, 
gamma knife radiosur gery, or rhizotomy (51, 52).
Potential barriers to proper pain treatment were un-
derscored by the results of a recent study in Croatia. The 
cross-sectional controlled study was conducted on 100 
patients with chronic neuropathic orofacial pain of non-
odontogenic origin. The results confirmed previous find-
ings that pain imparts a significant effect on quality of 
life as measured by standardized parameters (53). The 
study also revealed that the treatment of chronic neuro-
pathic pain is not in accordance with recommendations 
from IASP, European Pain Federation EFIC or The Cro-
atian Pain Society. The study found that 61% of patients 
used NSAIDs and another 34% of patients used the 
weak opioid tramadol alone or in a fixed combination 
with paracetamol. Only 20% of the study participants 
were receiving an anticonvulsant. Medicines from the 
group of strong opioids, tricyclic antidepressants, corti-
costeroids and spasmolytics were not used by any respon-
dent. An insignificant number of patients reported using 
some other treatment, such as acupuncture or biofeed-
back. Some respondents were not receiving any ongoing 
therapies. 
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It can be concluded from this study that the majority 
of neuropathic pain treatments administered in Croatia 
are not in accordance with current guidelines. This may 
be largely explained by administrative restrictions on drug 
prescriptions. Physicians nationwide are largely guided in 
their choice of drug therapy by the extent to which spe-
cific medications are fully covered by the Croatian Health 
Insurance Fund. 
conclusion
The future of orofacial pain treatment depends on the 
development of several key areas. Firstly, further research 
is required to firmly establish a comprehensive, sensitive 
and specific diagnostic classification scheme for all types 
of orofacial pain. This tool should integrate quality of life 
indicators such that they provide additional data on clin-
ical outcomes (54). Additionally, the curriculum of study 
for doctors of both medicine and dentistry should include 
an increased number of educational hours devoted spe-
cifically to the treatment of pain. Finally, health policy 
should be harmonized such that the guidelines for pre-
scribing medications established by insurance providers 
match the most recent evidence-based recommendations 
for the treatment of neuropathic pain.
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Ultrasound use for nerve blocks and management 
strategies in outpatient surgery
introduction
Advances in surgical technique favoring minimally invasive ap-proaches and economic pressure to reduce hospital costs have led 
to a worldwide increase in the number of surgeries performed on an 
ambulatory or day-case basis, with patients admitted to the hospital on 
the day of surgery and discharged several hours later.
That trend is most pronounced in the United States, where the major-
ity of surgeries are being performed as day-cases and a similar trend is 
expected in surgical centers across Europe as well. 
The challenge for the anesthesiologist is to provide anesthesia that 
will combine pain and stress-free surgery with rapid recovery and good 
postoperative pain control to enable the patient to be discharged from 
the hospital capable of self-care in a home environment. Anesthesia re-
lated factors including insufficient postoperative pain control, drowsi-
ness and postoperative nausea and vomiting (PONV) have been identi-
fied to be among the main reasons for delayed discharge and unplanned 
readmission after ambulatory surgery (1, 2).
Although ambulatory procedures are considered to be minor surgical 
interventions, a significant proportion of patients still experience mo-
derate to severe pain after these procedures (3), especially after orthope-
dic surgery.
Regional anesthetic techniques have been shown to significantly re-
duce pain scores, postanesthesia care unit utilization, postoperative 
nausea and vomiting (PONV) and need for opioid rescue analgesia 
compared to general anesthesia in patients undergoing ambulatory sur-
gery (4). Although it is reasonable to assume this should translate into 
earlier home readiness and shorter total hospital stay, such an advantage 
has not been consistently demonstrated for regional anesthesia in the 
ambulatory setting.
Introduction of ultrasound guidance for peripheral nerve block per-
formance and perineural catheter placement has led to a reduction in 
block performance time, volume of local anesthetic administered and 
less intravascular injections, and resulted in lower need for opioid rescue 
analgesia compared to neurostimulation guided techniques (5, 6,7) 
however reduced overall complication rates compared to traditional 
techniques could not be demonstrated (8). 
Ultrasound guidance is also used to facilitate the performance of 
blocking deeper lying neural structures (e.g. paravertebral blocks), how-
ever these procedures involve a greater risk of potentially serious com-
plications such as pneumothorax or deep hematoma formation and the 
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benefit of their use in ambulatory patients should be care-
fully weighed against these risks (9).
Orthopedic procedures involving upper and lower ex-
tremities are ideally suited to be performed using easy to 
learn regional procedures providing excellent operative 
anesthesia as well as postoperative analgesia.
GenerAl principles
Depending on type of surgery, patient and surgeon 
preference, regional nerve block techniques can be used 
as the sole anesthetic or can be combined with sedation 
or general anesthesia to improve patient comfort and pro-
cedure tolerance. If the later is the case, care should be 
taken to choose sedative/anesthetic drugs which will al-
low for rapid recovery of consciousness and carry a mini-
mal risk of postoperative nausea and vomiting (10). If 
airway patency maintenance is an issue a laryngeal mask 
airway device may be preferable to endotracheal tube 
placement since it does not require the administration of 
muscle relaxant agents and is better tolerated by the pa-
tient reducing or precluding the need for intraoperative 
opioid administration.
Regional blocks should be performed prior to the pro-
cedure even if combined with general anesthesia, since 
they have significant opioid sparing effects, enhancing 
patient recovery by reducing opioid related side effects 
such as PONV, respiratory depression and drowsiness. 
Performance of regional anesthetic techniques has 
been associated with increased induction times compared 
to general anesthesia (4) and therefore if possible, to re-
duce operation room occupancy, should be performed 
outside the OR in a dedicated “block room” or in front of 
the OR while it is being prepared in between patients.
If postoperative neurologic assessment is an issue then 
a perineural catheter should be placed prior to the proce-
dure and a bolus of short acting or dilute long acting local 
anesthetic used to cover the operative period and allow 
for quick block resolution thereafter. After return of mo-
tor and sensory function and postoperative neurologic 
evaluation is completed a bolus of long acting local anes-
thetic can be administered to provide prolonged postop-
erative analgesia and the catheter removed before dis-
charge from hospital or the patient discharged home with 
a portable pump delivering a continuous infusion of local 
anesthetic solution. 
There are different types of portable pumps that can 
be used in an ambulatory setting. Simple dispensable elas-
tomeric pumps deliver a fixed rate of local anesthetic and 
are easy to use not requiring any special intervention by 
the patient after being set up. Using more complex pro-
grammable mechanical pumps the delivery rate of LA can 
be adjusted and boluses administered as needed according 
to variations in pain intensity and the need for mobiliza-
tion and performance of daily activities. Pumps can be set 
up to allow re-programming by the patient with limits set 
to maximum infusion rate and number of boluses admin-
istered or can be remotely controlled by medical staff after 
being contacted by the patient. Besides theoretical advan-
tages, there is no clear evidence to show superiority of 
re-programmable pumps over modern fixed rate delivery 
systems (11, 12, 13).
The lowest concentration of local anesthetic providing 
satisfactory analgesia should be chosen for continuous 
infusion, ideally allowing for at least partial preservation 
of motor function (e.g. ropivacaine 0.2% or bupivacaine 
0.0625%-0.125% at 6-8ml/hr for upper extremity blocks 
and 4-6 ml/h for lower extremity blocks).
If local organizational issues and safety concerns pre-
clude the use of continuous regional techniques in ambu-
latory patients, single shot nerve block duration can be 
prolonged by the use of adjuvants such as dexamethasone.
Clear and easy to follow institutional protocols must 
exist for ambulatory patients discharged with a regional 
block in place. Motor and sensory function should be 
documented prior to block placement and at discharge 
and the patient receive verbal as well as written instruc-
tions on precautions necessary to protect the insensate 
body region. An immobilizing device as a simple sling or 
orthosis should be provided to prevent injuries to the up-
per extremity and crutches and/or locked orthosis to allow 
ambulation and weight bearing with an insensate or 
weakened lower limb.
If a perineural catheter is placed the patient should be 
instructed on proper care and how to remove it once the 
infusion runs out. Ideally the catheter should be removed 
by medical personnel and documented, however this may 
impose further organizational and economic burdens and 
a simple telephone interview to receive patient feedback 
may be sufficient and preserve cost-effectiveness and pa-
tient satisfaction (14).
Regardless whether the patient is discharged with a 
single shot or continuous nerve block, clear instructions 
must be provided to manage breakthrough and pain after 
the block wears off. A multimodal oral regimen combin-
ing paracetamol and nonsteroidal anti-inflammatory 
drugs (NSAIDs) or selective COX-2 inhibitors with tra-
madol for more severe pain is appropriate for the first 3-5 
postoperative days. Ideally a basal oral regime of 
paracetamol should be started already at the hospital after 
an intraoperative intravenous “loading” dose. This may 
diminish discomfort related to the perineural catheter, 
which can itself be a source of mild pain, or relieve tender-
ness at the block performance site. NSAIDs may then be 
added towards the end of the expected block duration 
period to prevent or lessen rebound pain and tramadol or 
another oral opioid analgesic agent added in cases where 
more severe pain is expected. 
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upper eXtremity blocKs
Surgery of the entire upper extremity is particularly 
suited to be performed under regional anesthesia since all 
of its innervation is derived from a single neural structure 
– the brachial plexus, originating from the ventral rami of 
the 5th cervical to the 1st thoracic (C5 to Th1) nerve roots 
with minor contribution coming also from C4 and Th2. 
Various approaches to the brachial plexus have been 
described using surface anatomical landmarks above and 
below the clavicle (15). The traditional approaches to the 
brachial plexus are the interscalene, supraclavicular, in-
fraclavicular and axillary approach. Using ultrasound to 
directly visualize the components of the brachial plexus 
and surrounding structures has enabled anesthesiologist 
to be more flexible with their approach and tailor it ac-
cording to the individual anatomy of the patient. It re-
duces block performance time, the number of needle 
passes and incidence of vascular puncture, shortens sen-
sory block onset time and improves block success (16).
The space inbetween the fascia of the anterior and me-
dial scalene muscles and covered by the prevertebral fascia 
contains the roots and trunks of the brachial plexus (Fig-
ure 1). Landmark techniques usually use the cricoid car-
tilage to mark the level of needle point entry lateral on the 
neck (C6 level). Blocking the plexus at this level has con-
sistently produced excellent analgesia for shoulder surgery 
since it reliably blocks both the suprascapular and the 
axillary nerves, supplying the majority of sensory innerva-
tion to the shoulder joint. Traditonally up to 50ml of LA 
have been used for interscalene block. Ultrasound guid-
ance has enabled precise deposition of LA immediately 
adjacent to individual nerve roots and/or trunks of the 
brachial plexus producing reliable blocks with much 
smaller volumes, thus decreasing concerns of local anes-
thetic systemic toxicity. A volume of 20ml of levobupiva-
caine will produce shoulder analgesia for 12-16 hours. 
Adding 8mg of dexamethasone to a long acting local an-
esthetic will increase block duration to nearly 24 hours 
(17). Interscalene block is linked to a high incidence of 
ipsilateral phrenic nerve block resulting in hemidiaphrag-
matic paralysis and therefore should be used with caution 
in respiratory compromised patients. Involvement of the 
recurrent laryngeal nerve is also a concern. The C8 and 
Th1 roots often remain spared by this block making it 
unsuitable for surgery involving the ulnar nerve distribu-
tion on the arm or hand.
Patients undergoing shoulder arthroscopy, rotator cuff 
repair and even arthroplasty have been successfully man-
aged using interscalene brachial plexus blocks and consis-
tently report less pain, lower opioid consumption and 
earlier commencement of passive range of motion exer-
cises compared to those who received general anesthesia 
(18). Inserting a catheter for continuous LA infusion in 
the interscalene region can prolong analgesia in patients 
undergoing shoulder surgery and has successfully been 
used in ambulatory patients with no significant complica-
tions (19).
The trunks and divisions of the brachial plexus are 
tightly grouped together as they converge to pass above 
the first rib and below the clavicle adjacent to the subcla-
vian artery, making this an ideal location to block the 
entire brachial plexus with a single injection. Prior to in-
troduction of ultrasound guidance the supraclavicuar ap-
proach to the brachial plexus has fallen out of favor due 
to concerns of pneumothorax and a high risk of intravas-
cular injection since the dorsoscapular artery often runs 
in between parts of the brachial plexus (20). With ultra-
sound guidance it is an excellent block for all surgical 
procedures on the upper extremity below the shoulder 
(Figure 2.). Due to its complete coverage of the brachial 
plexus it is also referred to as “the spinal of the arm”.
The deeper position of the brachial plexus cords in the 
infraclavicular region may make ultrasound visualization 
more difficult compared to supraclavicular and axillary 
approaches, especially in obese or muscular patients. In-
jecting local anesthetic adjacent to the posterior cord de-
creases incomplete infraclavicular block rates due to ulnar 
nerve sparing. Due to easy catheter fixation and mainte-
nance the infraclavicular approach is especially suitable 
for continuous analgesia after arm and hand surgery. 
Studies have demonstrated superiority of the infracla-
vicular approach to general anesthesia for day-case surgery 
in terms of postoperative pain control and patient satisfac-
tion (21, 22).
The axillary block is the mainstay of regional anesthe-
sia for elbow, forearm and hand surgery. It is a rather safe 
and easy to perform block. Due to its superficial location 
ultrasound provides excellent visualization of individual 
nerves surrounding the axillary artery and reduces the 
risk of vascular puncture. The musculocutaneous nerve 
Figure 1. Brachial plexus in the interscalene region. ASM – ante-
rior scalene muscle; MSM – medial scalene muscle.
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often separates high in the axilla from the rest of the bra-
chial plexus and enters the coracobrachialis muscle often 
resulting in incomplete anesthesia and decreased tourni-
quet tolerance after paresthesia and neurostimulation 
guided techniques. Ultrasound guidance helps reliable 
identification and blockade of the musculocutaneus nerve 
at the axillary level. 
Selective distal individual nerve blocks around the el-
bow are easily and quickly performed using direct visual-
ization under ultrasound and can be used as the sole an-
esthetic for minor procedures on the wrist and forearm 
involving a single nerve teriotory or as “rescue” procedures 
following an incomplete proximal brachial plexus block.
Intravascular regional anesthesia (IVRA / Bier’s block) 
has been a popular technique for below elbow procedures 
of short duration since it is simple to perform and has a 
high success rate. In short, IVRA is performed by exsan-
guinating a limb, applying a pneumatic tourniquet to cut 
off circulation and injecting local anesthetic into a vein 
distally on the limb. It provides good anesthesia for sur-
gery involving soft tissue and superficial structures yet 
may be insufficient for procedures involving bone and 
articular structures. Drawbacks are risks of premature 
tourniquet deflation leading to systemic local anesthetic 
leakage, limiting it to short acting local anesthetics, poor 
tourniquet tolerance even with double chamber systems 
and negligible duration of postoperative analgesia. It can 
be used as a rescue procedure after incomplete brachial 
plexus and individual peripheral nerve blocks.
Local anesthetic infiltration can be used as the sole 
anesthetic for minor procedures on the wrist and hand or 
to supplement a regional block.
loWer eXtremity blocKs
Lower extremity innervation is derived from the lum-
bar (anterior divisions of L1, L2, L3 and part of L4 spinal 
nerves) and sacral (L4, L5, S1, S2 and S3 spinal nerves) 
plexus. 
Neuraxial anesthesia is the only way to provide anes-
thesia to the entire lower extremity via a single injection 
of local anesthetic. The advantages of spinal anesthesia for 
outpatient surgery are that it is simple, has a fast onset and 
low cost. Disadvantages include bilateral involvement, 
impaired ambulation, risk of urinary retention and fast 
onset of pain with block regression. Return of lower ex-
tremity motor function after spinal anesthesia is faster 
when short acting local anesthetics are used. Lidocaine 
has been a popular choice but its use has been discouraged 
after reports of a high incidence of transient neurologic 
symptoms (23). Chloroprocaine is a short acting local 
anesthetic that has regained popularity for outpatient sur-
gery in recent years. Block duration varies with the dose 
administered and roughly 40-60min of surgical anesthe-
sia can be expected with a dose of 30mg, prolonged by 
about 15min with each additional 10mg increase in dose 
(24). Another strategy is to use low-doses of hyperbaric 
ropivacaine or bupivacaine solutions in an effort to 
achieve unilateral spread with patient positioning and 
decrease block duration. In a prospective randomized 
trial doses of 8 mg of hyperbaric bupivacaine 0.5%, 8 mg 
of hyperbaric levobupivacaine 0.5% or 12 mg of hyper-
baric ropivacaine 0.5% resulted in similar discharge time 
for outpatient inguinal herniorrhapy (25). Doses of 4-5mg 
hyperbaric bupivacaine produce effective spinal anesthe-
sia for outpatient knee arthroscopy (26). 
Figure 2. A. Brachial plexus in the supraclavicular region. B. and C. In plane visualization of needle shaft (arrows) and tip (arrowhead) in 
“corner pocket” position. D. Trunks/divisions of the brachial plexus surrounded by local anesthetic. BP –brachial plexus; SA – subclavian artery.
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The lumbar plexus gives rise to the genitofemoral, lat-
eral femoral cutaneous, femoral and obturator nerves. 
Combination with a sciatic nerve block will result in com-
plete lower extremity anesthesia and when performed 
with short-acting local anesthetics has been shown to be 
associated with a superior recovery profile compared with 
general anesthesia in patients having outpatient knee ar-
throscopy (27).
Lumbar plexus or psoas compartment block is a deep 
block since the plexus is situated at a depth of 60-100mm 
within the psoas muscle anterior to the transverse pro-
cesses of lumbar vertebrae (28). When used in an outpa-
tient setting it should be reserved for skilled operators 
and major procedures where its analgesic benefits out-
weigh the risk of potential complications. The perito-
neal cavity, great vessels and kidney all lie anterior to the 
psoas muscle and can be penetrated with excessive needle 
advancement. Retroperitoneal and psoas muscle hema-
toma formation is also a potential complication of this 
block.
The femoral nerve is easily visualized by ultrasound as 
it emerges bellow the inguinal ligament into the upper 
thigh covered by the fascia lata and iliac fascia (Figure 3), 
the latter separating it from the femoral vessels. It always 
lies lateral to the femoral artery. Femoral nerve block pro-
duces anesthesia of the anterior thigh and knee and has 
been used to improve analgesia, facilitate early mobiliza-
tion and reduce opioid consumption and related side-ef-
fects after complex outpatient arthroscopic knee proce-
dures like anterior crutiate ligament repair (29) and 
arthroplasty. Quadriceps muscle weakness due to femoral 
nerve block impairs gait control and weight bearing and 
care must be taken to discharge the patient with adequate 
knee immobilization and crutches as well as written and 
verbal instructions how to prevent falls. To decrease quad-
riceps motor inhibition adductor canal nerve block target-
ing the saphenous nerve in the subsartorial mid-femoral 
region has become a popular option (30) although its an-
algesic benefit in outpatients undergoing ACL reconstruc-
tion has recently been questioned (31).
The sciatic nerve innervates the posterior thigh and 
almost the entire lower leg. Due to its deep location it 
is a technically demanding block when performed in 
the parasacral and gluteal region, however is readily 
visible with ultrasound from the subgluteal to popli-
teal region.
Proximal blocks of the sciatic nerve (Figure 4) are used 
to supplement lumbar plexus and femoral nerve blocks 
for surgeries performed on the thigh and knee, while 
blocking it at the popliteal region produces excellent an-
esthesia for  most below the knee surgical procedures with 
the advantage of preserving hamstrings muscle strength 
and knee flexion. Sometimes a saphenous nerve block is 
added to improve calf tourniquet tolerance and provide 
complete anesthesia for surgeries involving the anterome-
dial portion of the lower leg. Continuous sciatic blocks 
provide good postoperative analgesia after day-case foot 
surgery without increasing complication and readmission 
rates compared to inpatients (32).
Peripheral blockade of individual nerves around the 
ankle (ankle block) can be equally effective as a popliteal 
sciatic nerve block to provide both surgical anesthesia as 
well as postoperative analgesia after forefoot surgery (33). 
It has the advantage of preserving lower leg motor func-
tion but requires multiple injections and does not cover 
the use of a calf tourniquet. Ultrasound guidance enables 
faster block performance and reduces the amount of local 
anesthetic lessening patient discomfort during block per-
formance (Figures 5, 6). 
Figure 3 Femoral nerve in inguinal region. FA – femoral artery; FI 
– fascia iliaca; FL – fascia lata; FN – femoral nerve; Ip – iliopsoas 
muscle
Figure 4 Sciatic nerve in the upper thigh and in plane view of 26 
gauge needle (arrows) AM – adductor magnus muscle; BF – biceps 
femoris; SN – sciatic nerve; ST – semitendinosus
K. Oremuš  Ultrasound guided nerve blocks in ambulatory surgery
244 Period biol, Vol 117, No 2, 2015.
truncAl blocKs
The thoracic paravertebral space is situated between 
the vertebral body and intervertebral foramina medially, 
parietal pleura anterolaterally and superior costotrans-
verse process dorsaly. Injection of local anesthetic into this 
space results in segmental anesthesia similar to an epidu-
ral block. Thoracic paravertebral blocks have been suc-
cessfully used to reduce pain after breast surgery (34), 
minor and major thoracic surgery (35) and cholecystec-
tomy (36). It has also been used for pain control after rib 
fracture management in an outpatient setting (37). A re-
cent metaanalysis found PVB to be associated with less 
hypotension, PONV, urinary retention and failed block 
compared to epidural anesthesia (38). Nevertheles, para-
vertebral blocks have the potential for serious adverse ef-
fects, such as pneumothorax, vascular puncture and 
spread of local anesthetic into the epidural space. There is 
significant variability of spread of local anesthetic through 
the paravertebral space and sometimes injections at mul-
tiple levels may be necessary to achieve complete block of 
the surgical area. Injecting small volumes of local anes-
thetic at multiple levels may be a strategy to decrease the 
possibility of systemic toxicity as compared to achieve a 
greater segmental spread by injecting a greater volume at 
a single level. Inserting a catheter into the paravertebral 
space enables prolonged postoperative analgesia, however 
catheter dislogement and misplacement have occured 
relatively often prior to the introduction of ultrasound 
guided techniques (39). This technique should be reserved 
for skilled practitioners and its benefits carefully weighed 
against the risks in an outpatient population.
Transversus abdominis plane (TAP) block is achieved 
by administering local anesthetic into the fascial plane 
inbetween the internal oblique and transversus abdominis 
muscles producing unilateral segmental anesthesia of the 
abdominal wall. Ultrasound visualization has made this 
an easy to learn and easy to perform technique and safe 
alternative to paravertebral blocks to provide analgesia for 
surgical procedures in the periumbilical region and lower 
abdomen (40). TAP blocks performed in the subcostal 
area have been used to provide analgesia after cholecys-
tectomy (41), however they have no effect on visceral pain-
and a recent study found only marginal benefits in reduc-
ing pain while coughing and on reducing opioid 
requirements in patients undergoing laparoscopic day-
case cholecystectomy (42).
conclusion
Increased pressure to enhance patient turnover and 
decrease hospital length of stay, together with the ad-
vancement of surgical and anesthetic techniques has led 
to a significant increase in outpatient surgery. 
The use of regional anesthesia techniques consistently 
leads to reduced opiate analgesic requirements and im-
proved postoperative pain and patient satisfaction scores 
in surgical patients. It has been shown that it’s use in pa-
tients undergoing outpatient surgery results in a decrease 
in post anesthesia care unit utilization and reduces costs.
The use of ultrasound guidance for peripheral nerve 
block performance has decreased block performance 
time, enables visualization of the target nerve(s) and sur-
Figure 5. A. Posterior tibial nerve and artery in the supramaleolar region B. Spread of local anesthetic (arrowheads). PTA – posterior tibial artery; 
PTN – posterior tibial nerve; PTm – posterior tibial muscle; mFHL – flexor hallucis longus muscle; Sm – soleus muscle.
Figure 6. Deep peroneal nerve at the level of the ankle. DPA – dor-
salis pedis artery; DPN – deep peroneal nerve; EDL – extensor 
digitorum longus; EHL – extensor hallucis longus. 
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rounding anatomy and real time imaging of needle path 
and local anesthetic spread leading to a decrease in local 
anesthetic volume and a lower incidence of accidental 
vascular puncture. Further studies are needed to show 
whether the wide spread use of ultrasound guided re-
gional anesthesia will result in increased patient safety and 
shorter total hospital stay in patients undergoing surgical 
procedures on an outpatient basis.
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Scalp block for hemodynamic stability during  
neurosurgery
Abstract
Background and Purpose: For elective neurosurgery procedures main-
taining perioperative hemodynamic stability and optimal cerebral perfusion 
is of outmost importance. Beside numerous anesthetics techniques, risk of 
hemodynamic instability is still very high.
Materials and Methods: We retrospectively analyzed perioperative 
values of heart rate and arterial blood pressure in 39 patients who under-
went neurosurgery. We combined general anesthesia with scalp block. We 
blocked the supraorbital, supratrochlear, zygomaticotemporal, auriculotem-
poral, greater occipital, and lesser occipital nerves with  0,5%  chirocaine, 
including 5 μg/mL of epinephrine that was performed after general anes-
thesia induction, before pin placement. Heart rate and blood pressure values 
were measured before anesthesia induction, after induction, after pins place-
ment, after craniotomy and at the end of surgery. Changes of heart rate and 
blood pressure values less than 20% after painful stimuli was  considered 
as a good hemodynamic stability of applied anesthetic technique. 
Result: Scalp block was successfully performed in all patients without 
complications. Measured values of heart rate and blood pressure before and 
after anesthesia induction compered to values after painful stimuli were-
within the 20% change. 
Conclusion: Scalp block, combined with general anesthesia provide good 
hemodynamic stability during neurosurgery. 
introduction
For elective neurosurgery procedures maintaining perioperative hemodynamic stability and optimal cerebral perfusion is of out-
most importance. Especially in patients with elevated intracranial 
pressure or scheduled for aneurysm repair. Although numerous an-
esthetics techniques are available the risk of hemodynamic instabil-
ity at the very beginning of neurosurgical procedure during the place-
ment of cranial pins of the head holder, craniotomy and dural incision 
is still very high (1). Changes in blood pressure and heart rate could 
have adverse effect on patient cardiovascular system, intracranial 
pressure decreasing cerebral perfusion pressure and also could in-
crease risk of aneurysm rupture (2). One solution is high opioids 
techniques that could provide stress free anesthesia but has numerous 
drawbacks such as delayed emergence and incapability of early neu-
rological evaluation after surgery. Combining regional anesthesia 
technique of scalp block just after induction of general anesthesia 
offers several advantages for most patients. Blocking the nerves that 
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sensory innervates crania helps to blunt the hemody-
namic response to noxious stimuli stabilizing intraop-
erative hemodynamics, decrease the amount of opioids 
and decrease postoperative pain allowing smooth and 
fast emergence with lower incidence of chronic pain 
(3).
Scalp block is easily performed by direct local anes-
thetics infiltration  at the typical anatomical places and 
most proximal points where nerves that sensory innervate 
scalp and forehead (supraorbital nerve, the supratrochlear 
nerve, the zygomaticotemporal nerve, the auriculotempo-
ral nerve, greater and lesser occipital nerves) emerges from 
scull (1). Preferably long acting local anesthetics such as 
ropivacaine 0.75% or levobupivacaine 0.5% are used 
supplemented with 5 µcg/ml epinephrine for reducing 
systemic resorption and to elongate the duration of block 
(4). Scalp blocks proved useful during awake craniotomy 
and for supplementation of general anesthesia for other 
forms of craniotomy (1, 5).
Adverse effects of scalp block are rare and include un-
intentionally motor nerve infiltration with extension of 
the anesthesia to the motor nerves, unintentionally intra-
vascular injection systemic toxicity and unintentionally 
intrarticular  and intramuscular injection of the pterygoid 
muscles that can block temporomadibulary joint with 
limited oral opening and trismus (1, 2).
mAteriAl And methods
In observational study we retrospectively analyzed 
perioperative values of heart rate and arterial blood pres-
sure in 39 patients who underwent neurosurgery proce-
dure in whom we combined general anesthesia with scalp 
block. We included patients who underwent elective neu-
rosurgery for intracranial mass lesion and aneurysm or 
AV fistula repair, ASA I to III. All patients preoperatively 
signed informed consent and agreed with scalp block pro-
cedure. Exclusion criteria were previously cardiovascular 
medication, including beta blocker or antihypertensive 
therapy with previously known local anesthetics allergy. 
After patients arrived in operating theater standard neu-
roanesthesiamonitoring were placed (ECG, invasive arte-
rial blood pressure under local anesthesia, pulse oximetry) 
and peripheral intravenous line was introduced.  All pa-
tients underwent same anesthetics technique. Anesthesia 
induction was done with fentanyl and propofol. Endotra-
cheal intubation was facilitated with vecuronium. Scalp 
block was performed according to modern technique de-
scribed in literature after anesthesia induction because of 
better patients’ comfort (1). We blocked six sensory nerves 
at the typical anatomical places where they emerge from 
skull with direct infiltration of local anesthetic.
Supraorbital nerve was blocked as it emerges from the 
orbit. After identification of supraorbital notch the needle 
was inserted along the upper orbital margin perpendicu-
lar to the skin 1 cm medial to the supraorbital foramen.
Supratrochlear nerve was blocked as it emerges from the 
superiomedial angle of the orbit finger’s breadth medial 
to supraorbital nerve.
Auriculotemporal nerve was blocked over zygomatic 
process 1 to1.5 cm anterior to the ear at the level of the 
tragus. Before injection superficial temporal artery was 
identified anterior to the auriculotemporal nerve at the 
level of the tragus to avoid intravascular injection.
The zygomaticotemporal nerve emerges from scull 
above zygoma between supraorbital and auriculotempoal 
nerves. Nerve was blocked with infiltration from the su-
praorbital margin to the posterior part of the zygomatic 
arch with deep and superficial injection of local anesthet-
ics because of its ramifying. The greater occipital nerve 
was blocked by infiltration of local anesthetic 2.5 cm lat-
eral to the nuchal median line, halfway between the oc-
cipital protuberance and the mastoid process. Lesser Oc-
cipital Nerve was blocked by infiltration along the 
superior nuchal line, 2.5 cm lateral to the greater occipital 
nerve block.
As a local anesthetic, we used  0,5% chirocaine with 
addition of with 5 µcg/ml epinephrine. During each in-
filtration 2–5 ml was injected with previously checking 
for unintentionally intravascular injection. For anesthesia 
maintenance we used TIVA technique with propofoland 
fentanyl. Anesthesia depth was monitored with entropy.
Scalp block effectiveness was evaluated through main-
tained hemodynamic stability during painful stimuli of 
surgery (pinsplacement and craniotomy).  Heart rate and 
blood pressure values were measured for five times: Before 
anesthesia induction (T1), immediately after anesthesia 
induction (T2), after scalp block (T3), after placement of 
head pins (T3) after craniotomy (T4) and at the end of 
operation (T5).  Changes in heart rate and blood pressure 
values before painful stimuli (T1 and T2) of more than 
20% in contrast to values  after painful stimuli  (T3 and 
T4) was considered as hemodynamic instability and in-
adequate scalp block effectiveness for analgesia during 
painful stimuli. Data are presented as average and me-
dian values in tables and figure.
result
Demographic data are shown in table 1. In all patients 
planned scalp block was successfully performed after an-
esthesia induction and before painful stimuli. Average 
fentanyl dose during surgery was 0, 21 mg. Scalp block 
0,5% chirocaine dose  was 20 ml in all patients. In all 
patients measured values of heart rate and blood pressure 
before (T1) and after (T2) anesthesia induction compered 
to values after painful stimuli (T3 and T4) were almost 
the same with minimal variation that not  exceed 20% 
change (Table 2 , Figure 1). There were no complications 
associated with scalp block in any patients. 
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discussion
Optimal neuroanesthesia technique for craniotomy 
should enabled intraoperative hemodynamic stability 
with good perioperative pain control to avoid acute or 
chronic postcraniotomy headache. The main cause of 
pain arises from the insertion of scull pins into the peri-
osteum and craniotomy. Systemic application of opioids 
could blunt the stress responsebut used in high dose 
couldhave adverse effect of lowering blood pressure and 
delayed emergence (2). Regional anesthesia techniques, as 
a supplement to general anesthesia, could offer advan-
tages such as lower stress response, better hemodynamic 
stability and lower postoperative pain (3, 5). Most com-
monly used is scalp block and local infiltration of local 
anesthetic at the wound and the site of pins insertion. 
Several papers have described the use of scalp block to 
limit the neuroendocrine and hemodynamic response (2). 
Cardiovascular stability as well as pain control has shown 
positive findings in outcome of neurosurgical patients (2, 
4). In our study, we follow the systolic and diastolic blood 
pressure, heart rate and consumption of opioid in patients 
that underwent craniotomy in general anesthesia with 
scalp block. Scalp block is sensory blockade of scalp and 
forehead. According literature, scalp block is effective, 
simple to use, easy to learn, with known but rare side-
effects (1, 3). Various local anesthetics such as lidocaine, 
bupivacaine, ropivacaine, with or without adrenaline, 
could be used.  Papers reports application of block preop-
eratively or postoperatively after wound closure (1, 3, 5). 
Moderate to severe postcraniotomy pain is present in 
more than 50% of patient after craniotomy (5). According 
meta-analysis from 2013, scull block is associated with 
reduced postoperative pain in the first 12 hours and also 
reduced requirements of analgetics in the first 24 hours 
(3). On the other hand, use of analgetics in the neurosur-
gery is limited by their side effects. Guilfoyle et al discuss 
the advantages of blocks over the use of opioids (nausea, 
vomiting) and NSAID (often parallel use of steroids) (3). 
They conclude that poor treatment of postoperative pain 
in neurosurgery patients can be overcome with scalp 
blocks.Local wound infiltration is another alternative to 
scalp block. Geze et al carried out prospective, random-
ized, placebo-controlled study (2). Authors compared 
scalp block, infiltration block, and routine anesthesia in 
craniotomy on hemodynamic (mean arterial pressure, 
heart rate) and stress response (cortisol and adrenocorti-
cotropic hormone). They reported that scalp block had 
better results compared to local infiltration of each skull-
pin insertion point or routine anesthesia (2). It is easy to 
explain because scalp block provide much superior senso-
ryblockade of scalp and forehead while local wound in-
filtration provide only short lived analgesia of wound area. 
Our data showed excellent hemodynamic stability in all 
patients with combined regional anesthesia scalp block 
and general anesthesia. Almost identical measured values 
of heartrate and blood pressure could be explained with 
carefully titrated anesthetics dose with TIVA, selected 
group of patients withoutsignificant cardiovascular mor-
bidity and excellent suppression of painful stimuli of pins 
placement and craniotomy with previously done scalp 
block thatblunt stressresponse. These results were found 












Average (median) values of heart rate and 
arterial blood pressure.










68 (65) 123/68 (130/63)
T3
after  pins 
placement
66 (68) 124/67 (110/65)
T4
after carniotomy 66  (68) 121/67 (113/65)
T5
at the end of 
surgery
67 (68) 119/67 (1110755)
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to be consistent with the results of other studies. In our 
study (2, 4) there were no complications associated with 
the block. According different authors, side effects of scalp 
block are rare (1, 5). The main problem can result from 
the fact that local anesthetics should be given in rela-
tively high amount in very vascularized area. Thus, it can-
not beemphasize enoughthe importance of carefully ad-
ministration of local anesthetics, and caution about 
maximum doses. Our study also has several potential 
limitations. First, the small sample size with only descrip-
tive comparison of results, but it was conceived as pilot 
study and it should be confirmed on larger number of 
patients with proper statistical analysis. Second, biological 
different sensation of pain among patients could influence 
measured values so in the future studies some preopera-
tive evaluation of pain potency sensation could be ap-
propriate.. And third, because of small group of patients, 
incidence of complication can be under-recognized.  In 
conclusion, in our study scull block as adjunct to general 
anesthesia provided neurosurgical patients with excellent 
hemodynamic stability. Dose of 20 ml of chirocaine for 
blockade of sensory cranial nerves was required for ade-
quate scalp block. With regular precautionary measures 
throughoutthe blockadministration, scalp block was safe 
for patients, Scalp block prior painful stimuli, combined 
with general anesthesia, and couldbe anesthesia technique 
of choice for maintaining optimal perioperative hemody-
namic in neurosurgery.
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lumbar spinal stenosis: methods of treatment  
with emphasis on epidural steroid injections
Abstract 
Background and Purpose: The aim of the study was to compare two 
techniques of steroid application into epidural space to patients with lumbar 
spinal stenosis (LSS), a chronic degenerative spine disorder.
Patients and Methods: Sixty LSS patients have been distributed into 
2 groups: “BLIND” (n=30, interlaminar epidural steroid injection without 
RTG control) and “RTG” (n=30, transforaminal epidural injection with 
RTG control). All patients have received 80 mg of triamcinolon (Kenalog) 
into epidural space on L4/L5 level, together with 0,5% lidocain (patients in 
RTG group 3 ml and those in BLIND group 10 ml) in 3 week intervals. 
They were asked to describe the pain using visual analogue scales (VAS) at 
the beginning of treatment (VAS-0), after the first (VAS-1), the second 
(VAS-2) and the third epidural injection (VAS-3). The differences between 
groups were shown using t-test (age) and c2-test (gender). Medians of VAS 
scores were statistically described using non parametrial methods. P<0.05 
was considered as a statistically significant.
Results:  There is no statistical difference among patients regarding to 
age (P=0.93), gender (P=0.12) and VAS-0 score before the first injection 
(P=0.27). There is a statistically significant reduction of pain in relation to 
VAS-0 in both groups (P<0.001). Both groups do not statistically differ 
when it comes to their effectiveness in regards to VAS scores .
Conclusions: We  did not find any statistical difference in postinterven-
tional VAS scores among two groups of patients. Choice of technique depends 
on the experience of the anesthesiologist, as well as on the local technical 
possibilities (availibility of RTG devices).
introduction
Lumbar spinal stenosis (LSS) is a chronic, degenerative spine disorder and most common reason for pain and disability among people 
older than 60 years of age (1).
LSS can be a result of degenerative changes that result in neural 
ischemia and neurogenic claudication, a typical syimptom that is de-
scribed as a pain in the gluteus with irradiation into both legs, usually 
reaches knees; weekness, parasthesia. The pain is most often felt while 
walking, standing for longer periods and walking downhill. All these 
changes significantly decrease the quality of life (2).
LSS is a result of degenerative spinal cascade, hence the stenosis has 
effects on central canal and nerve root canals as well (Fig.1). It is believed 
that neurogenic claudication is a result of structural narrowing of central 
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spinal canal, which impeds the venous return, thus caus-
ing venous hypertension and arterial ischemia of cauda 
equina (3).
The pain is decreased when leaning forward and over 
a supporting object (pushing a shopping trolley or walk-
ing with the aid of walkers). Since more areas are involved, 
patients suffering from LSS can have unilateral, bilateral, 
monoradicular or poliradicular symptoms (4). 
pathogenesis
LSS pathogenesis depends on multiple factors. There 
are vascular, biochemical and biomechanical factors that 
contribute to the signs and symptoms of  LSS (3). 
diagnosis
Patients̀ history of illness states pain in glutei with ir-
radiation into both legs, usually above and at the level of 
knees, weekness, parasthesia that increases while standing 
and walking. 
The patients are at ease when flexing the spine. Com-
puted tomography (CT) scans and magnetic resonance 
imaging (MRI) confirm the diagnosis. 
Because of the involvement of more areas, patients 
with LSS can have unilateral, bilateral, monoradicular or 
poliradicular symptoms (5). 




• Walking aids (walkers)
•  Drugs (Paracetamol, nonsteroidal antiinflamatory 
drugs, low doses of opioids)
• Physical therapy and exercises
Interventional
• Epidural steroid injections
• Surgery
Conservative treatment is used early in the course of 
illness and among patients with mild to moderate symp-
toms. Multidisciplinary treatment is necessary and should 
involve physical therapy, wellness, smoking cessation and 
weight loss, if needed (6,7).
pharmacological treatment
The first choice are nonsteroidal antiinflamatory drugs 
(NSAID). Opioid analgetics undoubtedly decrease pain, 
but are still controversal as a treatment of spinal stenosis 
(8). There is not sufficient evidence that joint use of gaba-
pentin and physical therapy decreases pain and improves 
walking distance (9). Moreover, there is not enough evi-
dence for usage of muscle relaxants, prostaglandin and 
calcitonin. 
Surgical treatments are used after all other options 
have failed and in patients that experience moderate to 
severe symptoms (10, 11).
When it comes to interventional methods, epidural 
steroid injections (ESI) are one of the most common used 
methods in treatment of chronic pain in lowerback and 
legs (6, 12, 13).
There are 3 most often used approaches when injecting 
steroids.
• interlaminar (blind method)
• caudal 
• Ttransforaminal (controlled with RTG)
Transforaminal approach implies the use of RTG in 
order to reach the nerve root. That is why a smaller amount 
of drug can be used and that makes it superior to the two 
therapy approaches. However, the chances for nerve dam-
age with this approach are significantly higher (6, 14).
The effectiveness of injecting steroids into epidural 
space of patients with LSS is wellknown. However, there 
are not so many papers that compare the difference be-
tween both techniques when it comes to pain relief. The 
aim of this retrospective study is to show the difference 
between transforaminal and interlaminar epidural ste-
roids injections and theire efect on pain reduction. 
pAtient And methods
Sixty patients with LSS have been distributed into 2 
groups: “BLIND”(n=30, interlaminar epidural steroid 
injection without RTG control) and “RTG” (n=30, trans-
foraminal epidural injection with RTG control).Patients 
in both groups have received 80 mg of triamcinolon 
(Kenalog) into epidural space on L4/L5 level, together 
with 0,5% lidocain (patients in RTG group 3 ml and 
those in BLIND group10 ml). Patients from both groups 
received epidural steroid injections in 3 week intervals. 
They were asked to describe the pain using visual ana-
logue scales (VAS) at the beginning of treatment (VAS-0), 
Figure: 1.
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after the first (VAS-1), the second (VAS-2) and the third 
epidural injection (VAS-3).The differences between 
groups were shown usingt-test (age) i c2-test (gender). 
Medians of VAS scores were statistically described using 
non parametrial methods. P<0.05 was considered as a 
statistically significant.
results
There is no statistical difference among patients when 
it comes to age (P=0.93), gender (P=0.12) and VAS-0 
score before the first injection(P=0.27). There is a statisti-
cally significant reduction of pain in relation to VAS-0 in 
both groups (P<0.001). Both groups, “BLIND” and 
“RTG”, do not statistically differ when it comes to their 
effectiveness in regards to VAS scores (Table 1).
Table 1
VAS scores after the epidural steroides injec-
tions (Mann-Whitney U test).
VAS








VAS-0 8 (7, 9) 7.5 (7, 9) .266
VAS-1 6 (5, 6) 5 (4, 6) .072
VAS-2 5 (4, 6) 4 (4, 5.25) .098
VAS-3 4 (3, 5) 4 (3, 4) .085
conclusion
We did not find any statistical difference in postinter-
ventional VAS scores among patients with LSS who re-
ceived interlaminal (»BLIND») and transforaminal 
(“RTG”) epidural steroid injections.  Even though this 
research was conducted with a small number of partici-
pants, we conclude that the choice of technique depends 
on the experience of the anesthesiologist, as well as on the 
local technical possibilities (availibility of RTG devices). 
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Radiofrequency denervation of lumbar facet joints 
in the treatment of chronic low back pain
Abstract 
Low back pain is the most common pain syndrome and a global health 
burden. The etiology in most cases is multifactorial and the facet joints can 
be a source of low back pain. The facet joint is innervated by the medial 
branch of the dorsal ramus of the spinal nerve. Facet joint disturbances can 
be responsible for 10% to 50% of all cases of chronic lumbar pain. In the 
absence of predictive clinical or radiologic findings, nerve blocks are consid-
ered to be the best way of diagnosing presumed facet-mediated pain. Radio-
frequency ablation to induce thermal necrosis of the facet neural fibers has 
been reported to provide significant pain reduction in patients for 6–12 
months. A radiofrequency neurotomy is a type of injection procedure used 
to treat facet joint pain caused by arthritis or other degenerative changes, or 
from an injury. In this procedure, a heat lesion is created on certain nerves 
with the goal of interrupting the pain signals to the brain, thus eliminating 
pain. Medial Branch Neurotomy could be considered an option for patients 
suffering persistent axial and referred non-radicular leg pain unresponsive 
to less invasive conservative measures.
introduction
Low back pain is the most common pain syndrome and a global health burden. The etiology in most cases is multifactorial and the 
facet joints can be a source of low back pain. As first described by Gold-
twaith in 1911 the facet joints can be a source of low back pain (1). The 
facet joint is part of the motion segment and consists of two articular 
surfaces, which are orientated almost vertically in the lumbar spine. Both 
the synovial folds and the capsule contain nociceptive nerve endings. 
The facet joint is innervated by the medial branch of the dorsal ramus 
of the spinal nerve (2). Each facet joint receives nerve endings from two 
heights. For example the facet joint L4–L5 receives nerve endings from 
the dorsal ramus from the 4th spinal nerve for the upper parts und from 
the 5th spinal nerve from the lower parts (3). The contribution of facet 
joints to low back pain is thought to linked to intervertebral disc degen-
eration in the concept of ‘segmental instability’. As with degenerative 
changes the height of the intervertebral disc lowers there is more stress 
on the facet joints and the joint capsule with occurring osteoarthritic 
changes of the facet joint and possible pain generation (4). As degenera-
tive changes occur in almost every person, facet joint osteoarthritis can 
be found in about 90% of all patients older than 50 years, but like in 
other locations there is little correlation between the extent of osteoar-
thritic changes and perceived grief (5). Between 8% and 12% of all 
patients with lumbar pain comprise chronic cases, with complaints last-
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ing longer than three months (6, 7). Facet joint distur-
bances can be responsible for 10% to 50% of all cases of 
chronic lumbar pain (8–11). However, clinical history or 
physical examination cannot identify facet joint altera-
tions as the origin of pain nor does imaging (e.g., radiog-
raphy, computed tomography or magnetic resonance im-
aging (12–20). In the absence of predictive clinical or 
radiologic findings, nerve blocks are considered to be the 
best way of diagnosing presumed facet-mediated pain 
(21–25). Diagnostic blocks remain the mainstay in the 
diagnosis of facet joint syndrome and are used in most 
studies, even if they are questioned because of their sensi-
tivity and specifity (26, 27). A resolution or improvement 
of pain after image guided injection of local anesthetics 
around the joint capsule corresponding to the presumed 
time of action of the used local anesthetic makes the in-
volvement of the facet joint probably (Figure 1). 
In patients with unspecific chronic low back pain and 
unsuccessful conservative therapy (non steroidal anti-in-
flammatory drugs, physiotherapy) involvement of the 
facet joint should be considered and confirmed or ruled 
out with diagnostic blocks (Figure 2). Controlled diag-
nostic blocks imply having a patient undergo 2 separate 
injections, at different times, using anesthetic agents of 
different durations of action. 
A positive response occurs when a threshold of pain 
relief (usually between 50–80%) is experienced and the 
duration of relief is consistent with the known duration 
of the anesthetic. Single diagnostic blocks use only a 
single injection and anesthetic agent.The only tool to iden-
tify facet joint alterations as the cause of pain is the veri-
fication of an analgesic response to anesthetic injections 
into the zygapophyseal joints or at their nerve supplies and 
medial dorsal branch blocks are easier to perform (28–
30). The diagnostic power of the blockade is based on the 
assumption that anesthetizing the facet joint or the cap-
sule containing the innervations would result in pain re-
lief. A positive result (i.e., pain relief) would mean that 
the facet joint is the site from which the pain originates. 
The technique of medial dorsal branch block consists of 
blocking each of the medial branches that innervate a 
facet above and a facet below their corresponding roots 
and also blocking the multifidus and interspinous muscles 
in the region of the corresponding dermatome (27, 28).  
discussion
Radiofrequency ablation to induce thermal necrosis of 
the facet neural fibers has been reported to provide sig-
nificant pain reduction in patients for 6–12 months (28, 
29). Radiofrequency facet joint denervation procedures 
have been common practice for 2 decades in treatment of 
chronic low back pain. A radiofrequency neurotomy is a 
type of injection procedure used to treat facet joint pain 
caused by arthritis or other degenerative changes, or from 
an injury. In this procedure, a heat lesion is created on 
certain nerves with the goal of interrupting the pain sig-
Figure 1. Radiofrequency denervation in the operating room under 
the control of fluoroscopy and with the monitoring of patients.
Figure 2.  A. Oblique radiograph of the lumbar spine during lumbar medial branch block; B. Anterior-Posterior radiograph of the lumbar spine 
during lumbar medial branch block.
                                                  A                                                                                B
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nals to the brain, thus eliminating pain. The terms radio-
frequency ablation and radiofrequency neurotomy are 
used interchangeably (Figure 3).     
Both terms refer to a procedure that destroys the func-
tionality of the nerve using radiofrequency energy. Suc-
cess rates vary, but typically about 30% to 50% of patients 
undergoing this procedure for low back pain will experi-
ence significant pain relief for as much as two years. Of 
the remaining low back pain patients, about 50% will get 
some pain relief for a shorter period. As a general rule, if 
effective, the ablation will often provide pain relief lasting 
at least 9 to 14 months and sometimes for longer. After 
this period of time, however, the nerve will regenerate and 
the pain may return. Radiofrequency denervation showed 
efficacy in open as well as in placebo- controlled trials and 
could be a treatment option in carefully selected patients 
(30). After positive diagnostic blocks, denervation or 
therapeutic blocks with long acting local anesthetics and 
corticoids should be tried (31). Although medial branch 
neurotomy may benefit properly selected patients, the re-
lief achieved is rarely complete or permanent. Because of 
this, treatment decisions are best based upon having a 
realistic understanding of expected outcomes in relation 
to a patient’s current level of pain and physical function. 
Candidates for radiofrequency facet denervation should 
meet all of the following criteria:
• No prior spinal fusion surgery in the vertebral 
level being treated; 
•  Low back (lumbosacral) or neck (cervical) pain, sug-
gestive of facet joint origin as evidenced by absence 
of nerve root compression as documented in the 
medical record on history, physical and radiographic 
evaluations; and the pain is not radicular; 
•  Pain has failed to respond to three months of conser-
vative management which may consist of therapies 
such as nonsteroidal anti-inflammatory medications, 
acetaminophen, manipulation, physical therapy, and 
a home exercise program; 
•  A trial of controlled diagnostic medial branch blocks 
(2 separate positive blocks or placebo controlled series 
of blocks) under fluoroscopic guidance has resulted 
in at least a 50% reduction in pain; and 
•  If there has been a prior successful radiofrequency 
denervation, a minimum time of six  months has 
elapsed since prior radiofrequency treatment (per 
side, per anatomical level of the spine). 
Radiofrequency facet joint denervation is performed 
as a day procedure. All patients are given intravenous se-
dation to ensure they are as comfortable as possible 
throughout the procedure. The doctor performing the 
procedure will use local anaesthetic to numb patient skin 
before accurately inserting a needle using x-ray guidance 
next to the medial branch nerve to the facet joint. The 
doctor will then check that the needle is properly posi-
tioned by stimulating the nerve. This may cause muscle 
twitching and provoke some of pain. Once the needle is 
in the correct position, the area will be numbed and ra-
diofrequency energy used to disrupt the medial branch 
nerve. Several nerves may need to be treated to obtain 
optimal pain relief. Patient will be monitored for 1–2 
hours following the procedure prior to discharge. Full 
pain relief from the procedure may take several weeks. 
Most patients are able to return to work within two days 
following the procedure. Nerves regenerate after radiofre-
quency facet joint denervation. This usually takes be-
tween six months and two years. Dreyfuss et al followed 
15 patients showing >80% relief on controlled diagnostic 
blocks. 13 had relief of >60% at one year, with 9 of these 
exceeding 90% pain reduction (22). Lakemeir et al as-
sessed the 6-month response to medial branch neurotomy 
in 29 patients after showing a minimum of 50% pain 
relief to a single diagnostic block. Average pain scale re-
Figure 3. A. Oblique view demonstrating placement of radiofrequency cannulae after contact with “eye” of Scotty dog and slipped off the supe-
rior margin of the transferse processes; B. Anterior-Posterior radiograph of the lumbar spine during lumbar radiofrequency treatment of the 
lumbar facet jointsview of placet radiofrequency canulae, C. Lateral view of placement RF cannulae along the lumbar superior articular 
processes.
                                A                                                                               B                                                                                 C
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duced from 6.6 to 4.7. Oswestry Index reduced from 40.8 
to 28. This study also compared facet denervation to in-
tra-articular steroid injection, finding no statistical differ-
ence between the two procedures (32). The response to 
radiofrequency rhizotomy, after having successful com-
parative nerve blocks, in Goldfeld et al’s study of 174 
patients showed 119 having good (50%) to excellent 
(80%) pain relief and 55 showing no improvment. 96% 
of those with good-excellent responses had relief lasting 
between 6–24 months with 43% of that cohort showing 
sustained benefit for 2 years (38). Cohen et al. followed 
262 patients who had a positive controlled diagnostic 
block with >50% pain relief. Following medial branch 
neurotomy, 54% had pain relief >50% lasting at least 6 
months. There was no difference in response between 
those reporting >80% relief on confirmatory blocks as 
compared to those reporting relief of between 50–80% 
(33). A later study of his reinforced this finding, further 
concluding that the use of more stringent diagnostic cri-
teria (higher pain relief thresholds or double as compared 
to single blocks) would likely result in withholding a ben-
eficial procedure from a substantial number of patients 
without a corresponding improvement in success rates. 
Not all studies have shown favorable results for Medial 
Branch Neurotomy. One of the largest double blind ran-
domized trials found no difference in pain scores, physical 
function, or medication use between active intervention 
and sham groups (34). As briefly discussed earlier, even 
when Medial Branch Neurotomy is successful, relief is 
rarely complete or permanent. Smuck et al reviewed 16 
articles finding that the average duration of >50% pain 
relief for an initial procedure was 9 months. Repeat Me-
dial Branch Neurotomy carried a success rate between 
33–85% with an average duration lasting 11.6 months 
(35). These statistics were similar to an earlier study also 
showing a 10-month average duration of benefit for both 
initial and repeat procedures (36). In general, a reasonable 
number of patients with > 50% pain relief on controlled 
diagnostic blocks (and possibly even a single diagnostic 
block) could expect to experience similar relief with me-
dial branch neurotomy for an average duration of 6–12 
months. Repeat medial branch neurotomy tends to yield 
similar results. Complication rates with Medial Branch 
Neurotomy are considered to be low, minor, and in most 
cases, transient. As with most procedures, there is a re-
mote risk of bleeding, infection, nerve injury or allergic 
reaction to the medications used. In addition, the injec-
tions may cause some temporary soreness in back. How-
ever. complications from these techniques may occur. 
These include discomfort around the injection site, numb-
ness of the skin, neuritis, pain from muscle spasm at injec-
tion site, permanent nerve pain and reactions to admin-
istered medications (36). Kormick et al had performed 2 
studies involving a total of 741 denervations. These re-
vealed 5 cases of neuritic pain lasting longer than 2 weeks, 
5 cases of muscle soreness lasting less than 2 weeks, one 
case of prolonged muscle spasm, and no instances of mo-
tor deficits, sensory deficits, or infections (37–39). In 
summary, Medial Branch Neurotomy could be consid-
ered an option for patients suffering persistent axial and 
referred non-radicular leg pain unresponsive to less inva-
sive conservative measures.
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Temporomandibular joint disorder and  
headache – one-year-follow-up
Abstract
Background and Purpose: Aim of this study was to compare the clin-
ical characteristics of patients from the subgroup with osteoarthritis (G-1) 
and patients with disc displacement (DD) (G-2) of TMJ related types of 
headaches and with one-year-follow-up after treatment.
Patients: G-1 included 70 patients who were treated for signs and 
symptoms of OA of TMJ. Pain intensity (at first examination T0) in TMJ 
was shown on the visual-analogue scale (0, no pain; 10, the worst pain) as 
well as headaches. They were treated by an occlusal splint and/or physical 
therapy with a six-month(T1) and one-year (T2) follow-up. G-2 included 
35 patients from a subgroup with DD. Definitive TMJ-diagnoses were 
confirmed by magnetic resonance imaging. 
Results: There was a significant age difference (p<0.001) between the 
two subgroups of TMJ diagnoses, however there were no differences in pain 
during the follow-up period. In the beginning, the pain amounted to T0: 
G-1 6.5 / G-2 6.1 and at T2: G-1 1.6 / G-2 1.7. The applied treatment 
modalities at T1/T2 achieved TMJs without pain in 27.14%/64.29% of 
patients from G-1 and in 28.57%/57.15% of patients from G-2. There were 
equal shares of patients without headache (G-1 54.3%; G-2 48 %). The 
share of tension headaches was G-1 10%, G-2 11.4%, migraines G-1 
15.2%, G-2 22.9%, TMJ-related headache G-1 4.3%, G-2 11.4% and 
cervicogenic headache G-1 15.7%, G-2 5.7%. 
Conclusions: Pain intensity and treatment success do not vary within 
the observed groups. Migraine and TMJ-related headaches are more com-
mon in patients from G-2.
introduction
Craniofacial pain is a medical issue related to several diagnostic and pain treatment specialist fields which include neurologists, phys-
iatrists as well as doctors of dental medicine(1, 2). The most common 
types of non-odontogenic orofacial pain are temporomandibular pain 
and musculoskeletal pain related to masticatory muscles and temporo-
mandibular joints (3, 4).
TMJ disorder is an umbrella term for several TMJ diagnoses, the 
most common being osteoarthritis (OA) and disc displacement (DD)
(5–8). Apart from the musculoskeletal pain of the orofacial region, head-
aches are the most common neurological pain (9–11). Also, musculosk-
eletal diseases can develop in other anatomically-topographically ap-
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Clinical diagnostics of TMJ disorders are related to the 
existence of another type of headache, particularly since 
a special diagnosis of TMJ-related headache according to 
research criteria for temporomandibular disorders (RC/
TMD) was introduced (15, 16). On the other hand, cer-
vicogenic orofacial disorders (headaches) can be viewed 
in co-morbidity with TMJ disorders. Other most com-
mon primary headaches (migraine, tension headache) 
were also found in TMJ patients (17–22).
Magnetic resonance imaging (MRI) is the gold stan-
dard in TMJ disorder diagnostics (23–25). Reversible 
treatments are the primary choice for the treatment of 
TMJ disorders, with the occlusal splint and TMJ physical 
therapy both equally successful (26–28).
The aim of this study was to compare the relationship 
between clinical characteristics of the patients from the 
subgroup with osteoarthritis (G–1) and patients with disc 
displacement (G-2) of TMJ related types of headaches 
and with one-year-follow-up after treatment.
mAteriAl And methods
The study included 105 patients (mean age 37.8±12.8, 
90% women) diagnosed with a TMJ disorder that came 
to the Department of Removable Prosthodontics at the 
School of Dental Medicine in Zagreb where their treat-
ment and recalls were carried out. The patients were di-
vided into two subgroups according to different diagnoses 
of TMJ disorders; the G1 subgroup consisted of 70 pa-
tients with OA of TMJ (mean age 48.8±14.5, 94.3% 
women). These patients were compared to the G2 sub-
group of 35 patients who only had DD of TMJ (mean age 
27.6±11.1, 85.7% women).
clinical part of the study
Clinical examination was performed based on the 
DC/TMD protocol and by manual functional analysis 
(MFA) according to Bumann and Groot Landeweer (15, 
29, 30). The main clinical symptoms were pain in the 
TMJ (that is in the preauricular region) with limited 
mouth opening and noticing of noise (crepitation, click-
ing). Patients with the following traits were excluded: 
previous trauma resulting in mandibular and/or maxil-
lary fractures, rheumatoid or psoriatic arthritis, facial or 
jaw anomalies, severe acute, chronic or malignant ill-
nesses or wearing an orthodontic appliance during the 
diagnostic period. The entire study was approved by the 
Ethics Committee of the School of Dental Medicine, 
University of Zagreb and all of the patients gave a written 
consent for the participation in the study.
The duration of TMJ pain from the onset until the first 
examination was recorded (in months). Pain in the TMJ 
was measured on a visual-analogue scale (VAS, 0 – no 
pain, 10 – strongest experienced pain). Occurrence of 
TMJ noise was recorded on active mandibular move-
ments and it was recorded during dynamic and passive 
mandibular manipulations within the MFA. The G1 sub-
group of patients with OA was determined by crepita-
tions, whereas the patients from subgroup G2 who were 
diagnosed with DD had previous clicking in medical his-
tory with limited mouth opening and no current clicking 
and current clicking in the TMJ.
Diagnoses of headache and cervical syndromes (cervi-
cobrachial syndrome, cervicocranial syndrome, cervical 
syndrome) were made based on previous medical history, 
examination and diagnosis by a neurologists and physiat-
rist-rheumatologist. Special attention was paid to the oc-
currence of headache related to TMJ disorder symptom-
atology, according to RC/TMD criteria (15).
Definitive diagnoses
Definitive clinical diagnoses of all the patients’ TMJs 
were made by MRI imaging of joints at the Department of 
Diagnostic and Interventional Radiology, Clinical Hospital 
Center ‘Sestre milosrdnice’.  The criteria for OA were sub-
chondral sclerosations with or without preserved cortical 
bone contours. DD was determined according to disc posi-
tion within the articular fossa, that is, by the anterior posi-
tion with respect to the narrowest distance between the 
condylar head and posterior contour of the tuberculum. 
The superconductive magnet device ‘Avanto’ with 1.5 
T magnetic field by Siemens (Erlangen, Germany) was 
used. MRI parameters for the oblique sagittal view of 
TMJ for T1-weight image were the followng: time of echo 
9.4–15 ms, time of repetition 380–410 ms, field of view 
180x180, and matrix 410x512, and proton density image 
with: time of echo 90 ms, time of repetition 2800 ms, fiel 
of view 160x160, and matrix 320x320.
treatment and follow-up 
The patients from both subgroups were treated in the 
same way using the occlusal splint and physical therapy (27, 
28). Recall was carried out 6 and 12 months after the first 
examination at the Department of Removable Prosthodon-
tics, School of Dental Medicine, University of Zagreb.
statistical analysis
The collected data were encrypted and organized as a 
Microsoft Office Excel 2010 file on a personal computer. 
Statistical analysis was performed by using SAS software. 
Descriptive statistics was used for determining the basic 
statistical parameters (average values, standard deviations, 
medians, minimum and maximum values). The following 
statistical methods were used: t-test, chi-squared test, and 
Fischer’s exact test (31).
Clinical variables (numerical and normative) were 
compared between the two groups (G1 and G2) as well 
as within the total number of patients (G1+G2) for par-
ticular clinical features in the period of the first examina-
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tion (T0) and on two recalls: after 6 months (T1) and 
after one year (T2).
Previous pain duration (in months), pain on VAS in 
TMJs, active mouth opening (in mm), bruxist activity 
(no, yes), occurrence of headache (no, yes; and certain 
types of headache: tension headache, migraine, cervico-
genic headache, TMJ-related headache), existence of cer-
vical syndromes and polyarthritis (no, yes) were recorded 
Table 1
Distribution of the share of patients according to treatment success after 6 months (recall T1) and 
after 12 months (recall T2) between the examined patient subgroups.
Subgroup of 




T1 18 (25.71%) 15 (21.43%) 26 (37.14%) 11 (15.71%)
70 (66.67%)
T2 24 (34.29%) 21 (30%) 14 (20%) 11 (15.71%)
G-2
T1 3 (8.57%) 7 (20%) 14 (40%) 11 (31.43%)
35 (33.3%)
T2 7 (20%) 13 (37.15%) 9 (25.71%) 6 (17.14%)












related to TMJ Total
G-1 38 (54.29%) 7 (10.00%) 11 (15.71%) 11 (15.71%) 3 (4.29%) 70 (66.67%)




Distribution of the total number of patients according to the occurrence of headache and diagnosis of 
cervical disorder.
Variable No cervical disorders Cervical disorders Total
No headache 38 (36.19%) 17 (16.19%) 55 (52.38%)
Headache present 18 (17.14%) 32 (30.48%) 50 (47.62%)












related to TMJ Total
No cervical 
disorders 37 (35.24%) 5 (4.76%) 10 (9.52%) 1 (0.95%) 3 (2.86%) 56 (53.33%)
Cervical  
disorders 17 (16.19%) 7 (6.67%) 9 (8.57%) 12 (11.43%) 4 (3.81%) 49 (46.67%)
Total 54 (51.43%) 12 (11.43%) 19 (18.10%) 13 (12.38%) 7 (6.67%) 105 (100%)
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at T0. Pain on VAS was measured at T1 and T2. Subjec-
tive treatment success was determined as: condition with-
out discomfort, discomfort in TMJ, less pain than at T0, 
unchanged pain intensity compared to T0. 
The reliability of MRI assessment was evaluated for 
each diagnosis of DD on the basis of two researchers’ (a 
radiologist’s and a dentist’s) inspection by means of Kap-
pa statistics (31, 32), which was conducted on MRI im-
ages independently of the clinical signs of 12 patients, 
twice on the same MRIs of both TMJs. Using Cohen’s 
kappa statistics, the interexaminer agreement was mea-
sured between 0.8 and 1.0 for MRIs. 
results
There was a significant age difference (t-test=7.632 
(df103) with p<0.001) between the two subgroups of 
TMJ diagnoses, however there were no differences in pain 
during the follow-up period. In the beginning, the pain 
on VAS at T0 for G-1 amounted to 6.5 and for G-2 it was 
6.1 (t-test=1.3977 (df103) with p=0.2175). During the 
first recall (T1) pain on VAS for G1 was 2.3, and for G2 
it was 3.3, which had borderline statistical significance 
(t-test=–1.9155 (df103) with p=0.0582). During the T2 
recall pain intensity was much lower but without signifi-
cance in the subgroups: pain on VAS for G1 was 1.6, and 
for G2 was 1.7 (t-test=–0.2984 (df103) with p=0.7660). 
The applied treatment modalities at T1/T2 achieved 
TMJs without pain in 47.14%/64.29% of patients from 
G-1 and in 28.57%/57.15% of patients from G-2 (Table 
1). There were equal shares of patients without headache 
(G-1 54.3%; G-2 48 %; chi-squared test (df1)=0.3055 
with p=0.5805). The share of certain types of headaches 
in both groups was 55 tension headaches (52.38%), 11 
migraines (10.48%), 13 cervicogenic headaches (12.38%), 
and headache related to TMJ-disorder in 7 patients 
(6.67%). There was no statistical significance in the dis-
tribution between the G-1 and G-2 subgroups of patients 
(Fisher’s Exact p=0.2792; Table 2).
In the subgroup with OA (subgroup G-1), 51.4% of 
patients suffered from cervical spine disorders whereas 
only 34.3% of patients from G-2 suffered from the same 
disorders. There was a statistically significant difference 
(chi-squared test (df1)=11.5227, with p<0.0007; Table 3) 
regarding the total sample of patients (G-1+G-2) depend-
ing on the occurrence of headache.  The distribution of 
certain types of headaches depending on diagnosed cervi-
cal disorder is statistically significant (Fisher’s Exact Test 
p=0.001; Table 4). 
discussion
The term TMJ disorder encompasses a series of differ-
ent diagnoses involving musculoskeletal diseases mani-
fested in the stomatognathic system.Although clinical 
diagnostics is of primary importance to musculoskeletal 
disease diagnostics, the variability of symptomatology, 
apart from the generally present joint pain, makes the 
final diagnosis difficult (2–4, 33). On the other hand, the 
use of MRI and other radiological procedures is impos-
sible in everyday practice. Due to that, a system of unified 
diagnostics has been developed and in the latest revision 
it was called RC/TMD (15, 16 ).
There are two main diagnoses in the unique popula-
tion of patients with TMJ disorder, DD and OA (6–8). 
This study also confirmed that patients with OA of TMJ 
had higher mean age. As opposed to clinical studies, there 
is a problem with determining the diagnosis in joints with 
only arthralgia and therefore MRI remains the gold stan-
dard in TMJ diagnostics. Manfredini et al. (7) deter-
mined the mean age for the subgroup with DD which was 
32.7 and the mean age for OA patients which was 54.3 
years, both values higher than the age values in this study.
Also, the predominance of females was confirmed, up to 
91.3%. 
Along with the main symptoms of TMJ, secondary 
diagnostic symptoms are also mentioned, otalgia being 
one of the more significant ones, but also headaches. How-
ever, those are not pathognomonic symptoms and the 
symptoms related to the ear are also viewed as a part of 
otorhinolaryngological diagnostics (33), whereas head-
aches have a greater significance for neurological diagnos-
tics of orofacial and craniomandibular pain (9). Primary 
headaches are mainly related to myogenic TMDs and not 
arthrogenic ones (20) and this is supported by the results 
of the recent study: more than half (52.5%) of all patients 
do not have headaches at all and cervicogenic headache is 
typical for OA patients. 
Headache as a symptom was significantly more fre-
quent in TMD patients than in the group of non-TMD 
subjects (20). Plesh et al. (19) mention the five times 
greater prevalence of migraine (20%) in female patients 
who are twins which is connected to the occurrence of 
 TMDs, also predominant in women and it has a genetic 
background (22).
Two groups of arthrogenic TMD patients were com-
pared in this study and there were no differences between 
them although more patients with DD of TMJ (G-2 sub-
group) had migraine and TMJ-related headache. The 
results of this study are not completely comparable to 
previous studies with the same subject because a recent 
study used a new diagnosis of ‘TMJ contributed or re-
lated headache’ which better explains orofacial pain bor-
dering between TMJ arthralgia and tension headache. 
The complex nature of the trigeminal system sensory 
features is obvious in the mandibular and maxillary in-
volvement in migraine pain and this should be taken into 
account in differential diagnostics (21). 
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The neuroanatomical basis for the interaction between 
the orofacial (trigeminal sensory area) and the cervical 
region is evident from the assumption that the sensory 
nerve fibers in the centrifugal tract of the trigeminal nerve 
interact with sensoryfibers from the upper cervical roots 
belonging to the trigeminocervical nucleus. Cervicogen-
ic headache is often related to myofascial disturbances 
which can also affect masticatory muscles. The prevalence 
of cervicogenic headache in the sample of patients at pain 
management clinics was around 20% and four times 
higher in women (12); which was also shown in our study 
for patients with OA of TMJ (15.7%). 
There was no consensus for the confirmation of the 
interdependence between TMJ disorder and cervical 
spine disorders (14). Hyperlordosis of cervical spine was 
determined in patients with TMDs but without definite-
ly confirming the risk of its occurrence (18).
There is an existing opinion that there was potential 
interdependence between asymptomatic DD of TMJ, 
which would correspond with cervical spine disc prolapse 
(34). Parallel follow-up of TMJ treatment by occlusal 
splint and of the spinal parameters (spinal pain and mo-
bility) revealed simultaneous significance of healing (17). 
Michigan occlusal splint is considered to be the optimal 
reversible means of occlusal orthosis and it has been 
shown to significantly reduce pain in the TMJ along with 
physical therapy. However, similarly to our study, there 
were no differences in the influence of TMJ treatment on 
the entire treatment success (26–28). Patients of younger 
age with lesser cervical spine disorders (patients with DD, 
subgroup G-2) have equal possibilities of treatment suc-
cess as the subgroup of patients who are older and with 
greater cervical spine involvement in painful syndromes.
Although TMD diagnostics using the standardized 
DC/TMD protocol enables us to compare different re-
searches, in order to make a definitive diagnosis, MRI is 
needed (23–25).
In conclusion, among patients with TMJ disorder 
there are two age groups: patients with OA (G-1) are sig-
nificantly older. Pain intensity and treatment success do 
not vary within the observed groups. Cervical disorders 
and the related headache are dominant in G-1 patients. 
Migraine and TMJ-related headaches are more common 
in patients from G-2. Treatment failure in both patient 
groups was almost equal, between 15.7% and 17.1%. The 
analysis of the total sample showed that patients with 
cervical spine disorders had more headaches. 
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attenuation of systemic inflammatory stress response 
after preoperative analgesia with clonidine compared 
to levobupivacaine-a randomised clinical trial
Abstract
Background and Purpose: Use of analgetics before the pain stimulus 
(preventive analgesia) obstruct development of neuroplastic changes in cen-
tral nervous system, and reduces pain. Furthermore, preventive analgesia 
can block harmful central nervous system response and inflammation as an 
early consequence of operation as well. Investigation hypothesis is that pre-
operative central clonidine will reduce systemic inflammatory stress response 
better than levobupivacaine. 
Materials and Methods:. Patients were allocated to three groups, ac-
cording to preoperative epidural use of 5 μg/kg clonidine (n=17), 0.25% 
levobupivacaine (n=12) or saline as control group (n=13). Before operation, 
1 h after the beginning, 1 h, 6 h, 12 h and 24 h after the operation follow-
ing parameters were analyzed: procalcitonin (PCT), interleukine-6 (IL-6), 
C-reactive protein (CRP) and lactate. 
Results: There were no significant differences between groups in age, 
gender, body mass index and operation time. We demonstrated significant 
reduction in PCT, IL-6, CRP and lactate levels in preoperative clonidine 
group, compared to preoperative levobupivacaine group and controle group. 
Conclusion. These results support importance of clonidine central effect on 
pain pathways and systemic inflammatory stress response blockade. 
introduction
Investigations showed that rising production of prostaglandine E2 and interleukin-6 at central sites is an important component of surgery 
induced inflammatory response in patients. Postoperative period is as-
sociated with an increased production of cytokines, which augment pain 
sensitivity. Use of analgesics for immunomodulation can improve pa-
tient recovery (1, 5, 9). 
Preventive analgesia is based on the concept that the occurrence of 
strong pain stimulus, hyperexcitation and hyperalgesia are possible to 
prevent by early blockade of pain pathways (1, 2). Prolonged pain sti-
mulus leads to secondary neuroplastic changes in the central nervous 
system, known as central sensitization, resulting in exaggerated respon-
se to afferent pain stimulus and amplification of pain (hyperalgesia). 
Administration of analgesics before the pain stimulus or surgical trau-
ma, prevents harmful central nervous system response and inflamma-
tion as an early consequence of operation as well (3, 4). In order to ac-
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conditions, i.e. complete suppression of the afferent pain 
stimulus and adequate duration in the early postoperative 
course (4). 
Clonidine is an a2-adrenergic agonist with known se-
dative, analgesic and hemodynamic properties. It inhibits 
transmission of nociceptive stimuli in the dorsal horn of 
the spinal cord, acting on the inhibitory descending pat-
hways (5, 6). Nader et al. showed that preoperative pero-
ral administration of clonidine reduced TNF-alpha level 
in plasma and cerebrospinal fluid (7). Investigation of Wu 
et al. reported reduced IL-1RA, IL-6, IL-8 and postope-
rative pain levels during and after operation, associated 
with preoperative epidural clonidine treatment (8). 
Investigations of long-acting local anesthetic levobu-
pivacaine administered by epidural and intrathecal route 
provide evidence for improved postoperative analgesia 
with reduced analgesic consumption (10, 11, 12, 13). But, 
it remains unknown if that analgesia is sufficient enough 
to blockade inflammatory stress response during periope-
rative time. 
The aim of the present study is to investigate hypothe-
sis that preoperative administration of epidural clonidine 
will attenuate systemic inflammatory stress response 
better than epidural levobupivacaine. The study was de-
signed to compare clonidine and levobupivacaine, and 
than both with the control group.
mAteriAls And methods
The investigation was carried out in the double-blin-
ded manner, with due approval from the institution Et-
hics Committee and an informed consent from all study 
subjects. 
Inclusion criteria were patients with well-defined colo-
rectal carcinoma, without spread of malignant disease, 
confirmed by colonoscopy and computerized tomography 
(CT), body mass index (BMI) under 30, and periopera-
tive risk for anesthesia and operation, classified as ASA 
(American Society of Anesthesiologists) physical status I 
or II. Exclusion criteria were diabetes mellitus, renal in-
sufficiency (kreatinin level>120µmol/L), liver insufficien-
cy (bilirubin level>20 µmol/L, aspartat-aminotransfera-
se>35 i.j./L, alanin-aminotransferase>35 i.j./L), 
autoimmune disease, corticosteroid and immunosupre-
ssive use, and operation time exceeding six hours.
According to a computer generated randomisation list, 
50 patients were randomly assigned for one of three in-
tervention groups. Eight patients were dropped out; one 
could not have the epidural catheter placed. Finally, 42 
patients concluded the study (clonidine group, n=17; le-
vobupivacaine group, n=12, controle group, n=13). On 
the day before the operation, patients were informed on 
the perioperative procedure, especially of introducing an 
epidural catheter for pain therapy. Epidural catheter was 
inserted at the Th10-L1 level (BRAUN Perifix 20 G cat-
heter, winged 18 G Tuohy needle). Correct positioning 
was tested using 2 ml 2% lidocaine. Patient was observed 
for 5 minutes for the development of sensory blockade 
changes.
One hour prior to skin incision patients received 5 µg/
kg of clonidine [Catapres®, Boehringer Ingelheim, Ger-
many] or 7 mL of 0.25% levobupivacaine [Chirocaine®, 
Abbott S.p.A., Italy] or saline. Epidural catheter insertion 
and drug administration were performed by the anesthe-
siologist, who was not involved in the anesthesia mainte-
nance. The operation was performed under general ane-
sthesia using midazolam (0.15 mg/kg), fentanyl (2 µg/kg) 
and vecuronium (0.1 mg/kg) to facilitate endotracheal 
intubation, and sevoflurane, nitrous oxide 50% in oxygen, 
boluses of fentanyl and muscle relaxant for maintenance. 
After the surgery and recovery from anesthesia, patients 
were transferred to intensive care unit for continuous mo-
nitoring of vital functions and homeostasis. On their de-
mand, upon the pain complaint all patients received bo-
luses of epidural morphine 0.06 mg/kg diluted in 20 mL 
of isotonic saline. 
Before operation (T0), 1 h after the beginning (T1), 1 
h (T2), 6 h (T3), 12 h (T4) and 24 h (T5) after the ope-
ration following parameters were analyzed: procalcitonin 
(PCT), interleukine-6 (IL-6), C-reactive protein (CRP) 
and lactate.
The PCT level was measured using a semi-quantitati-
ve immunochromatographic rapid test (BRAHMS PCT-
Q, Diagnostica, Berlin, Germany). All samples were cen-
trifuged and examined using 6 drops of serum with 
enclosed dropper pipette into the cavity of the kit. After 
30 minutes at room temperature the PCT concentration 
range of the sample was determined. A PCT concentra-
tion ≥0.5 ng/ml can be seen as a reddish band; the color 
intensity is directly proportional to the PCT concentra-
tion. The validity of the test was checked in comparison 
of the control band. The PCT ranges were as follows: 
slightly elevated PCT = 0.5 ng/ml, moderately elevated 
>0.5 ng/ml, markedly elevated PCT ≥2 ng/ml and seve-
rely elevated PCT ≥10 ng/ml.
Measurement of IL-6 was performed with enzyme-
linked immunosorbent assay (ELISA), using commerci-
ally available kits (Bender MedSystems GmbH, Vienna, 
Austria). The study of CRP was determined by immuno-
turbidimetric method on the Olympus AU2700 analyzer 
(Tokyo, Japan). 
A randomisation schedule was computer generated by 
a biostatistician (not otherwise involved in the study). 
Statistical analysis was performed using SPSS 15.01 Sta-
tistical Package (SPSS Inc, Chicago, IL, USA). Kolmogo-
rov-Smirnov test was used to determine intragroup dis-
tribution. For quantitative variables with normal 
distribution one-way analysis of variance (ANOVA) and 
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Pearson correlation were used. When ANOVA yielded 
P<0.05, Scheffe’s multiple comparison test was used. Data 
were expressed as Mean±SD. Variable without normal 
distribution (PCT) was analyzed with nonparametric 
Kruskal-Wallis test and Spearman correlation. Data was 
expressed as median (25th–75th percentile). Qualitative 
data were compared using the c2 test. Statistical signifi-
cance was set at P<0.05.
Results
There were no significant differences in age, gender, 
body mass index (BMI), body surface area (BSA) and 
duration of operation among the groups of patients (Table 
1). In preoperative clonidine group, PCT levels remain 
unchanged, compared to preoperative levobupivacaine 
group, where PCT inceased at the end of investigation. 
Statistical differences were found at investigation times 
T3, T4 and T5 (Table 2). 
IL-6 levels were significantly lower in preoperative 
clonidine group throughout investigation time, compa-
red to preoperative levobupivacaine group. Statistical 
differences were comfirmed at investigation times T1, 
T2, T3, T4 and T5 (Table 3). CRP levels were signifi-
cantly lower in clonidine group compared to levobupi-
vacaine group at T5 (Table 4). Lactate levels were signi-
ficantly lower in clonidine group compared to 
levobupivacaine group in investigation time T0, and 
compared to controle group in investigation times T1, 
T2, T3 and T4 (Table 5).
Discussion
Patients undergoing major surgical resection are at 
high risk for postoperative infectious complications. They 
may benefit from early and efficient perioperative analge-
sia in order to attenuate systemic inflammatory stress 
response (17, 18). Epidural clonidine was superior to in-
Table 1
Patient’s characteristics (X±SD).
Clonidine group Levobupivacaine group Control group P
Age (yr)
Gender     
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travenous route in postoperative pain control and immu-
ne stress response blockade in investigation of Novak-
Jankovic et al., which benefit to his central effect  (5).
In our study, clonidine and levobupivacaine were ad-
ministered by epidural route. We did not observe side 
effects or complications of epidural analgesia during in-
vestigation. Usually, elective surgery induces an increase 
in PCT after 2 h, rapidly increases between 6–8 h, with 
highest concentrations at 18 h. The magnitude of elevati-
on is related directly to surgical trauma and inflammation 
(3, 4). Postoperatively, PCT levels were increased in pre-
operative levobupivacaine and controle group, but rema-
in unchanged in preoperative clonidine group. These re-
sults are similar to those of Sarbinowski et al. who 
emphasized importance of PCT as an early marker in 
differentiation of non-SIRS and SIRS patients following 
major oncological surgery (18), as well as results of Watt 
et al. (3).
Levels of IL-6 increases proportionally to severity of 
tissue trauma and inflammation within 1–3 h, with con-
centration peak at 6 h, and may remain elevated for 48–
72 h. In our study levels of IL-6 were significantly higher 
in levobupivacaine group and controle group, with high-
est rise at 6 h (T3). The pattern of change of IL-6 was 
similar to that of PCT, and comparable to results of Mo-
kart et al. (19) and Neunhoeffer et al. (16). Levels of CRP 
and lactate were also lower in preoperative clonidine 
group, but it was much less prominent.
In conclusion, using the centrally acting a2-adrenergic 
agonist clonidine before the pain stimulus has set in re-
sulted in reduced systemic inflammatory stress response 
compared to levobupivacaine. From the clinical point of 
view, this effect can contribute to reduction of postopera-
tive complications, which may be a worthwhile advantage 
to postoperative patients.
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Comparison of minimum effective volume of local  
anesthetic for ultrasound guided supraclavicular block 
(MeaV95) in elderly and middle aged patients
Abstract 
Backgrund and Purpose: The aim of this study was to determine the 
minimum effective volume of local anesthetic (LA) required to produce an 
efficient supraclavicular block in 95% of patients (MEAV95) using an ul-
trasound (US)-guided technique in an elderly (>65 y) and a middle aged 
group (<45 y) of patients. Furthermore, we aimed to calculate potency ratio 
of LA between the groups. We assumed a reduced MEAV95 in elderly group.
Matherials and Methods: Fourty-four patients (N=22 per group) un-
dergoing upper limb surgery received a US-guided supraclavicular block. 
The study method is a previously validated step-up/step-down sequential 
model where the volume of LA for each following patient is determined 
according to the outcome of the previous block. The starting volume was 30 
mL; in the case of block failure, the volume was increased by 5 ml. After 
successful block, the volume was reduced by 5 mL. MEAV95 was calculated 
using probit transformation and logistic regression. Potency ratio of LA is 
calculated using Fieller’s method.
Results and Conclusions: The calculated minimum effective anes-
thetic volume in 95% of patients was 16.49 mL (95% CI, 12.23–20.75 
mL) in elderly and 44.52 mL (95% CI, 19.05–69.99 mL) in middle aged 
group (95% CI, 0.7–55.3 mL, P=0.044). A potency ratio of LA between 
middle aged and elderly is 2.69 (95% CI 2.13 to 3.44). The minimum 
volume requirement for effective US-guided supraclavicular block in 95% 
of elderly patients was significantly reduced. A potency ratio of 2.69 indicates 
almost three times stronger LA potency in the elderly. 
introduction
Ultrasound-guided supraclavicular brachial plexus block (US-SCB) is widely used for upper extremity surgery because of its ability to 
anesthetize all four distal upper extremity nerve territories (the median, 
radial, ulnar and musculocutaneous) at the level of the clavicle. Elderly 
patients (>65 years) are particularly sensitive to local anesthetics (LA) 
in peripheral blocks and several mechanisms may account for the in-
creased sensitivity. Conduction velocities, number of large diameter fi-
bers and peripheral nerve (Na+, K+) ATP-ase all decrease with aging and 
smaller doses of LA are required for regional blocks in elderly patients 
(1, 2). Up to date, Duggan et al. (3) reported the minimum volume 
required for an effective US-SCB in 95% of patients (MEAV95). They 
performed a study on a population with an average of 48 years of age 
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and found MEAV95 to be 42 ml. Recently we conducted 
a  study where we described structural changes of bra-
chial plexus in the elderly population (4). We observed a 
significantly smaller surface area in comparison to the 
younger patients. Also, we determined the minimum vol-
ume of LA required for an effective US-SCB in 50% of 
patients (MEAV50) using the Dixon and Massey study 
protocol. However, in clinical practice, the MEAV50 car-
ries little probative value, the MEAV90 or MEAV95 pro-
vide a more accurate measure of the volumes needed to 
ensure a successful block. The aforementioned structural 
changes to the brachial plexus in addition to the increased 
sensitivity that the elderly patients exhibit to LA render 
the data referring to the minimum anesthetic volume re-
quired for an effective US-SCB in 95% of middle aged 
patients not applicable to the elderly population. There-
fore, the aim of this study is to calculate the minimum 
effective volume of LA (50:50 mixture of 0.5% levobupi-
vacaine and 2% lidocaine) required to produce an effec-
tive US-SCB for surgical anesthesia in 95% of patients in 
elderly patients (>65 years) and in middle aged patients 
(<45 years) by using logistic regression. We hypothesize 
reduced LA requirements for the elderly as compared to 
the middle-aged patients. Since the present study is a 
dose-response model, the secondary outcome is a potency 
ratio of LA between the two groups.
mAtheriAls And methods
After we obtained a Hospital Ethics Committee ap-
proval for the study as well as a written informed consent 
from every participant, we recruited 22 elderly (>65 years) 
and 22 middle aged (<45 years) patients undergoing upper 
limb surgery to this observer-blinded, up–down sequen-
tial allocation study. The study was registered in Clinical-
Trials.gov and identifier number NCT01467596 has been 
issued on the November 4th, 2011. The inclusion criteria 
were age (>65 years in elderly group and 18–45 years in 
middle aged group) and a pressumed upper limb surgery 
in nerve territories of the brachial plexus. Exclusion crite-
ria were the patient’s refusal of regional anesthesia, neu-
rologic or neuromuscular diseases, diabetes mellitus and 
clinical signs of cutaneous infection at the site of needle 
insertion. We examined all patients with the same ultra-
sound (Nemio Toshiba Medical System Inc 2001, Japan) 
with a linear 12 MHz probe. The patients were placed in 
a supine position with their heads turned opposite to the 
upper extremity being anesthetized. Brachial plexus is 
found lateral to the round pulsating hypoechoic subcla-
vian artery that lies on top of the hyperechoic first rib. 
Prior to performing the block we administered 25 mcg of 
fentanyl to all patients. We placed a 25G spinal needle (90 
mm, Quincke type, Vygon, France) on the outer (lateral) 
end of the probe and advanced it along the long axis of 
the probe in the same plane as the ultrasound beam (in 
plane techniqe). Once the needle tip almost reached the 
cluster on the ultrasound image, half of the LA volume 
was injected in proximity to the plexus. We then reposi-
tioned the needle cranially in order to distribute the re-
maining anesthetic volume around the entire brachial 
plexus cluster. For the purpose of block assessment, we 
defined time zero as the time of needle removal from the 
skin. Every 5 min for up to 30 min, a blinded observer 
checked for pinprick anesthesia with a 23G needle as well 
as for the loss of cold sensation by applying an alcohol 
swab in the central sensory region of each nerve location 
(the median, ulnar, radial and musculocutaneous nerve). 
The response was compared to the same stimuli delivered 
to the contralateral arm. We defined a successful block as 
a total loss of pinprick sensation and total loss of cold 
sensation in all four regions innervated by the distal 
nerves assessed within 30 min of LA injection. 
The starting volume of the LA mixture was 30 mL. If 
a successful block was achieved, volume of LA adminis-
tered to the following patient was reduced for 5 ml. Oth-
erwise, if a complete sensory block in any of distal nerve 
distributions did not occur, we declared it as failed block 
and increased the volume administered to the following 
patient for 5 mL of LA. We first estimated the minimum 
effective volume required in 50% of patients (MEAV50) 
and then applied logistic regression to calculate the 
MEAV95. We only used the data of unsuccessful blocks to 
estimate MEAV50 and its 95% confidence interval (CI), 
applying it to the empirical formula of Dixon and Massey 
for large sample (x =(∑fi xi / n) + d/2; x is MEAV50;  xi is 
volume of LA;  fi  is frequency of successful or unsuccess-
ful sensory blocks associated with used LA volume; n is 
the total number of patients with successful or unsuccess-
ful blocks, and d is volume interval-5 ml) (5). We based 
the sample size calculation on the anticipated mean LA 
volume from previous studies that analysed US-SCB (3, 
6–8). Since our recent study showed structural changes 
of the  brachial plexus in elderly associated with an almost 
50% reduction in MEAV50 of LA, we presumed a mini-
mum of a 40% reduction of MEAV95 in elderly patients. 
Based on that assumption, we expected a MEAV95 of 25 
Table 1





Age, (years) 74.7 ± 7.1 41.6 ± 5.9
BMI, (kg/m2) * 26.5 ± 3.5 25.9 ± 2.9
Male/Female, (n) 8/14 13/9
ASA status I/II/III/IV, (n)** 0/5/14/3 7/14/1/0
Surgical time, (min) 76.1 ± 33.9 89.6 ± 33.8
Data are expressed as mean ± SD or n (Number of patients)
* BMI – body mass index
**  ASA status – American Society of Anestesiology classification sys-
tem for assessing the fitness of patients before surgery
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ml (i.e. 40% of 42 ml from Duggan’ study) with an esti-
mated SD of 10 ml. Such volume difference is also clini-
cally significant (effect size, d=0.6). A probability level of 
0.001 and power of 0.90 yielded a sample size of at least 
21 patients for each tested group. We performed all cal-
culations using the Minitab 15 statistical software.
results
Twenty-two patients in each group completed the 
study protocol. We achieved an appropriate ultrasound 
visualization of the brachial plexus at the first rib for all 
patients. The study group baseline characteristics are 
shown in Table 1. The sequence of successful and unsuc-
cessful US-SCB in elderly group is presented in Figure 1. 
The same data for the middle-aged group are shown in 
Figure 2. We calculated effective volumes of 16.49 mL 
(95% CI, 12.23 – 20.75 mL) and 44.52 mL (95% CI, 
19.05 – 69.99 mL) for US-SCB in 95% of patients in the 
study group and in the middle aged group, resepctively. 
A potency ratio of local anesthetics between the middle 
aged and the elderly is 2.69 (95% CI 2.13 to 3.44). The 
administered volumes ranged from 30 to 5 mLfor the 
elderly group, while the administered volumes ranged 
from 35 to 10 mL in the middle-aged group. Nine pa-
tients in the elderly group had a failed block. Ten patients 
in the middle-aged group had a failed block. 
discussion
In the present study we demonstrated that the calcu-
lated minimum effective LA volume required to produce 
an effective US-SCB in 95% of patients is 16 mL for the 
elderly and 44 mL for the middle-aged patients thus sup-
porting our hypothesis of a reduced LA volume required 
for US-SCB in the elderly. We found that the elderly re-
quired an approximately two and half times smaller vol-
ume of LA mixture for an effective US-SCB in 95% pa-
tients in comparison to the MEAV95 determined for the 
middle aged population. On one hand, these results 
might be explained by the morphological changes of pe-
ripheral nerves due to aging, and on the other hand by 
increased sensitivity of the elderly to LA agents. Aging 
related structural changes of brachial plexus in supracla-
vicular region were assessed by measuring the cross sec-
tional surface area as high-resolution sonography appears 
to be accurate and previously validated tool for the assess-
ment and mapping of the brachial plexus (6, 9–12). The 
brachial plexus surface area of the elderly patients, as mea-
sured at the first rib, is approximately two times smaller 
than the brachial plexus surface area of the middle aged 
patients, measured at the same site. We attribute the dif-
ference to global involutive changes of the peripheral ner-
vous system that affect brachial plexus as well. Since the 
area to be blocked was two times smaller in comparison 
to the middle aged population, we assume that the LA 
requirements are reduced for elderly patients. Further-
more, the present study explored the dose-response rela-
tionship of LA according to different age of patients and 
we report a potency ratio of 2.69 indicating that LA re-
quirements in middle age are greater by a factor of 2.69. 
Therefore, a dramatically stronger effect of LA is observed 
in elderly patients as LA requirements for effective sen-
sory blockade are two and half times lower.
The present study might have some limitations. To 
date, the majority of published dose-finding studies have 
focused exclusively on MEAV50 and relied on the Dixon 
and Massey up-down method (3, 13–16). Historically, 
the up and down methods were employed to investigate 
the concentration of inhaled anesthetic agents required to 
Figure 2. Up-and-down sequences of US-SCB in middle aged group
Figure 2 presents step-up/step-down sequence model where the local anes-
thetic volume for the following patient is determined by the outcome of 
previous block. The starting volume was 30 ml. In the case of block failure, 
the volume was increased by 5 mL whereas after successful block, the volume 
was reduced by 5 mL. The calculated effective volume for US-SCB in 95% 
of patients (MEAV95) is 44.52  mL.
Figure 1. Up-and-down sequences of US-SCB in elderly group
Figure 1 presents step-up/step-down sequence model where the local anes-
thetic volume for the following patient is determined by the outcome of 
previous block. The starting volume was 30 ml. In the case of block failure, 
the volume was increased by 5 mL whereas after successful block, the volume 
was reduced by 5 mL. The calculated effective volume for US-SCB in 95% 
of patients (MEAV95) is 16.49  mL.
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prevent movement upon surgical incision in 50% of pa-
tients, the ED50 which is also known as minimal alveolar 
concentration (17). As the concentration-response relation 
for inhaled anesthetics is steep, the ED95 can be estimat-
ed using the ED50 (18). Furthermore, the sample sizes 
required by up and down methods are usually small (17). 
These two factors have contributed to their great popular-
ity. Unfortunately, the dose –response curve of other an-
esthetic agents differs (for example, LA) and may not be 
as steep as for inhaled anesthetics. Therefore, the particu-
lar Dixon and Massey up and down methodology has 
recently been criticized as insufficient for accurate deter-
mination of LA doses, particularly the extrapolation of 
the MEAV95 number. Tran et al. recently published two 
studies in which the biased coin design was used to ap-
proximate minimum effective LA volume for ultrasound 
guided peripheral nerve blocks (19, 20). However, the 
present study reports a MEAV95 of 16 mL in the elderly 
and 44 mL in the middle aged patients that strongly cor-
relates with our clinical practice and provides an accurate 
measure of the volume needed to ensure successful blocks. 
Therefore, as far as we are concerned, the Dixon and 
Massey method is still methodologically acceptable, even 
though it is now becoming a little outdated.
In conclusion, the present study demonstrates reduced 
requirements (MEAV95) as well as a stronger effect of LA 
in elderly patients. 
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arterial pressure and heart rate changes in patients 
during “beach chair position” for shoulder surgery: 
comparison of the regional and general anesthesia 
techniques
Abstract
Background and Purpose: Patients scheduled to shoulder surgery are 
placed in a sitting position called  “the beach chair position” during the 
operation. This type of surgery can be performed with two anesthetic tech-
niques: general anesthesia or regional anesthesia (interscalene block). This 
patient positioning is characterized by changes in heart rate and systemic 
blood pressure. The aim of this study is to show whether the type of anes-
thetic technique influence the changes in systemic pressure and heart  rate 
in this particular patient position. 
Materials and Methods: Retrospective clinical study with reviewed 
anesthetic charts and medical documentation of the patients scheduled for 
elective shoulder surgery. Point measurements of systolic and diastolic blood 
pressure and heart rate were: before surgery, after the positioning of the 
anesthetized patient, at the end of the operation (lodging of the patient) and 
then the lowest recorded pressure and heart rate during surgery.
 Results: The study included 66 patients in the sitting position for shoul-
der surgery. Positioning  the patients in the beach chair position for shoulder 
surgery in a population of patients undergoing general anesthesia in relation 
to the population of patients treated under regional anesthesia, had a sig-
nificant effect on the decline in systolic blood pressure  (p<0.001) and dya-
stolic blood pressure (p=0.008). 
Conclusion: Regional anesthesia has proven again to be the superior 
technique over general anesthesia,  including cardiovascular stability in 
patients subjected to shoulder surgery in the beach chair position.   
introduction
Shoulder surgery is a common ortopaedics procedure, more often per-formed in the sitting position called “the beach chair position” (BCP). 
This position offers the surgeon a better shoulder joint access and visu-
alisation, especially during shoulder arthroscopy. Nevertheless, this posi-
tion from the anesthesiologist point of view, carries significant risks for 
the patient.  It is known that positioning the patient which is anesthetised, 
raises a certain issues related to changes in arterial pressure and pulse 
regulation (1). General anesthesia (GA) is an attenuating factor for phys-
iological regulating mechanisms due to changes of the body position. 
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Muscular relaxation as well as analgesia and anesthetic 
drugs contibute significantly to cardiovascular instability 
(2) related to  the  modification of the auto nomic nervous 
system activity (3). Positioning the awake patient with in-
terscalene block (ISB) performed, also changes the arterial 
pressure, because of the postural hypotension and the time 
needed for autonomic nervous system to adjust. It has been 
noted that some patients with ISB  in BCP also have hy-
potensive episodes during the surgery, which are sudden 
and often accompanied with profound bradicardy (4).
This type of surgery can be performed with two anes-
thetic techniques: general anesthesia with  mechanical 
ventilation or regional anesthesia (interscalene block) with 
or without sedation. Sometimes, these two techniques can 
be combined. In this study, we compared two groups of 
the patients, general and regional anesthetic technique 
and their influence on the changes of heart rate and  arte-
rial pressure due to body positioning required for this type 
of surgery.  
mAteriAls And methods
A retrospective analysis of the  medical documentation 
and anesthetic charts was performed for 66 patients un-
dergoing elective shoulder surgery in the beach chair po-
sition. Shoulder arthroscopy was done in 46 patients, and 
open shoulder surgery in 20 patients.  General anesthesia 
with mechanical ventilation was performed in 21 patients, 
and interscalene block with or without sedation in 45 
patients. Every patient was sedated preoperatively with 
midazolam, with venous access and standard monitoring 
established (pulse oximetry, electrocardiography and non-
invasive arterial blood pressure monitoring).
Induction to general anesthesia was done with thiopen-
tal or propofol and neuromuscular relaxation with vecuro-
nium or rocuronium, with dose adjusted to body weight. 
After the tracheal intubation, the maintenance of anesthe-
sia was done with sevoflurane (Sevorane , Abbot) or isoflu-
rane (Forane, Abbot) in O2:N2O=35–40%:65–60%. In-
traoperative analgesia was achieved either with fentanyl or 
sufentanyl.
Interscalene block was performed under the ultraso-
und guidance (ALOKA ProSound 3, Hitachi Medical 
Corporation and Hitachi Aloka Medical Ltd., Tokyo, 
Japan) with 0,5 % levobupivacaine or 0,75 % ropivacaine, 
with or without  2% lidocaine added, varying  the local 
anestehetic dosage from minimum of 17 ml to maximum 
of 30 ml. After the skin preparation with chlorhexidine, 
the ultrasound guided interscalene block was performed. 
With ultrasound guidance cervical and brachial plexus 
nerves were  visualised between the scalene muscles and 
the needle was directed towards with the injection of local 
anesthetic. After the procedure, sensory and motor block-
ade were evaluated in 10-minutes intervals (warm, cold, 
touch, pain, movement). During the operation some pa-
tients required additional sedation with midazolam, pro-
pofol, fentanyl or sufentanyl, but all of them were breat-
hing spontaneusly during the operation.    
Four points for measurement of systolic and dyastolic 
blood pressure and heart rate were analysed: before sur-
gery,  after the positioning of the anesthetized patient to 
the BCP, at the end of the operation (positioning the pa-
tient supine) and then the lowest recorded pressure and 
heart rate during the surgery. Results are reported as mean 
±SD and considered statistically significant at the  p<0.05. 
Demographic data were descriptively analysed, whereas 
BP and heart rate values at dedicated time in study for 
both groups were compared using Two-way ANOVA re-
peated measures (RM) and Student’s t-test for indepen-
dent samples for comparison of the lowest recorded valu-
es of heart rate and BP. Data were analysed using the 
statistical program Prism 5.03, GraphPad Software Inc., 
La Jolla, USA).
results 
The study included 66 patients in the BCP for shoulder 
surgery. Of these, 34 patients were men and 32 women. 
ASA I – 15 patients, ASA II – 42 patients, ASA III – 9 
patients. In 46 patients shoulder arthroscopy was perfor-
med and open shoulder surgery in 20 patients. GA with 
mechanical ventilation was performed in 21 patient and 
ISB with or without sedation was done in 45 patients.
There are no differences in age, weight, intraoperative 
fluid intake and duration of the operation between these 
two groups. The two groups of patients were comparable 
Table 1
Data from 66 patients in the beach chair positi-
on. Values are mean ±SD for age, body weight, 
fluid intake and the duration of the operation and 
descriptive for sex, hypertension, smoking, and 
the need for atropine or ephedrine; * p=0.003, 
Fischer exact test.
IBS group (n=45) GA group (n=21)
Age (years)   53,56 ±9,45 51,48 ±11,29
Sex ratio (F:M) 21:24 9:12
Body weight (kg) 81,40 ±14,86 75,62±16,26
Intraoperative fluid 
intake (ml) 888,89±317,82  1047,62±218,22 
hypertension 20 6
smoking 16 5
need for atropine 8 5
need for ephedrine* 2 7 
duration of the 
operation 46,00 ±16,88 44,52 ±15,16
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When these two groups (GA and ISB) were compared, 
positioning the patients in the BCP had a significant ef-
fect on the decline in systolic blood pressure in a popula-
tion of patients undergoing GA (99.76 ± 20:28 mmHg) 
during shoulder surgery in relation to the population of 
patients treated under ISB (128.00 ± 23.61 mmHg; F 
(1,64)=14.01, p<0.001, Two-way ANOVA RM; Figure1.). 
As with systolic pressure, when we compared these two 
groups, positioning the patient in the BCP had a signifi-
cant consequence to the dyastolic pressure decrease in the 
group with GA in comparison to the group with ISB (F 
(1,64)=7.41, p=0.008, Two-way RM ANOVA; Figure 1.).
Comparing the heart rate values recorded at these four 
points of measurement, there were no significant differen-
ce between groups at any time. (F(1,64)=7.41, P=0.2313, 
Two-way ANOVA RM). Hypertensive patients were 
com pared with non-hypertensive patients in GA and in 
ISB group, within the group, and there were  no signifi-
cant difference in BP (both systolic and dyastolic) in any 
point of measurement, as well as in hypertensive patients 
compared between the groups. 
Comparison betwen the  GA and ISB group was done 
regarding the lowest recorded pressure and heart rate  du-
ring the BCP . There is a statistically significant differen-
ce between the GA and ISB group with both, systolic (t 
(64) = 4.125, p=0.000) and dyastolic pressure t(64) = 
3.429, p=0.001 (Student’s t-test for independent samples). 
There is no statistically significant difference in heart rate 
between these two groups (t(64) = 1.566, p=0.122, 
Student’s t-test for independent samples) as shown in Fi-
gure 2.
discussion
This study demonstrates significant changes in the 
blood pressure variations observed during the elective 
shoulder surgery in BCP, between the two groups of pa-
tients (regional or general anesthesia). Patients in this 
particular position during the surgery are prone to hypo-
tension due to venous pooling and postural hypotension. 
General anesthesia has a tendency to blood pressure and 
heart rate variations due to the blunting of the sympathe-
tic nervous system. But, it is not always so easy to find the 
balance between avoiding too harmful surgical stimuli 
and keeping the protective role of the sympathetic nervo-
us system for patients.  
It is very well known that peripheral nerve blockade 
offers more cardiovascular stability that general anesthe-
sia, which is again proved  in our study. That is not enti-
rely true. There are numerous reports of vehement, pro-
found bradycardia and hypotension which can progress 
to cardiac arrest (4), particularly in patients during sho-
ulder surgery in BCP performed in ISB. This is called the 
Bezold-Jarisch reflex, and there are many attempts to 
explain this event. Some authors however doubt that the-
Figure 2. Comparison between the GA and ISB group regarding the 
lowest recorded pressure and heart rate during the BCP (*p<0.001; 
**p=0.001, Student’s t-test for independent samples).
Figure 1. Comparison of the systolic and dyastolic blood pressure at 
different points of measurement (baseline, after the positioning of 
the anesthetized patient in the BCP and at the end of the operation) 
between the group of patients undergoing GA to the population of 
patients treated under ISB  during shoulder surgery, *p<0.001 
(Two-way ANOVA RM)
within baseline characteristics. There is a statistically sig-
nificant difference in the need for ephedrine between 
groups; the GA group received more ephedrine (Table 1).
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se dramatic events are related to this reflex (5). There are 
some possible explanations in the recent literature related 
to this occurence:  adverse effects of interscalene brachial 
plexus block, vasovagal syncope, carotid sinus hypersen-
sitivity or orthostatic syncope. Other proposed mechani-
sms to explain the  bradycardia, hypotension, and perip-
heral vasodilation  are that this triad is mediated by 
activation of some inhibitory reflexes, which have origin 
with cardiac sensory receptors which leads to stimulation 
of the parasympathetic and inhibition of the sympathetic 
activity. This vasovagal reaction could be related to veno-
us pooling (because of  the sitting position and epinep-
hrine-induced beta-adrenergic effect) and increased heart 
inotropy (also beta-adrenergic effects of epinephrine). 
Epinephrine may be released  endogenously due to the 
reduced venous return and carotid baroreceptor stimula-
tion, or exogenously from epinephrine sometimes admi-
nistered by the surgeon due to wound infiltration or via 
the irrigation solution. An empty hypercontractible ven-
tricle, due to increased sympathetic tone, causes stimula-
tion of intramyocardial mechanoreceptors C fibers, wit-
hdrawal of sympathetic outflow induces vasodilation and 
vagal overbalance which leads to bradycardia and hypo-
tension and may be then followed by syncope (3). In this 
study four patients in IBS group had this sudden bradycar-
dia or hypotension. They were all treated with atropin, 
two of them required repeated doses and one patient lost 
consciousness, so he had to be intubated. After the ope-
ration they all recovered without any neurological deficits. 
Questions are raised about the influence of hypotensi-
on on cerebral perfusion in these  patients during the BCP 
(6) Many authors suggest the additional monitoring in 
the perioperative period for cerebral perfusion and oxy-
genation (7) in order to anticipate and prevent possible 
brain damage (5). 
There are also some proposed maneuvers how to atte-
nuate these events: slowly increasing the angle of the ope-
rating table for the elevation in the BCP, allowing the time 
for the  cardiovascular system adaptation. Several studies 
have shown that if blood vessels can be compressed from 
the outside (using tight compression garments or military 
anti-shock trousers), the abnormal heart rate and BP chan-
ges  can be reduced or eliminated. Surgeons often ask for 
help from anesthesiologist to induce hypotension for 
better visualisation and bleeding control, but the safer 
option is to raise the arthroscopic pump pressure, rather 
than risk the inadvertent cerebral hypoxia. There is also 
an issue on blood pressure measurements: how and where 
to measure the arterial blood pressure in patients which 
are positioned in BCP. Some authors suggest that measu-
rements should be performed at the level of the brain, for 
that purpose, because of the large hydrostatic gradient 
existing between the brain and the site of BP measurement 
(1, 8). According to them, there is a decrease of approxi-
mately 2 mm Hg for every inch (2,54 cm) of height dif-
ference between the blood pressure cuff and the brain. So, 
the conclusion drawn from this is that a blood pressure 
measurement taken with cuff at brachium does not accu-
rately reflect the actual values at the brain level (9). 
There are some limitations regarding to this study: the 
major drawback is its retrospective character following 
different medications used in different dosages, unequal 
number of participants between the groups and credibil-
ity of the recorded BP and heart rate data in the anes-
thetic medical chart. 
To conclude, the regional anesthesia has proven many 
times to be superior technique over GA during the whole 
perioperative period for many reasons, including: cardio-
vascular stability, analgesia, faster recovery and fewer 
complications. With ultrasound guidance and direct vi-
sualisation of the nerves potential neurological damage is 
minimal.  Even though, during the shoulder surgery in 
the BCP, both in GA or ISB, one must be careful, due to 
events described in this paper.  Monitoring the regional 
cerebral oxygen saturation in patients undergoing shoul-
der surgery in the upright (BCP) position, could be an 
useful tool  during routine anesthesia management in or-
der to prevent possible catastrophic events.
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The influence of dexamethasone administration in  
spinal anesthesia for femur fracture on postoperative 
cognitive dysfunction
Abstract
Background and Purpose: Cognitive side-effects often complicate 
postoperative care especially in elderly and fragile patients.The aim of this 
research is to establish the influence of intrathecal dexamethasone admin-
istration in spinal anesthesia with levobupivacaine on postoperative pain, 
consciousness and values of cortisol levels for patients with femur fracture.
Methods: The study is planned as a prospective, interventional, random-
ized clinical trial. A total of 60 patients ASA2 and ASA3 status, scheduled 
for surgical procedures will be sorted into two groups and undergo surgery. 
One group will have spinal anesthesia with levobupivacaine, SA group, and 
the other study group will have spinal anesthesia with addition of dexa-
methasone, DSA group. The primary outcome measure is the occurrence of 
postoperative disturbance of consciousness and plasma cortisol levels. As a 
secondary outcome measure, we are following pain intensity, blood glucose 
levels and recovery. Cortisol and glucose are analysed in five measurements. 
Peripheral venous blood samples are collected before anesthesia, one hour 
after surgery, third, fifth and on the tenth day after surgery. Postoperative 
cognitive dysfunction is defined by using Confusion Assessment Method 
(CAM) criteria. Visual analog scale (VAS) is used to record pain severity 
among patients. 
Results: We collected data for 28 patients so far. Preoperative cortisol 
levels were 713,25nmol/L,pain intensity(VASscore) 8,3.  Postoperative cor-
tisol plasma levels in 17 patients in DSA group were significantly lower 
384(184-511) nmol/L in comparison to 11 patients in SA group with post-
operative cotisol plasma levels 551(397-753) nmol/L. The duration of anal-
gesia in DSA group was 428(350-510) minutes and in SA group 212(183-
254) minutes. According to CAM criteria, postoperative cognitive 
disturbances were seen in 8 (72%) patients in SA group, and 3 (17%) pa-
tients in DSA group.
Conclusion: The addition of dexamethasone to the local anesthetic has 
proven so far that it significantly prolongs the duration of sensory block 
and, thus, decreases opioid requirements and postoperative cognitive dis-
turbances.
introduction
Surgical stress is the systemic response to surgical injury and is char-acterized by activation of the sympathetic nervous system, endocrine 





1  Department of Anesthesiology,
Reanimatology and Intensive Medicine,  
University Hospital “Sveti Duh” 
Sveti Duh 64, 10000 Zagreb, Croatia
2  Department of Anesthesiology, 
Reanimatology and Intensive Medicine,  
University Hospital Center Zagreb  
Ki{pati}eva 12, 10000 Zagreb, Croatia
3  Department of Psychiatry 
University Hospital Center Zagreb,  
Ki{pati}eva 12, 10000 Zagreb, Croatia
4  Faculty of Medicine, University  of Osijek
Department of Anesthesiology,  
Reanimatology and Intensive Medicine  
Cara Hadrijana 10/E, 31000 Osijek, Croatia
 
Correspondence:  
Livija [aki}, MD 
Department of Anesthesiology,  
Reanimatology and Intensive  Medicine  
University Hospital “Sveti Duh”,  
Sveti duh 64, 10000 Zagreb, Croatia 
E-mail: mitzilivila@yahoo.uk.com
 
abbreviations (in alphabetical order):
ASA = American Society of Anesthesiologists 
CAM  = Confusion Assessment Method  
CI =  Cognitive Impairment   
DSA = Dexamethasone in Spinal Anesthesia  
HPA = Hypothalamic -Pituitary- Adrenal 
MCI =  Mild Cognitive Impairment   
POCD = Postoperative Cognitive Dysfunction  
SA = Spinal Anesthesia  
VAS  = Visual Analog Scale
 
Received May 5, 2015.
Livija Šakić et al. Dexamethasone  in stress response, perioperative  analgesia and postoperative cognitive dysfunction
282 Period biol, Vol 117, No 2, 2015.
3). Spinal analgesia administered before the pain stimulus 
or surgical injury, prevents harmful central nervous sys-
tem response and inflammation as an early consequence 
of operation as well (4, 5, 6). Neuroinflammation is be-
lieved to have a role in the pathogenesis on postoperative 
delirium /confusion and postoperative cognitive dysfunc-
tion (8).
Cognitive side-effects such as emergence agitation 
(EA), postoperative delirium (POD) and postoperative 
cognitive dysfunction (POCD) are often complicating 
the postoperative care especially in elderly and fragile pa-
tients (8).
The aim of this research is to establish the influence of 
intrathecal dexamethasone administration in spinal an-
esthesia with levobupivacaine on postoperative pain, con-
sciousness and values of cortisol levels for elderly patients 
with femur fracture.
MATERIAL AND METHODS
The research was carried out in the double-blinded 
manner, with due approval from the institutional Ethics 
Committee and an informed consent from all study sub-
jects. The study is planned as a prospective, interven-
tional, randomized clinical trial. Inclusion criteria were 
patients with well-defined fracture femur for surgical 
procedure in spinal anaesthesia. Exclusion criteria were 
diabetes mellitus, autoimmune disease, corticosteroid 
and immunosupressive use. A total of 60 patients ASA2 
and ASA3 status, scheduled for surgical procedures were 
sorted into two groups and undergo surgery in spinal 
anesthesia with 12,5mg of levobupivacaine, SA group, 
and with addition of  8mg of dexamethasone, DSA 
group. The primary outcome measure was the occur-
rence of postoperative disturbance of consciousness and 
plasma cortisol levels. As a secondary outcome measure, 
we followed pain intensity, blood glucose levels and re-
covery. Cortisol and glucose were analyzed in five mea-
surements. Peripheral venous blood samples were col-
lected before anesthesia, one hour after surgery, third, 
fifth and on the tenth day after surgery. Postoperative 
delirium was defined by using Confusion Assessment 
Method (CAM) criteria. Visual analogue scale (VAS) is 
used to record pain severity among patients.
RESULTS
We collected data for 28 patients with femur fracture 
undergoing surgery so far. In DSA group median age was 
83 years (range 73-95), and  SA group median age was 78 
years (range 54-91), 6 patients were ASA 2, 22 were ASA 
3. All patients completed the study; there was no statisti-
cal difference in patients’ demographics.Preoperative cor-
tisol plasma levels in 17 patients in DSA group and 11 
patients in SA group were increased (Table 1). 
Postoperative cortisol plasma levels in 17 patients in 
DSA group were significantly lower  384(range 184-511) 
nmol/L in comparison to 11 patients in SA group with 
postoperative cotisol plasma levels 551 (range 397-753) 
nmol/L. The duration of analgesia in DSA group was 
428+72.57minutes and in SA group 212+34.76 minutes. 
A pain-free period in the DSA group was longer than that 
in the SA group(P<0.001). Receiving time to VAS >6 and 
the first analgesic dose prescription in the DSA group was 
significantly longer than that in the SA group (P<0.001) 
Table 2. 
According to CAM criteria some kind of postoperative 
cognitive impairment was seen in 8(72%) patients in SA 
group of which we had 5 patients (45%) with moderate 
cognitive impairment (hyperalert, overly sensitive to en-
vironmental stimuli, startled easily) and 3 patients (27%) 
with mild cognitive impairment (disorganized thinking). 
In the DSA group we had 3 patients (17%) who developed 
Table 1
Comparisons of patient’s demographic and clinical data with hip fracture.
Group DSA Group SA
N Median Minimum Maximum N Median Minimum Maximum
Age (yr) 17 83 73 95 11 78 54 91
Cortisol before block nmol/L 17 713,25 445,10 1020,64 11 639,50 301,15 887,56
VAS before block 17 8,2 5 10 11 8,3 6 10
Duration of surgery (min) 17 114,54 65,15 170,00 11 108,30 63 175
Data presented as median(min-max) measured variables. Age, Cortisol  before block, VAS = visual analog scale, duration of analgesia P<0.05
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mild or moderate cognitive impairment which was due to 
patients’ preoperative cognitive status.
Hypotension was mild to moderate in both groups and 
was not different. 
There was not postdural puncture headache detected. 
Other complications such as bradycardia, nausea, and 
vomiting were not different between the two groups and 
no neurologic deficit was observed in any patients.
discussion
Femur fracture is a common, mutilating and very ex-
pensive health problem. 10% of all fractures are femur 
fractures and these patients occupy more than 25% of 
beds in orthopedic hospitals. The mortality rate is very 
high, and only less than a half of injured people become 
mobile again after surgery (1). In Croatia, there are about 
6000 fractures per year.
These are mainly elderly patients. Approximately 70% 
of patients will be of ASA physicalstatus 3–4: 35% have 
one co-morbidity; 17% have two; and 7% have three or 
more. The most common comorbidities are cardiovascu-
lar disease (35%), respiratory disease (14%), cerebrovas-
cular disease (13%), diabetes (9%), malignancy (8%) and 
treated renal disease (3%) (9).
Approximately 25% of patients with hip fracture have 
moderate or severe cognitive impairment, and a further 
15–25% have mild cognitive impairment. Approximately 
25% of patients with hip fractures have at least moderate 
cognitive impairment (abbreviated mental test score < 7), 
20% are institutionalised, and 50% require walking aids 
or are immobile (10).
Mortality after hip fracture has remained relatively 
unchanged for the last two decades. Currently, 8.4% of 
patients die within 30 days of surgery. However, it has 
been suggested that up to half of postoperative deaths 
are potentially preventable. Thirty-day mortality is in-
creased for older, sicker, male patients. Up to 15–30% of 
patients die within a year of surgery (11, 12). The dura-
tion of the recovery of cognition after anesthesia and 
surgery is multifactorial and among other factors is de-
pendent on the type of anesthesia used, the type of sur-
gery and the patient. POCD is considered to be a subtle 
deterioration in cognitive function, lasting for weeks, 
months or longer. It can be considered to be a mild cog-
nitive disorder characterized by impairment of memory, 
learning difficulties and reduced ability to concentrate. 
Patients are frequently anxious about the surgery they 
are about to undergo (13).
Major surgery causes an endocrine response with 
release of hypothalamic-pituitary-adrenal (HPA) and 
sympathetic nervous system hormones. Cognitive im-
pairment has been associated with high levels of gluco-
corticoids, as documented in a variety of experimental 
and clinical studies. Cortisol has been found to be 
toxic to cells in the hippocampus, and this structure 
plays a critical role in the consolidation of short-term 
into long-term explicit memory as well as descending 
control of the HPA axis. This gave rise to the hypoth-
esis that repeated episodes of stress cause decreased hip-
pocampal inhibition of the HPA axis and, thus, pro-
longed hyperactivation. It seems that cortisol secretion 
pattern is profoundly affected (i.e. flattened) by major 
surgery and this flattening is significantly related to the 
occurrence of early postoperative cognitive dysfunction 
(14, 15, 16).
Our early results confirm corellation between in-
creased plasma cortisol levels after fracture with VAS 
score and cognitive imapairment. Mild cognitive impair-
Table 2
Comparisons of postoperative cortisol levels, pain level, analgesia duration and POCD.
Group DSA Group SA
N Median Minimum Maximum N Median Minimum Maximum
Cortisol after block nmol/L 17 384,56 184,10 511,35 11 551,40 397,05 753,17
Total of analgesia 17 428 350 510 11 212 183 254
VAS 12h postop 17 0 0 0 11 0,60 0 3
VAS 1 postop day 17 1 1 6 11 3,87 1 6
VAS 2 postop.day 17 0,50 1 2 11 2,50 1 5
CAM POCD (%) 17 3 Mild CI 2 (11%)
Moderate 





Data presented as median(min-max) measured variables. VAS postop = postoperative visual analog  scale, TA = total analgesia; CAM=Confusion As-
sessment Method, POCD= Postoperative Cognitive Dysfunction, CI=Cognitive Impairment , P<0.05
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ment (MCI) is associated with a higher risk of postopera-
tive delirium. Perioperative cortisol and inflammatory 
alterations observed in MCI may provide a physiological 
explanation for this increased risk (13). Spinal anaesthesia 
results in less immunosupression, i.e. maintains the num-
ber of Th1 cells, thus stimulating the cell immunity (6). 
Recent findings demonstrate a neuroprotective effect of 
local anaesthetics, leading to significant reduction in cog-
nitive dysfunction after surgery (4). Elderly patients > 60 
yr of age and undergoing major surgery subjected to gen-
eral anaesthesia displayed more frequent cognitive impair-
ment during the immediate postoperative period in com-
parison to those who received a regional technique (12). 
Daniels AH et al. showed that many elderly hip fracture 
patients had unrecognized CI before surgery, and cogni-
tive impairment (CI ) patients had significantly more pain 
than normal cognitive (NC) patients did. Appropriate 
identification of preoperative CI and treatment of pain 
are crucial in optimizing patient outcomes. Patients with 
PreCI have an increased incidence of POCD and cogni-
tive decline. Preoperative CI is a good predictor of subse-
quent postoperative cognitive dysfunction (POCD ) and 
cognitive decline after 12 months in this group of patients 
is low (11). Dexamethasone added to the local anesthetic 
and administered intrathecally relieves pain by reducing 
inflammation and blocking transmission of nociceptive 
C-fibers and by suppressing ectopic neural discharge (17). 
It has been shown that the duration of postoperative an-
algesia was prolonged when dexamethasone is given as an 
adjunct for peripheral nerve blocks (18, 19). Although 
dexamethasone has been used intrathecally for many 
years, it has not been evaluated when it was given in con-
junction with bupivacaine intrathecally. Our  investiga-
tion confirmed  the effect of conjugation of dexametha-
sone with levobupivacaine  the prolong  duration  time of 
spinal anesthesia and analgesia compared with spinal an-
esthesia with only levobupivacaine.
conclusion
The addition of dexamethasone to the local anesthetic 
significantly prolongs the duration of sensory block and 
decreases opioid requirements and postoperative cognitive 
disturbances.  There is a need to improve their knowledge 
around risk factors, prevention and management of post-
operative cognitive dysfunction.
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effects of age on onset time and duration of sensory 
blockade in ultrasound guided supraclavicular block
Abstract
Background and purpose: Involutive changes of brachial plexus occur 
with aging. The aim of this study was to determine if these changes would 
effect onset time and duration of sensory blockade in all four distal nerves of 
brachial plexus  in middle aged (<50 years) and elderly patients (>65 years).
Materials and Methods: Middle aged (N=22) and elderly patients 
(N=22) undergoing upper limb surgery received an ultrasound guided su-
praclavicular block with a mixture of local anesthetics (50 : 50, 0.5% levo-
bupivacaine, 2% lidocaine). The prospective, observer-blinded study method 
is a previously validated step-up/step-down sequential model where the local 
anesthetic volume for each following patient is determined by the outcome 
of the previous block. The starting volume was 30 ml. Only the blocks with 
complete sensory blockade in all four regions of distal nerves were analyzed 
for the onset time and duration of sensory blockade.
Results and conclusions: The mean (SD) block onset time was 25.8±0.6 
min and the mean (SD) block duration was  151.5±8.9 min in the entire 
middle aged group. In the entire elderly group, the mean (SD) block onset time 
was 21±0.82 min and the mean (SD) block duration was 195.75±14.99 min. 
The difference in both, onset time and duration was significant (P=0.0002, 
95%CI 3.352–6.248; P=0.0023, 95% CI 65.63–22.95, respectively). In 
conclusion, local anesthetics have a faster onset time and longer duration of 
sensory blockade in elderly due to alterations of peripheral nerves and in-
creased sensitivity to local anesthetics.
 
introduction
Ultrasound-guided supraclavicular brachial plexus block (US-SCB) is widely used for upper extremity surgery as it enables anesthesia 
of all four distal upper extremity nerve territories (the median, radial, 
ulnar and musculocutaneous) at the level of the clavicle (1). Several 
mechanisms may account for the increased sensitivity of elderly popula-
tion (>65 years) to local anesthetic agents in peripheral blocks. Conduc-
tion velocities, number of large diameter fibers and activity of periph-
eral nerve (Na+, K+) ATPase all decrease with age. Hence, smaller 
doses of local anesthetic (LA) agents are required for regional blocks in 
elderly patiens (2).  Global involutive changes in elderly population affect 
brachial plexus (BP) resulting in lower anesthetic volume required for 
effective US-SCB (3). Involutive changes of BP, assessed by measuring 
the cross-sectional area (CSA) of BP at the first rib, result in signifi-
cantly smaller CSA in elderly patient as compared with  younger patient 
(0.60±0.08 cm2  vs  0.91±0.13 cm2). The study of Paqueron and col-
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in the central sensory region of each nerve locations (the 
median, ulnar, radial and musculocutaneous nerve) in 
comparison with the same stimuli delivered to the con-
tralateral arm. Duration of sensory  blocks for every distal 
nerve was tested in 30 minutes intervals after surgical 
completion only for patients with successful blocks. A 
successful block is defined as complete sensory blockade 
(total loss of pinprick sensation and total loss of cold sen-
sation) in all four regions of distal nerves assessed within 
30 min of local anesthetic injection. The duration of sen-
sory blockade was calculated from onset time to the time 
of  full recovery in all four distal nerves. The starting 
volume of LA mixture was 30 ml. After a successful block 
was achieved, the subsequently recruited patient received 
a reduced LA volume of 5 ml. Otherwise, if complete 
sensory blockade in any of the distal nerve distributions 
did not appear, the block was declared as unsuccesful, and 
the next recruited patient received a volume of LA in-
creased by 5 ml. No further data were obtained from 
patients with unsuccesful blocks. Unless otherwise stated, 
the data are expressed with mean ±SD. The unpaired t-test 
with Welch correction was used to test for the statisti-
cally significant differences in mean between the groups. 
Calculations were performed by software package Stat-
Soft, Inc. (2011), STATISTICA, version 9.1, (Tulsa, OK, 
USA).
results
Twenty-two patients completed the study protocol. 
Appropriate ultrasound visualization of BP at first rib was 
achieved in all patients. The study group baseline charac-
teristics are shown in Table 1. For the middle-aged pa-
tients, the administered volumes of LA ranged from 35 
to 10 ml (mean 20 ml). Ten patients in the middle-aged 
group had a failed block. One patient  had incomplete 
anesthesia in the radial nerve territory. Two patients had 
failed block in the median nerve and one in the ulnar and 
median nerve distribution, respectively. Of the six re-
maining  patients with failed block, five had incomplete 
leagues analyzed influence of age on peripheral nerve 
blocks (4). They found a positive relationship between age 
and the duration of a complete sensory blockade. Ap-
proximately a 2.5-time longer duration of complete sen-
sory block in the elderly is observed in comparison with 
young patients indicating that LA agents administered in 
peripheral nerve blocks have a dramatically different ef-
fect on the elderly population. However, they employed 
ropivacaine, local anesthetic with different pharmacody-
namic profile than local anesthetics used in our study. 
Additionaly, Paqueron et al. analyzed a different type of 
peripheral block in their study (mid-humeral block). In-
creased sensitivity to local anesthetics administered for 
peripheral nerves blocks  in elderly in addition to struc-
tural changes of brachial plexus led us to believe that 
sensory block onset time as well as duration of block for 
each distal nerve of  brachial plexus in elderly would be 
different in comparison with middle aged patients. We 
hypothesized a shorter onset time and loger duration of 
sensory blockade in elderly patients.
mAteriAl And methods
After we obtained an approval from Hospital Ethics 
Committee as well as a written informed consent from 
every participant, we recruited 22 elderly patients (>65 
years) undergoing upper limb surgery to this observer 
blind, up–down sequential allocation study. We regis-
tered the study with ClinicalTrials.gov and were issued 
number NCT01467596. Exclusion criteria were the pa-
tient’s refusal of regional anesthesia, any neurologic or 
neuromuscular disease, diabetes and clinical signs of cu-
taneous infection at the site of needle insertion. Patients 
received no premedication before arrival in the operating 
room and standard monitoring equipment (EKG, non-
invasive blood pressure measurement, pulse oximetry) 
was used  during  the performance of  supraclavicular 
brachial plexus block. Prior to US-SCB we infiltrated the 
skin with LA  and administered 25 mcg of fentanyl intra-
venously. We placed a 25 G spinal needle (90 mm, 
Quincke type, Vygon, France) on the outer (lateral) end 
of the probe and advanced it along the long axis of the 
probe in the same plane as the ultrasound beam (in plane 
technique). We observed the needle movement in real 
time. Once the needle tip reached the brachial plexus 
cluster on the ultrasound image, injected the mixture of 
LA. After administering half of the determined LA vol-
ume in „pocket corner“, we repositioned the needle crani-
ally toward the neural cluster in order to apply the other 
half ofthe LA. For the purposes of block assessment, we 
defined time zero as the time of removal of the needle 
from the skin. Sensory block onset time for each distal 
nerve was recorded  in 5 minutes intervals during the first 
30 minutes after time zero. An observer blinded to vol-
ume of administered LA checked for pinprick  anesthesia 
(to a 23-gauge needle) and loss of cold sensation (by the 




group (n = 22)
Middle-aged 
group (n = 22)
Age (years) 74.7±7.1 41.6±5.9 
BMI (kg/m2) 26.5±3.5 25.9±2.9
Male/female (n) 8/14 13/9
ASA I/II/III/IV (n) 0/5/14/3 7/14/1/0
Operated side L/R (n) 13/9 8/14
Duration of surgery (min) 76.1±33.9 89.6±33.8
Data are expressed as mean ± standard deviation or n (number of 
patients). 
ASA, American Society of Anesthesiologists; BMI, body mass index; 
L/R, left/right.
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block  in the ulnar and one in musculocutaneous nerve 
territory, respectively. For the elderly patients, the admin-
istered volumes ranged from  30 to 5 ml (mean 14 ml). 
Nine patients had a failed block. Sensory block failed in 
ulnar nerve distribution in two patients,  in musculocu-
taneous nerve distribution in three patients, in ulnar and 
radial nerve distribution in one patient, in musculocuta-
neous and median nerve distribution in one patient,  in 
median and radial nerve distribution in one patient and 
in ulnar and musculocutaneous nerve distribution in one 
patient. Characteristics of the sensory blockade between 
the tested groups are shown in Table 2 and 3. For the 
entire middle-aged group, the mean (SD) block onset 
time was 25.8± 0.6 min and the mean (SD) block dura-
tion was 151.5±8.9 min. The mean (SD) block onset time 
was  26.5±3.5, 25.0±3.3, 25.7±4.0, 25.9±3.8 for the ulnar, 
median, radial and musculocutaneous  nerve, respective-
ly. The mean (SD) block duration time was 164.6±15.1, 
147.1±23.1, 144.6±23.8, 149.6±24.4 for the ulnar, me-
dian, radial and musculocutaneous  nerve, respectively. 
For the entire elderly  group, the mean (SD) block onset 
time was 21±0.82 min and the mean (SD) block duration 
was  195.75± 14.99 min. The mean (SD) block onset time 
was 22.5±3,09, 20.25±3.02, 20.75±4.66, 20.58±4.63 for 
the ulnar, median, radial and musculocutaneous  nerve, 
respectively. The mean (SD)  block duration time was 
213.46±25.77, 192.69±26.97, 177.31±27.12, 199.61±26.17 
for the ulnar, median, radial and musculocutaneous 
nerve, respectively. The difference between onset time of 
the entire groups as well as every distal nerve  and dura-
tion of sensory blockade of entire groups as well as every 
distal nerve was statistically significant, as shown in Table 
2 and 3.
discussion
The present study demonstrated that  a LA agents have 
a faster onset and longer duration of sensory blockade in 
elderly patients. Both alterations of peripheral nerves 
propeties due to ageing as well as increased sensitivity of 
elderly on LA agents might explaine these results (2, 5). 
Paqueron et al. analyzed influence of age on peripheral 
Table 2
Sensory block characteristics-onset time.





(<45 g.)       (>65g.)
P 95% CI 
(Confidence interval)
UL N 26.5±3.5 22.5±3.1 16 18 0.0013 1.69–6.30 
MDN 25.0±3.3 20.2±3.0 19 20 0.0001 2.78–6.81
RN 25.7±4.0 20.7±4.7 21 20 0.0007 2.24–7.75 
MCN 25.9±3.8 20.6±4.6 21 17 0.0004 2.53–8.06
+Group 25.8±0.6 21.0±1.0 4 4 0.0002 3.35–6.24
Data are expressed as mean ± standard deviation or n (number of patients).
+ Group (mean ± standard deviation of onset time for the entire group).
¶ N,  number of patients with complete sensory blockade in  distal nerve territory.
ULN,  ulnar nerve
MDN,  medial nerve
RN,  radial nerve
MCN,  musculocutaneous nerve
Table 3
Sensory block characteristics-duration of sensory blockade.






(<45 g.)       (>65g.)
P 95% CI 
(Confidence interval)
ULN 164.6±15.1 213.5±25.8 12 13 0.0001 66.59–31.21 
MDN 147.1±23.1 192.7±27.0 12 13 0.0002 24.72–66.47 
RN 144.6±23.8 177.3±27.1 12 13 0.004 11.52–53.88 
MCN 149.6±24.4 199.6±26.1 12 13 0.0001 29.05–70.95 
+Group 151.5±8.9 195.7±15.0 4 4 0.0023 65.63–22.95
¶ N, Number of patients with complete sensory blockade in all four distal nerve territory.
+ Group (mean ± standard deviation of onset time for the entire group).  
ULN,  ulnar nerve 
MDN, medial nerve 
RN,  radial nerve 
MCN, musculocutaneous nerve
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nerve blocks and they found a positive relationship be-
tween age and duration of complete sensory blockade. 
The similarities between  present and the study of Pa-
queron are outcomes that we analyzed (onset time and 
duration of sensory  blockade). Hovewer, our results do 
not entirely confirm theirs as we found a faster onset time 
(22 vs. 27.5 min) and a shorter duration of sensory blocks 
(196 vs. 390 min) in distal nerves of BP in elderly popula-
tion. Different LA (ropivacaine vs. mixture of levobupi-
vacaine and lidocaine) as well as type of brachial plexus 
block (mid-humeral block vs. supraclavicular brachial 
plexus block) between present and Paqueron study make 
it difficult to directly compare the results. However, we 
believe that marked differences in neural architecture and 
size of surrounding adipose tissue compartments, which are 
demonstrated between proximal and distal parts of the bra-
chial plexus, are the main reasons contributing to the discrep-
ancies of characteristics of sensory blockade between present 
and Paqueron study. The nonneural tissue (stroma and 
connective tissue) inside and outside the BP increased 
from proximal to distal, being significant between inter-
scalene/supraclavicular and midinfraclavicular/subcora-
coid regions (6). In proximal regions (interscalene, supra-
clavicular), the BP is surrounded with less fat and stroma 
within and out of its epineurium than in distal regions 
(midinfraclavicular, subcoracoid) which certanly make dif-
ferences in pharmacokinetics of LA between these two 
regions.
In conclusion, we believe this finding is of importance 
for clinicians since elderly patients are frequent in our 
daily practice, especially in one-day surgery. We should 
be alert to their increased sensitivity to elderly on local 
anesthetic agents and should adjust doses of LA agents in 
order to avoid prolonged sensory blockade in peripheral 
nerve blocks  that can delay discharge from hospital.
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Does rotation thrombelastometry (ROTeM) improve 
early prediction of coagulopathy in  breast tumor?
Abstract
Background and Purpose: Breast Cancer is the second most common 
cancer among women after skin carcinoma. Incindence in Croatia in 2012 
was 2227 new cases per year with mortality 1033 women per year. One of 
the most pronaunced caracteristics of cancers in general are changes in co-
agulation factors. Except usual coagulation factors there is thrombelasom-
etry which is dynamic method for evaluation of coagulation factors. We have 
been used thrombelastometry to see differences in coagulation factors for 
carcinomas and benign breast diseases.
Materials and Methods: We included 132 patients with benign and 
malignant breast diseases in Institute of Thumors, Clinical Hospital Center 
“Sisters of Mersy”, Zagreb, Croatia gathered in prospective study in 
2012/2013. We compared differences in coagulation parameters with 
throm belastometry and usual coagulation factors in earlier mentioned two 
groups of patients with Mann-Whitney U test what is graficly described with 
Box and Whiskers plots and correlatio coefficients are described in table with 
Spearman correlation coefficients.
Results: A5,A10,A15,A20,A25 and A30, MCF and AUC intem are 
significatly higher in malignant breast disease patients. Significant trend of 
elevation of these values is present in both patients groups, but those are si-
gificantly higher in patient group with malignant tumors. While in patients 
group with malignant tumors almost every correlation coefficients between 
A5-A30, MCF and AUC intem and cogulation markers are significant, 
those correlations among patients with benign diseases are not significant. 
Those values suggests that A5-A30, MCF and AUC intem are significatly 
correlated with most common used coagulation markers only in patients 
with malignant diseases.
Conclusions: There are differences in coagulation factors in patients 
with benign and malignant breast diseases. Trend of elevation of markers 
of coagulation values is present in both disease, but significantly higher 
values are in malignant tumor. Our results are based on small numbers and 
larger number of patients with precise data of coagulation parameters are 
still needed.
introduction
Breast cancer is the second most common cancer afer skin cancers and it is first cause of death from malignant tumors in women. The 
most common type of breast is ductal carcinoma (NST) which begins 
in the linining of the milk ducts. Another type of breast cancer is lobu-
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abbreviations: 
TNM – tumor-node-metastasis classification 
NST – no special type 
NOS – not other specified 
ROTEM – rotation thrombelastometry 
TEG – Thromboelastography 
CT=R – clotting time 
CFT = k – clot formation time  
MCF = MA – maximum clot formation 
AUC  – area under the curve 
A –  Amplitude of cloth formation after  5-30  
minutes
PT – prothrombin time 
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breast cancer is breast cancer that has spread from where 
it began in the breast ducts or lobules to surrounding 
normal tissue. The incidence in Croatia is around 2300 
new cases of breast carcinoma in women with around 800 
deaths  from these disease in 2013. in University Hospital 
for Tumors 600 patients had breast biopsy for suspitious 
breast tumors and afterward therapy after protocol for 
breast cancer. Surgical treatment have been based on bi-
opsy for suspicious breast tumors and emergency patohis-
tological analysis. Patients with carcinomas are at risk of 
coagulopathy which can be the first sign of malignant 
disease.
The hemostatic system with its procoagulant effects 
mediated directly by cancer cells are considered to play 
principal role in the development of cancer-induced hy-
percoagulability and major thromboembolic complica-
tions (1). 
Recently, rotation thrombelastometry (ROTEM)  is a 
method to evaluate the whole process of blood coagula-
tion as a graph from the beginning of clot formation to 
fibrinolysis providing information related to the cumula-
tive effects of various parameters of all stages of the co-
agulation and fibrinolytic processes (2).
The  benefits of ROTEM_ technology include rapid 
availability of test results and enhanced reproducibility 
the data  which are also continuous, digital, and retriev-
able for further calculations (3, 4).
The goal of the study is to prove connection between 
changes in coagulation factors and pathystological analy-
sis. In the study standard methods for coagulation factors 
analysis and thrombelastometry (ROTEM) have been 
used. Thrombelastometry gives quantitive and graphic 
measurment from inicial thromb formation to its retrac-
tion and lysis. Coagulation factors  in correlation with 
patohistological analysis will contribute to better under-
standing perioperative treatment of benign changes and 
malignat breast tumors and more rational thrombopro-
filaxis and treatment with anticoagulant and antiagrega-
tion therapy. 
mAteriAls And methods
Using information after prospective study2012/2013. 
in University Hospital for Tumors, University Hospital 
Center “Sisters of Mersy”, Zagreb, Croatia. Our study 
have been included 132 patients:59 of those had a breast 
cancer and all the rest(73) benign breast disease. All pa-
tients had mean age 59,15 +- 11,6.  This study have been 
done with aproval of Etical Commity of School of Medi-
cine, University of Zagreb and University Hospital Cen-
ter “Sisters of Mersy” in Zagreb.All hospitals, pathology 
laboatories and coagulation parameters laboratories where 
from University Hospital Center “Sisters of Mersy”. Pa-
tohistological samples where surgicaly removed by traind 
specialists for oncologic breast surgery. Patohistological 
analysis were analysed by trained patologists who are spe-
cialised for breast surgery tumors. Mean tumor size were 
20,0 +- 11,2 mm.  Breast cancer staging was based on 
pathologic tumor-node-metastasis (TNM) classification. 
We also analysed therapy after surgery (Chemotherapy, 
radiotherapy or unknown). 
From coagulation factors we analysed FVIII, PC, PT, 
INR  PT. We also used rotation thromelastometry 
(ROTEM) in all patients and analysed A5, A10, A15, 
A20, A25, A30 intem, MCF intem and AUC intem. We 
analysed with differences in this coagulation factors 
among patients benign and malignant breast diseases.
Patients with preexisting hematological or coagulation 
disorders, those taking anticoagulants and those with 
liver or renal dysfunction were excluded from the study. 
Sample collection for subsequent coagulation analysis 
blood samples were drawn into 4.5 ml vacutainers (Bec-
ton Dickinson) containing 3.2% trisodium citrate with a 
citrate/ blood ratio of 1:9.  and for platelet count into 
Becton Dickinson EDTA tubes.
coagulation analyses
The  laboratory tests of coagulation were performed on 
full automated STA compact device of Diagnostica ST-
AGO for all patients: platelet count, prothrombin time 
(PT) and activated partial thromboplastin time (APTT), 
fibrinogen, and D-Dimer. The normal ranges for these 
tests are: APTT (26–36 s), PT (9.4–15.4 s), Fibrinogen 
(200– 400 mg/dl), and D-Dimer (0.00–0.50 lg/ml).
rotem_ thrombelastographic analysis
Thrombelastography analysis was performed with the 
ROTEM_ Coagulation Analyzer (Pentapharm, Munich, 
Germany). Four channels were available for simultaneous 
measurements. Each test required 300 ll citrated whole 
blood. The blood was re-calcified with 20 nl 0.2 mol/l 
CaCl2 (star-TEM_; Pentapharm, Munich, Germany) 
and activation of coagulation was performed with differ-
ent agents:
INTEM: Contact pathway activation of the coagula-
tion with 20 nl of contact activator (partial thromboplas-
tin–phospholipid from rabbit brain extract and ellagic 
acid, in-TEM_; Pentapharm, Munich, Germany).
EXTEM: Tissue factor pathway activation of the co-
agulation with 20 nl of tissue factor (TF, tissue thrombo-
plastin from rabbit brain extract, ex-TEM_; Pentapharm, 
Munich,Germany).
APTEM: TF plus 20 nl of aprotinin, plasmin-antag-
onist (ap-TEM_; Pentapharm, Munich, Germany).
FIBTEM: TF plus inhibition of thrombocytes with 
20 nl of cytochalasin (fib-TEM_; Pentapharm, Munich, 
Germany).
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The test starts automatically after injection of the 
blood sample with an automated pipette and calculated 
graphical results are obtained by the integrated computer 
of the device. All ROTEM samples were analyzed within 
30–90 min of blood collection.
The following ROTEM_ parameters were determined: 
clotting time (CT = R) represents a measure of the initia-
tion of clot formation, clot formation time (CFT = k) 
represents the speed of clot formation, and maximum clot 
formation (MCF = MA) represents maximum clot 
strength.
statistics
Data were shown in tables in figure. Descriptive stas-
tics were made to describe investigated patients sample 
Kolmogorov-Smirnov test was used to analyse data nor-
mality and due to its results appropriate non-parametric 
tests were used in following analysis. Differences between 
patients with malignant and benign breast disease were 
analysed with Mann-Whitney U test. Correlations be-
tween A5-A30, MCF and AUC intem and coagulation 
markers regarding malignant and benign breast disease 
were done with Spearman correlations coefficients. All P 
values below 0,05 were consindered significant. IBM 
SPSS Stastistics version 19.0.01. had been used as stastis-
tical software (www.spss.com).
results
Majority of patients: 35 (59,3%) had tumor grade 2, 
39 (66,1%) had LumTP grade B. Among those patients 
that have valid data  from TNM clasification (N=28) 13 
(46,4%) had T grade 2, 18 (64,3%) N grade 0 and 13 
(46,4%) M grade 1 (metastasis in lymphatic nodules). 
Average tumor size was 20,0 +- 11,2 mm. There was no 
significan age difference between benign and malignant 
breast disease group (Z = -0,5; p=0,540; Mann-Whitney 
U test)
A5, A10,A15,A20, A25, A30, MCF and AUC intem 
values are significantly higher in malignant breast disease. 
Table 2. shows descriptive statistics and differences be-
tween benign and malignant breast disease regarding A5-
A30, MCF, AUC intem and coagulation markers. Sig-
nificant trend of elevation these values is present in both 
Table 1































Without data 31 52,5%
Therapy
Without data 15 25,4%
Chemotherapy 11 18,6%
Radiotherapy 33 55,9%
Age (years):  
mean ± SD 59,15 ± 11,6
Tumor size (mm): 
mean ± SD 20,0 ± 11,2
Figure 1. Differences in A5 – A30 intem values in benign and 
malign breast disease.
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group (p;0,001; Friedeman test), but significantly higher 
values in group with malignant tumor (Figure 1). 
While in patients with malignant disease almost every 
correlation coefficients between A5 –A30, MCF and 
AUC intem coagulation markers are significant,those cor-
relations among patients with benign disease are not sig-
nificant. Among patients with malignant disease positive 
correlations were found between A15-A30,MCF and 
AUC intem and FVIII and PC. Significant negative cor-
relations were found with PV and INRPV. Different pat-
terns of significant correlations between A5-A30, MCF 
and AUC intem and coagulation markers regarding ma-
lignant and benign breast disease are shown in Table 3.
discussion
Although breast cancer is one of the most common 
carcinoma in women there are small number of studies 
which analyse differences between malignant and benign 
breast disease with rotation thrombelastometry  and cor-
relations between thrombelastometry factors and coagu-
lation factors which we used in our study. 
After analyzing all gethered data from our prospective 
study we concluded that there are strong connection be-
tween A5, A10, A15, A20, A25 i A30, MCF and AUC 
intem with malignant disease and that it is significantly 
higher in group with malignant diseases than in group 
with benign breast diseases. Also our values suggests that 
A5-A30, MCF and AUC intem are significantly corre-
lated with most common used coagulation markers only 
in patients with malignant disease. 
The strength of our study is that we find differencies 
in specific  coagulation parameters with thrombelastom-
etry and standard coagulation tests in patients with ma-
lignant disease and we proved significant difference in 
some specific parameters what we mentioned earlier. 
Many studies demonstrates thromboelastographic 
evidence of hypercoagulability in patients suffering from 
cancer  with a high rate of venous thromboembolic events 
(5).Thrombotic episodes may also precede the diagnosis 
of cancer by months or years thus representing a potential 
marker for occult malignancy (6). Abnormal hemostasis 
has been reported in cancer patients, including the short-
ening of the activated partial thromboplastin time, ele-
vated levels of coagulation proteins (fibrinogen, factors V, 
VIII, IX, and XI), thrombocytosis, elevated fibrin/fibrin-
ogen degradation products, and an accelerated rate of fi-
brinogen turnover (5). 
Hypercoagulability is difficult to detect by standard 
coagulation tests in cancer patients, but ROTEM (7), is 
Table 2
Differences in significant correlations between A5-A30, MCF and AUC intem and coagulation mark-
ers regarding malignant and benign breast disease: Spearman correlation.
   
Malignant disease Benign disease
N=59 N=70
  FVIII PC PVs INRPV FVIII PC PVs INRPV
A5 intem
Rho 0,251 0,149 –0,290 –0,261 –0,005 0,081 –0,040 –0,057
P 0,055 0,259 0,026 0,046 0,967 0,505 0,741 0,637
A10 intem
Rho 0,256 0,235 –0,334 –0,313 0,072 0,093 –0,075 –0,093
P 0,050 0,073 0,010 0,016 0,553 0,442 0,537 0,445
A15 intem
Rho 0,298 0,267 –0,332 –0,314 0,100 0,108 –0,090 –0,111
P 0,022 0,041 0,010 0,016 0,412 0,373 0,458 0,361
A20 intem
Rho 0,289 0,287 –0,334 –0,304 0,146 0,139 –0,135 –0,144
P 0,026 0,028 0,010 0,019 0,227 0,251 0,266 0,234
A25 intem
Rho 0,316 0,293 –0,330 –0,297 0,200 0,148 –0,145 –0,158
P 0,015 0,024 0,011 0,022 0,098 0,221 0,232 0,191
A30 intem
Rho 0,314 0,280 –0,310 –0,270 0,222 0,169 –0,168 –0,185
P 0,016 0,032 0,017 0,039 0,064 0,161 0,165 0,125
MCF 
intem
Rho 0,284 0,279 –0,326 –0,298 0,180 0,127 –0,128 –0,136
P 0,029 0,033 0,012 0,022 0,135 0,294 0,289 0,260
AUC 
intem
Rho 0,311 0,297 –0,326 –0,289 0,219 0,135 –0,117 –0,112
P 0,016 0,022 0,012 0,027 0,069 0,264 0,336 0,358
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a sensitive method that is able to identify and measure 
hypercoagulability, which is not detected by routine lab-
oratory tests (8, 9, 7). ROTEM, by using whole blood, 
measures both quantity of clotting and, most important-
ly quality of clotting which is not recorded by routine 
coagulation profile (10.4). Hypercoagulability was diag-
nosed readily by the presence of an accelerated clot forma-
tion, as evidenced by shortening of CFT and an increase 
of the clot strength, as evidenced by increasing of MCF. 
ROTEM_ tracings on all assays (INTEM, EXTEM, 
FIBTEM, APTEM) revealed a statistically significant 
increasing of MCF in cancer patients. While it is likely 
that certain cancer types are more prone to thrombosis 
(11), we could not predict which tumors are most com-
monly associated with thrombosis since ROTEM param-
eters did not differ among cancer subgroups. 
In the literature, postoperative hypercoagulability, de-
tected by TEG, has been reported in patients undergoing 
hepatic surgery (12), general abdominal procedures (13, 
14), and neurosurgery (15). Other clinical settings associ-
ated with hypercoagulability detected by TEG include 
ischemic heart disease (16), end-stage renal failure (17), 
insertion of cutdown intravenous catheters (18) exposure 
to oral contraceptives (19). 
Thromboelastographic analysis of hypercoagulability 
has been also performed in patients with malignancies in 
the earlier literature using first the native whole blood 
TEG and then the celite-activated TEG (21, 22). Our 
findings are by utilizing a newer and more powerful tech-
nique, the modified rotation thromboelastogram ana-
lyzer, ROTEM_. Hyperfibrinogenemia and thrombocy-
tosis have been frequently reported in patients with 
malignant disorders (23, 24). We therefore sought to cor-
relate these laboratory parameters with those of ROTEM_ 
and observed that MCF had a strong positive correlation 
with plasma fibrinogen concentration and platelet counts. 
MCF measures the maximum clot strength, which is de-
pendent on platelet function and fibrinogen level. The 
contribution of platelet component and fibrinogen to the 
clot strenght has been demonstrated in adult patients 
without tumors (25, 26, 27, 28). 
Since ROTEM demonstrates hemostasis as a whole 
dynamic process, ROTEM data gives more information 
on interaction between platelets and the coagulation cas-
cade rather than the conventional coagulation screens; 
PT, APTT, platelet count, and fibrinogen concentrations. 
Identification by the ROTEM of a hypercoagulable state 
in  patients  with breast tumor may help to identify those 
at risk for cancer-induced thromboembolic events and the 
test may be more valuable if combined with scoring sys-
tems for grading deep vein leg thrombosis (29). Further 
investigations that correlate this hypercoagulability with 
the clinical picture are needed to determine if TEG data 
can be applied on therapeutic interventions in this patient 
population.
On the other hand, the limitation of this study are the 
small number of patients and we recomend to make a 
larger study with patients with malignant breast diseases 
which will confirm our data and which will help in future 
to diagnose breast tumors before even we found them 
with other diagnostic  means. The thing is that coagula-
tion disorders can be one of the first signs of malignant 
disease and that this can help us to discover the disease 
in the earlier stage and to make better prognosis in the 
end.
conclusion
In patients with malignant breast disease almost every 
correlation ROTEM coefficients between A5 –A30, MCF 
and AUC intem coagulation markers are significant,but 
those correlations among patients with benign disease are 
not significant. Among patients with malignant disease 
positive correlations were found between A15-A30, MCF 
and AUC intem and FVIII and PC and significant nega-
tive correlations were found with PV and INR. Signifi-
cant trend of elevation hypercoagulability values is pres-
ent in both disease but significantly higher values in 
malignant breast tumor. Rotation thrombelastometry 
(ROTEM) may improve early prediction of coagulopathy 
in (benign and malign)  breast tumor?
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Patient satisfaction with regional anesthesia  
in orthopedic surgery
Abstract
Background and Purpose: The patient satisfaction with perioperative 
care and anesthesia is important indicator of the quality of the health care 
system. The evaluation of the patient’s satisfaction is a necessity, and the 
continuous improvement of a quality is important in anesthesia nowadays. 
It is important to identify the reasons and the risk factors for patients dis-
satisfaction with anesthesiologic procedures. We conducted this study to 
asses determinants of regional anesthesia on patient satisfaction.
Materials and Methods: This was a prospective observational study 
which included 164 patients older than 18 years undergoing some orthope-
dic procedures in regional anesthesia. We noted basic characteristics of pa-
tients, important perioperative events and on the following day patients 
completed a specific questionnaire.
Results: Most patients (152/164) were satisfied or very satisfied with the 
regional anesthesia. Only 11 patients were unsatisfied, and the most common 
reasons for dissatisfaction were urinary retention, PONV, the multiple punc-
ture attempts and the pain on the puncture site. About 95% patients would 
receive regional anesthesia again and recommend this kind of anesthesia to 
the others. We found statistically significant percent (12%) of increasing 
satisfaction in previously unsatisfied patients (p < 0,001). 
Conclusion: Although, the satisfaction with regional anesthesia in or-
thopedic surgery in our institution is generally high, there are some factors 
which can influence on dissatisfaction rate. It is important to identify, 
monitor and modify them with aim of increasing the overall satisfaction 
rate.
introduction
The patient satisfaction with perioperative care and anesthesia is im-portant indicator of quality of health care system (1). Patients’ sat-
isfaction affects the outcome of health care and the use of health-care 
services (2). Many hospitals and different health care organizations fre-
quently use patient satisfaction ratings as an integral part of marketing 
and bench marketing of services. Continuous improvement in quality 
is important part in all kinds of anesthesia and evaluation of patient 
satisfaction is a necessity nowadays. It is important to identify the rea-
sons and the risk factors for patients’ dissatisfaction with anesthesio-
logic procedures. Many factors contribute to patient satisfaction, includ-
ing possibility of choosing the kind of anesthesia, interpersonal 
relationships, competence of health professionals and a patient’s own 
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thesia, but nevertheless, recovery from anesthesia is some-
times complicated by residual sedation, pain, nausea, 
vomiting or different major and minor complaints (3, 4). 
These unwished events significantly affects total patient’s 
satisfaction. 
Regional anesthesia is becoming a major trend nowa-
days in many types of surgeries due to many potential 
benefits. During procedure patient remains conscious 
with spontaneous respiration and preserved reflexes and 
aspiration of gastric content is unlikely. Reduction in sur-
gical stress, better postoperative analgesia, and earlier 
discharge for outpatients and less expense are also valuable 
advantages. Regional anesthesia and analgesia undoubt-
edly can improve clinically oriented outcomes (5). 
There are many studies in the field of anesthesia about 
patient satisfaction, but most of them are restricted on 
general anesthesia. The effect and factors of regional an-
esthesia on patient satisfaction did not satisfactory dem-
onstrate, so we conducted this study to asses determinants 
of regional anesthesia on patient satisfaction. The aim of 
this study was to evaluate patients’ satisfaction with previ-
ous (regional) anesthesia and to determine predictors as-
sociated with unwillingness to have regional anesthesia 
again in the case of future surgery.
mAteriAls And methods
This was a prospective observational study approved 
by the University Hospital Osijek Research Ethics Com-
mittee. Written informed consent was obtained from each 
patient. The study population included 164 patients old-
er than 18 years undergoing some orthopedic procedures 
in regional anesthesia, namely spinal or epidural anesthe-
sia or peripheral nerve blocks. All regional blocks were 
used as the primary anesthetic technique. We excluded 
the patients with neurological disorders, psychological 
diseases, coagulation defects, unlettered patients and 
those who didn’t understand the questions. Also, exclu-
sion criteria were the conversion to general anesthesia or 
uncompleted data sheet.
This study was conducted by collecting pre-operative, 
intra-operative and post-operative data on a constructed 
data sheet divided in three parts.  Prior to block admin-
istration, attending anesthesiologist entered patient’s per-
sonal data (age, sex, weight, height, BMI, previous anes-
thesia experience) in the first part of data sheet. 
Information about actual regional anesthesia technique 
(grade of the performer, patient’s position during the op-
eration, type of block, the needle size, number of attempts 
) and intraoperative adverse reactions (need for addition-
al sedation and analgesia, nausea/vomiting, hypotensia or 
conversion to general anesthesia) were noted in the second 
part of data sheet by the same investigator at the end of 
surgery. On the following day, a nurse not belonging to 
the surgical area and not aware of the anesthesia tech-
nique gave third part of data sheet, i.e. a questionnaire to 
the patient. A questionnaire contain 13 questions about 
early experiences with anesthesia, satisfaction or dissatis-
faction with actual regional anesthesia, willingness to ac-
cept regional anesthesia again and about recommendation 
this kind of anesthesia to the other persons.
Statistical analyses were performed using SPSS soft-
ware (version 20.0, SPSS Inc, IL, USA). Data normality 
distribution was tested by Smirnov-Kolmogorov test. Fre-
quency or arithmetic mean and standard deviation were 
calculated for all data. The difference of numerical vari-
ables was analyzed using Student’s t-test. Comparison of 
categorical variables was made with Chi-square test.  P < 
0.05 was considered statistically significant.
results
A study population includes 164 patients, and 18 pa-
tients were excluded from the study. The Table 1 shows 
demographic data of the study population. Previous ex-
periences with anesthesia had 76% (121/164) patients, 
mostly general anesthesia (60%), central neuraxial block 
(29%) or peripheral nerve block (6%). Seven patients 
didn’t remember an anesthesia technique. In this popula-
tion, 81% of patients (99/121) were satisfied or very satis-
fied with former anesthesia procedures and only 8 of 121 
patients were totally unsatisfied. 
Characteristics of actual regional anesthesia technique 
are described in Table 2. Most of patients (95%) replied 
that the technique of regional anesthesia was good or very 
good explained before application. The main reason for 
choosing a regional anesthesia was the recommendation 
of attending anesthesiologist in 70% cases. Remaining 
reasons were: fear of unconsciousness (11%),  expectance 
of less pain after operation (31%), wish to see and  hear 
during operation (22%), wish to eat and drink earlier af-
ter procedure (20%), the other people said that is region-
al anesthesia better than general (19%) or from  media 
became informed that is regional anesthesia better choice 
(8%). Most of patients (152/164) were satisfied or very 
Table 1 




Age (yrs) 47.2±16.75 (18-82)
Height (cm) 171±9.5(150-197)
Weight (kg) 79.9±14.9(52-130)
BMI (kg/m2) 23.3±3.92 (15.9-36.1)
BMI-body mass index
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satisfied with actual regional anesthesia and just 11 pa-
tients were unsatisfied.
The reasons of satisfaction or dissatisfaction with ac-
tual regional anesthesia are described in Table 3. Prevail-
ing part of satisfied patients s conspicuous from two rea-
sons, i.e. approximately 95% patients have willingness to 
have regional anesthesia again and would recommend 
regional anesthesia to the others. Also, we found statisti-
cally significant percent (12%) of increasing satisfaction 
in previously unsatisfied patients with regional anesthesia 
(c2 = 16,806, p < 0,001). Table 4 shows correlation be-
tween some variables and satisfaction with regional block. 
Need for additional sedation was found in 37% pa-
tients, mostly with midazolam 2-5 mg. Also, little portion 
of patients (23/164) had a need for additional analgesia 
during surgery, generally with little doses of fentanyl (25-
100 mcg). Adverse reactions during surgery were very 
rare, IONV (intraoperative nausea and vomiting) in only 
2 cases and hypotension in 6 patients. Conversion in gen-
eral anesthesia was done in 3 patients who are excluded 
from research.
discussion
Patient satisfaction is an important indicator of health 
care outcome and evaluation of the quality in anesthesiol-
ogy (6, 7). We conducted this study to show characteris-
tics and predictors of satisfaction with regional anesthesia 
among the patients underwent some orthopedic proce-
dures. The main outcome in our research was willingness 
to accept regional anesthesia again in the future. 
In this study we found the high rate (93%) of satisfac-
tion with regional anesthesia and the rate of absolute dis-
satisfaction was very low (1%). Most former studies in 
regional anesthesia also reported high levels of satisfac-
tion. Rhee et al. found on 1191 patients underwent spinal 
Table 2 








  Lumbosacral spinal/epidural
  Interscalene block
  Supraclavicular block
  Axillar block
  Femoral block
  Popliteal block
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Reasons of satisfaction or disatisfaction with 




No pain and sensations during surgery
No pain  early after surgery
Ability to eat and drink early after anesthesia







Higher number of punctures
Pain during block performing






Pain at the puncture site, parestesias, disorders of 
sensation and motor activity after anesthesia
Pain  early after surgery
Urinary retention













IONV – intraoperative nausea and vomiting; PONV – postoperative 
nausea and vomiting
Table 4 
Correlation between some factors and satis-





Presence of pain at the puncture site 5.115 0.024
Provider’s experience 0.561 0.454
Number of puncture attempts 3.133 0.077
Position during surgery 3.390 0.335
Explanation of anesthesia procedure 11.205 0.001
Application of sedatives during surgery 0.131 0.717
Application of analgesics during surgery 0.366 0.545
p≤0.05; BMI – body mass index
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anesthesia in different types of surgery also high level 
(96.3%) of satisfaction and 96.8% patients would accept 
spinal anesthesia in the future (8). Jlala et al. demonstrat-
ed that 88.4% patients were satisfied with regional anes-
thesia in orthopedic surgery (9). In a study of 246 women, 
Siddiqi et Jafri found high level of satisfaction (81.4%), 
and the desire to opt for spinal anesthesia in the future 
(53.7%) among patients receiving spinal anesthesia for 
cesarean section (10). In Kouki et al’s Greek study on 
subpopulation of 63 surgical patients underwent to re-
gional anesthesia, 98.4% described anesthesia procedure 
as good or excellent. Also, 85.7% of patients with region-
al anesthesia would like to receive the same anesthetic 
regimen again in the future (11). As it showed in most of 
studies, level of satisfaction with regional anesthesia was 
satisfactory high, but this rate can be overestimated be-
cause patients like to please medical staff and to meet 
social expectations by replying satisfied (8,10). 
The main reasons of dissatisfaction in our study were 
the recommendation for laying after spinal anesthesia, 
urinary retention, PONV and higher number of punc-
tures. Our study supports the results of a few former stud-
ies. Rhee et al. also found that PONV and postoperative 
backache were predictable factors for dissatisfaction with 
spinal anesthesia. Also, likewise to our study, they showed 
no statistical correlation between satisfaction and age, sex, 
experience of anesthesiologist, IONV, hypotension and 
intraoperative application of sedatives and analgesics (8). 
A study conducted by Sindhvananda et al. revealed that 
post-dural puncture headache, itching and PONV were 
predictors of dissatisfaction (12). Likewise, the main cause 
of discomfort from regional anesthesia in the study by 
Bhattarai et al. was reported to be the immobility of 
lower limbs (13). I our study, just two unsatisfied patients 
marked the immobility of limb as a reason for dissatisfac-
tion.
Statistical comparison between groups of satisfied and 
unsatisfied patient in our investigation showed no differ-
ence in satisfaction scores according to sex, age, BMI, 
experience of anesthesiologist, number of attempts, posi-
tion during surgery, IONV, hypotension and intraopera-
tive application of sedatives and analgesics. We found 
statistical correlation between presence of pain at the 
puncture site, quality of the procedure explanation and 
patient satisfaction. Thereby, patients with no pain were 
more satisfied regarding to those with pain at the punc-
ture site, mostly backache (c2 = 5.115, p = 0.024). In the 
study of Siddiqi and Jafri, the patients with lower satisfac-
tion scores with spinal anesthesia complained of a higher 
frequency and severity of backache (10). Choi et al. dem-
onstrated postoperative backache as a risk factor associ-
ated with refusing spinal anesthesia in the future (14). 
Also, Rhee et al. found the postoperative backache was 
one of predictable factors for dissatisfaction with spinal 
anesthesia (8). However, the study of Schwabe and Hopf 
showed that the backache after spinal anesthesia was not 
associated with patient’s characteristics or technical fac-
tors, and apart from preexisting back pain (15). Appropri-
ate selection patients for regional anesthesia, reducing the 
number of puncture attempts, usage of small needles and 
skilled anesthesiologist could contribute to better satisfac-
tion. 
Furthermore, rate of satisfied patients in our study was 
higher when the quality of explanation of the regional 
anesthesia procedure was better (c2 = 11.205, p = 0.001). 
Also, we found that the main reason for choosing the 
regional anesthesia by patients was the good recommen-
dation for this technique by attending anesthesiologist in 
70% cases. Caljouw et al. found that better informed pa-
tients also ranked staff-patient relationship higher, and 
that the information provision and staff-patient relation-
ship are the major determinants for patient satisfaction 
with perioperative care (16). Dharmalingam et Zainud-
din showed on the 200 spinal anesthesias for caesarean 
section that all the patients were satisfied with the com-
plete explanations provided by the trained personal re-
garding applicable anesthesia methods (17). In another 
study, Kouki et al. found that the interaction with the 
anesthesiologist during the intraoperative and immediate 
postoperative period was the most important element of 
patient satisfaction for all patients, regardless of the type 
of anesthesia performed (11). Also, Capuzzo et al. con-
cluded that kindness/regard of caregivers” along with 
“information given by the anesthetist” and “feeling safe” 
were good indicators for predicting patient satisfaction 
(18). 
Our study may have several limitations. First, we 
didn’t use a standardized protocol for performing region-
al anesthesia and treatment of intraoperative and postop-
erative adverse effects which can affect on the satisfaction 
level. Also, our questionnaire wasn’t standardized  accord-
ing to most relevant questionnaires in the field of  satisfac-
tion with perioperative medicine and anesthesia. We 
considered that this questionnaire is very easy to under-
stand for most of patients regardless of the level of their 
education. Third, patients completed the questionnaire 
second day after surgery when some complications (e.g. 
postdural puncture headache, neurological sequellaes) 
were not displayed yet. All these limitations could affect 
on satisfaction and especially on refusal rates for regional 
anesthesia in the future.
conclusion
Assessment of patient satisfaction is associated with 
multiple factors. Satisfaction with regional anesthesia in 
orthopedic surgery in our institution was generally high. 
Our study demonstrates that some variables are signifi-
cant predictors of good satisfaction with regional anesthe-
sia. The presence of some postoperative conditions (i.e. 
urinary retention, PONV, lying after spinal anesthesia) 
significantly contribute to patient’s dissatisfaction with 
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regional anesthesia. Fortunately, some of them can be 
corrected. Intraoperative application of drugs against 
PONV in risk population, one-time urinary catheteriza-
tion, skilled anesthesiologist and use of very small needles 
could minimize these negative conditions and contribute 
to better satisfaction. Also, good explanation of the pro-
cedure and participation in decision making during pre-
anesthetic visit should be the parts of anesthetic plan. 
Finally, the staff has to identify, monitor and modify the 
factors which may improve overall patients’ satisfaction 
with regional anesthesia.
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Ultrasound-guided transversus abdominis plane  
block in combination with ilioinguinal-iliohypogastric 
block in a high risk cardiac patient for inguinal hernia 
repair: a case report
Abstract
Background and Purpose: A high risk cardiac patient, ASA IV, was 
planned for inguinal hernia repair. Since general anaesthesia presented a 
high risk, anaesthesia was conducted  with a transversus abdominis plane 
(TAP) in combination with ilioinguinal-iliohypogastric (ILIH) block. 
Material and Methods: A 70-year old male patient with severe CAD 
and previous LAD PTCA, AVR, in situ PPM and severe MR and TR 3+, 
was planned for elective inguinal hernia repair. The preoperative ECHO 
showed IVS dyskinesis with apicoseptal hypokinesis, global EF 42% and 
grade III diastolic dysfunction. The patient also suffered from hypertension, 
diabetes mellitus and had severe stenosis of both femoral arteries. 
Preoperative preparation included IBP monitoring while the TAP block 
was carried out under ultrasound guidance using an 8 Hertz linear probe. 
The ilioinguinal and iliohypogastric nerves were identified with ultrasound 
and peripheral nerve stimulator. Local anaesthetic [0.5% levobupivacaine 
(Chirocaine®, Abbott Laboratories) ] was applied in two locations: in the 
upper right fascia of the transversus abdominis muscle (15 ml) and around 
the right ilioinguinal and iliohypogastric nerves (10 ml), totalling a volume 
of 25 ml. Skin infiltration was performed with 5 ml 2% lidocaine [Lido-
caine®, Belupo] and 5 ml of normal saline. 
Results: Sensory block onset was at 28 minutes after administration and 
lasted for approximately 18 hours. There were no haemodynamic disturban-
ces and the perioperative course was uneventful. 
Conclusion: During the first 18 postoperative hours, the patient was 
comfortable and satisfied with the anaesthetic procedure. 
introduction
Transversus abdominis plane (TAP) block has been used as a com-ponent of multimodal analgesia for postoperative pain relief fol-
lowing various abdominal surgeries such as for e.g. hernia repair (1). To 
improve intraoperative anaesthesia, a combined ultrasound-guided  ip-
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guidance should be considered to ensure correct needle 
position and to improve the accuracy of the TAP block 
technique while limiting the potential for inadvertent 
damage to the intraperitoneal structures (Figure 1). 
The TAP block was performed between the internal 
oblique and transversus abdominis muscles, using a 
22-gauge, 10 cm neurostimulating  needle [Stimuplex 
DÒ, Braun, Melsungen] with one attempt. It was carried 
out under ultrasound guidance using a linear probe of 8 
Hz and a neurostimulator. After that, the ilioinguinal and 
iliohypogastric nerves were identified medially from the 
cristae iliacae anterior superior with ultrasound and a ne-
urostimulator set at 1 mA. Local anaesthetic [0.5% levo-
bupivacaine (Chirocaine®, Abbott Laboratories) ] was 
applied in two locations: in the upper right fascia of the 
transversus abdominis muscle (15 ml) and around the 
right ilioinguinal and iliohypogastric nerves (10 ml), to-
talling a volume of 25 ml. Skin infiltration was performed 
with 5 ml 2% lidocaine [Lidocaine®, Belupo] and 5 ml of 
normal saline. 
results
Following the administration of the TAP block in the 
upper fascia of the transversus abdominis muscle, onset 
of sensory blockade occurred after 28 min. The sensory 
blockade of the ILIH block occurred earlier, 18 min after 
the administration of the anaesthetic around the nerves. 
The testing of the blocks was done with pick prick tech-
nique and a temperature discrimination test from the 
right side of Th 10 to L 1 dermatome. During the opera-
tive procedure, the patient was sedated with midazolam 
3 mg intravenously (iv). All measured vital parameters 
such as IBP, ECG/HR and SpO2 were of correct values. 
The surgical procedure lasted 45 min and was without any 
case report
A 70-year old male, high risk cardiac patient, catego-
rized as American Society of Anesthesiologists’ (ASA) IV, 
was scheduled for an elective inguinal hernia repair pro-
cedure. He was 84 kg of weight, had a height of 175 cm 
and a BMI of 27.4, with severe multivessel coronary artery 
disease (CAD), confirmed by coronary angiography 3 
months earlier when he underwent left anterior descend-
ing artery (LAD) stenting. Due to severe stenosis of the 
aortic valve, he also had a biological aortic valve implant 
with a remaining severe mitral and tricuspid valve regur-
gitation and a right ventricular systolic pressure of around 
50 mmHg. The preoperative ECHO showed an intraven-
tricular septal dyskinesis with apicoseptal hypokinesis and 
a left ventricular ejection fraction (LVEF) of 42% with 
grade III diastolic dysfunction. He also had an in situ 
permanent pacemaker due to third degree AV block. The 
patient had multiple comorbidities such as long term un-
controlled hypertension, diabetes mellitus and had severe 
stenosis of both femoral arteries, with a previous femoro-
distal bypass from the common femoral artery and the 
superficial and deep femoral arteries of the left side. He 
also suffered from chronic kidney disease, nephrotic syn-
drome, hypothyreosis and normocytic anaemia. Medica-
tion included a beta-blocker, amiodarone, a calcium 
channel antagonist in combination with an angiotensin 
receptor antagonist, moxonidine, aspirin and a high dose 
diuretic. 
mAteriAl And methods
Preoperative preparation included invasive blood pres-
sure monitoring (IBP), continuous electrocardiography 
(ECG), and pulse oxymetry (SpO2). As with many other 
regional anaesthetic techniques, the use of ultrasound 
Figure 1. Sonographic view of the three lateral abdominal muscles. The orientation of the probe was perpendicular to a line joining the anterior 
superior iliac spine and  the inferior rib to obtain a transverse view of the abdominal layers.
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accompanying complications, after which the patient was 
sent to the post anesthesia care unit (PACU) for contin-
ued perioperative monitoring of vital parameters. After 
one hour in the PACU, all the vital parameters remained 
within normal values, the arterial cannula was removed 
and the patient was discharged to the surgical ward. Dur-
ing the first 24 postoperative hours, the patient’s pain 
level was visually monitored using analgesic scales (VAS, 
0 = no pain, 10 = worst pain imaginable) every three 
hours. Sensory block lasted for 18 h postoperatively with 
a VAS scale value of 2 and after block regression, there 
was no need for any further analgesia. At the postopera-
tive follow up sessions, the patient reported his experience 
as without objections and was very satisfied with the an-
aesthetic treatment. His further course of recovery was 
also without any complications. 
discussion
Patients with coronary artery disease and multiple co-
existing diseases, posted for major abdominal surgery are 
unquestionably at a high risk for perioperative complica-
tions (2). We presented a high risk cardiac patient under-
going inguinal hernia repair, with significant comorbidi-
ties among which was multivessel CAD, severe mitral 
valve and tricuspid valve regurgitation, a decreased LVEF 
and diastolic dysfunction. Local infiltrative anaesthesia 
or regional blocks are the most suitable techniques in 
high-risk patients and patients with ASA II–IV status. 
Since general anaesthesia presented a high risk, a com-
bined ultrasound-guided ipsilateral TAP block along with 
ILIH block was the technique of choice, with the inten-
tion of reducing the possibility of failed block if only one 
of the blocks was attempted by itself.  There is no data 
thus far to support this combined approach in such a high 
risk case. Although, TAP was introduced in anaesthesia 
practice by Rafi (3) in 2001., our understanding of the 
TAP block and its role in contemporary practice remains 
limited, especially in high risk cardiac patients such as 
patients with severe mulitvessel CAD. On the other hand, 
the ILIH block is safer and easier to perform in order to 
provide analgesia for inguinal surgical procedures, but the 
drawbacks are that it has a relatively short duration and a 
relatively high failure rate of 10-25%, even in experienced 
hands (4, 5). Even though the TAP block provided effec-
tive analgesia during the first 24 h after surgery, there are 
no studies to confirm that this block is superior to other 
techniques of analgesia (6, 7). The confirmation of effec-
tiveness of a combination of a TAP block and an ILIH 
block has been presented previously in other high risk 
groups such as those with cirrhosis of the liver who were 
undergoing inguinal hernia repair procedures (8). In 
high-risk patients with CAD, there is always a possibility 
for deleterious intraoperative tachycardia and significant 
fluctuations in arterial blood pressure, which may pre-
cipitate acute myocardial ischemia if the anaesthesia of 
choice is not an opioid based technique. In this patient 
there were no undesired haemodynamic disturbances re-
lated to the performed TAP and ILIH blocks. 
In conclusion, ultrasound-guided ipsilateral TAP 
block in combination with an ILIH block in this case, 
was administered in a high risk cardiac patient, resulting 
in a successful sensory block, which lasted for 18 h after 
block administration. After block regression, there was no 
need for any further analgesic therapy from the side of the 
patient, neither were there any other complications. 
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The application of paravertebral block in high-risk  
patient with cardiorespiratory, liver and kidney  
problems: a case report
Abstract
Background and Purpose: We  present a case report of a patient of the 
American Society of Anesthesiologists’ (ASA) IV scheduled for a modified 
radical mastectomy (MRM) due to  malignant disease. The patient was a 
high risk patient for general anesthesia and we opted for the application of 
unilateral paravertebral block on several levels. Case report. A 86-year-old 
female was scheduled for a surgery due to recurrent malignant process on 
her right breast.  She was an ASA IV patient with chronic obstructive pul-
monary disease (COPD GOLD A), respiratory failure, diabetes mellitus, 
diabetic nephropathy, cirrhosis and chronic laryngitis. Echocardiography 
showed diastolic dysfunction and pulmonary hypertension of moderate de-
gree. During the preparation for the surgery, an invasive blood pressure 
measurement was set while the paravertebral space was identified with the 
neurostimulator using the linear ultrasound probe of 8 Hertz (Hz). The 
anesthetic [0.5% Levobupivacaine (Chirocaine®, Abbott Laboratories)] was 
applied in levels of Thoracic (Th) 2, Th3, Th4 and Th5 (5 milliliters(ml.) 
per level). We used 2% lidocaine [Lidocaine®, FC] for local infiltration at 
the site of the block.  
Results: Sensory blockade occurred after 32 minutes (min.) and lasted 
for about 8 hours (h) with normal perioperative period and hemodynamic 
parameters without accompanying complications. 
Discussion and Conclusion: This case report shows that the applica-
tion of paravertebral block with lower doses of long-acting local anesthetic 
at several levels leads to a satisfactory anesthetic and analgesic effect while 
maintaining hemodynamic stability.
introduction                                                                                                                             
Breast surgeries which involve modified radical mastectomy (MRM) with dissection of the axilla are usually performed under general 
endotracheal anesthesia with the use of mechanical ventilation. Patients 
with present significant cardiac and pulmonary problems have a very 
high risk for the use of general anesthesia. Here we show the American 
Society of Anesthesiologists’ (ASA) IV patient scheduled for modified 
radical mastectomy (MRM) with malignant disease present. Due to a 
high risk of general anesthesia, we decided to apply unilateral paraver-
tebralnog blocks on several levels. 
Case report: A 86-year-old, 84 kilograms (kg) in weight and 157 
centimeters high (cm.) female was scheduled for a surgery due to a recur-
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rent malignant process on her right breast. She was an 
ASA IV patient with chronic obstructive pulmonary dis-
ease (COPD GOLD A), respiratory failure, diabetes mel-
litus, diabetic nephropathy, adipositas, cirrhosis and 
chronic laryngitis. Auscultationally, she had prolonged 
expiratory phase with basal groan on both sides. Arterial 
blood gas analysis and spirometry showed obstructive 
disorders of moderate degree. The X-ray of the heart and 
lungs showed pronounced interstitial pattern on both 
sides with shallow lateral phrenicocostal sinuses. Echo-
cardiography showed diastolic dysfunction with ejection 
fraction of about 50%, with pulmonary hypertension of 
medium degree. Electrocardiogram showed left ventricu-
lar hypertrophy. The patient has a long history of diabetes 
with insulin therapy accompanied by  diabetic nephropa-
thy and liver cirrhosis.
mAteriAls And methods
Upon the arrival in the perioperative monitoring unit 
(with prior midazolam medication of 5 milligrams (mg.) 
intramuscularly (i.m.) in the department) a non-invasive 
monitoring of heart rate (HR), non-invasive arterial blood 
pressure (BP), fingertip arterial oxygen saturation (SpO2), 
and the needle cannula were placed on a patient. Then, 
the arterial cannula was placed with the infiltration of 
1ml. 2% lidocaine [Lidocaine®, FC] using the ultrasound 
surveillance with in plane technique in the left radial ar-
tery for invasive pressure measurements. After the adjust-
ment of the patient in the sitting position and aseptic 
washing of dorsal surface we detected paravertebral space 
using linear probe of 8 Hz and a depth of 4.5 cm. The skin 
and subcutaneous tissue were infiltrated with 1 ml. 2% 
lidocaine [Lidocaine®, Belupo] per level. In order to per-
fom a paravertebral block we used an ultrasound and a 
neurostimulator with neurostimulating needle [Stimuplex 
D®, BBraun Melsungen] 22 G,  10 cm in length. We used 
neurostimulators for the detection of paravertebral space 
of the initial values  of 2 Hz and lowered them to 0.5 Hz 
with the persistence of muscle contraction. After that,  we 
applied local anesthetic 0.5% Levobupivacaine [Chiro-
caine®, Abbott Laboratories] with the aspiration on the 
four levels of Th2, Th3, Th4 and TH5 (5 ml. per level) 
for analgesic and anesthetic effects.
results
Following the administration of a block, the sensory 
blockade occurred after 32 min and surgical anesthesia in 
40 min. The testing of the block was done with pick prick 
and warm - cold test from the right side of Th 2 to Th 6 
dermatoma. During the operative procedure, the patient 
was sedated with 3 mg. midazolam intravenously (iv) and 
50 micrograms (mcg.) of fentanyl iv. All measured vital 
parameters: heart rate (HR), fingertip arterial oxygen 
saturation (SpO2), invasive arterial blood pressure (BP) 
were of proper values. The surgical procedure lasted 90 
min. without accompanying complications after which 
the patient was sent in the unit for perioperative monitor-
ing with continuous monitoring of hemodynamic param-
eters and saturation. After 60 min. of normal hemody-
namic parameters, arterial cannula was removed and with 
the instructions to the staff, the patient was sent to the 
clinic for plastic surgery. During the first 24 postoperative 
hours, the patient’s pain level was visually monitored us-
ing analgesic scales (VAS, 0 = no pain, 10 = worst pain 
imaginable) every three hours. Sensory blockade lasted 8 
hours from the application of the block with VAS = 1. 
After 8 hours VAS = 3 diclofenac 75 mg. iv was applied 
once, which results after 30 min. in coupling pain and 
lowering VAS to 1 without a need for re-application of 
analgesia in any form. At postoperative interviews 48 h 
after the operation, the patient was very satisfied with the 
anesthesiologist treatment and no complications oc-
curred.
Figure 1. Patient position and  ultrasound image of local anesthetic 
spread. N = Neurostimulator needle  [Stimuplex D®, BBraun Mel-
sungen]; TP = transverse process; EICM = external intercostal 
membrane; LA = local anesthetic; PL = pleura
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discussion And conclusion
This case report shows the application of paravertebral 
block on ASA IV patient with present significant cardiac, 
pulmonary, liver and kidney problems. The patient was 
scheduled for MRM with dissection of the axilla. After 
the full examination of the patient’s condition, we want-
ed to avoid endotracheal intubation and mechanical ven-
tilation because of possible cardiorespiratory complica-
tions. Some of the techniques of regional anesthesia can 
adequately replace the general endotracheal anesthesia in 
breast surgeries. One of them is a thoracic epidural anes-
thesia (TEA) (1.2). This technique can result in bilateral 
symetrical anesthesia but also in a sympathetic block and 
frequent hemodynamic instability (3). Very important 
side effects such as nausea, vomiting and hypotension 
were more common in TEA than thoracic paravertebral 
block (TPVB) (4). There are many papers in favor of an-
esthesia in breast surgery only in the TPVB or in a com-
bination with general anesthesia (5-7). Tahiri et al. show 
the results of 11 studies that compared paravertebral 
blocks with general anesthesia. The research has proven 
significantly lower pain scores during the first 6 postop-
erative  hours and less requirements for pain relief in pa-
tients who had paravertebral block applied (6). Paraverte-
bral blocks proved to be very useful in reducing the 
development of chronic postoperative pain (8). Although 
there are many techniques performing paravertebral 
blocks (9 - 11), we have, in order to achieve a better preci-
sion in sensory blockade, decided to give blocks on sev-
eral levels using the ultrasound and neurostimulators in 
plane technique. Therefore, it should be noted that in a 
single shot block administration the occurence of very 
significant problems described as a failed block or epidu-
ral spread of local anesthetic (12) is possible.  With the 
frequent use of ultrasound, the application of paraveret-
bral blocks in high-risk patients as a method of choice (13, 
14) is becoming more common. We had to take into con-
sideration cardio-respiratory problem in our patient, to-
gether with the cirrhosis of the liver. It is known that 
amino - amide local anesthetics are metabolized in the 
liver and the worse the perfusion and function of the 
liver (15, 16) is, the longer their elimination half-life is. In 
conclusion, by cautious administration of small doses of 
local anesthetics (5 ml.) at four thoracic paravertebral lev-
els we achieved successful unilateral anaestetic effect 
without accompanying cardiorespiratory and metabolic 
complications.
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The use of an ultrasound-guided supraclavicular  
brachial plexus block in a high risk patient with  
cardiomyopathy 
Abstract
With the rapid growth of the elderly population, along with increased 
comorbidities and greater life expectancy, geriatric surgery has become more 
frequent and requires careful tailoring of anesthesia technique. Preanes-
thetic evaluation should concentrate on the identification of age-related 
diseases and an estimation of physiological reserve. Age-related cardiovascu-
lar changes are leading factors impacting perioperative outcomes among 
elderly patients. The management of a patient with dilated cardiomyopathy, 
who undergoes a non-cardiac surgery is always a challenge for an anesthe-
siologist, as this situation is associated with a high mortality rate. 
We report a use of the ultrasound guided supraclavicular brachial plex-
us block in 87-year old woman for revision of wound of left wrist and repo-
sition and immobilization of left forearm and elbow. Her previous medical 
records revealed that she arterial hypertension, chronic atrial fibrillation 
with dilated cardiomyopathy and chronic kidney disease, stage II. Postop-
eratively, she developed respiratory insufficiency.
This case report exemplifies how despite all the measures and precaution 
we had taken, with choosing anesthesia having only minimal hemodynam-
ic fluctuations and carefully planned and balanced hydration of patient we 
still had unwanted outcome.
introduction
In the last 50 years, the number of people over 65 years of age has tripled in the world. In Europe, they are expected to represent 30% 
of the population within 40 years (1). With the rapid growth of the el-
derly population, along with increased comorbidities and greater life 
expectancy, geriatric surgery has become more frequent and requires 
careful tailoring of anesthesia technique (2). Aging is a universal and 
progressive physiologic process characterized by declining in end-organ 
reserve, decreased functional capacity, increasing imbalance of homeo-
static mechanisms, and an increasing incidence of pathologic processes 
(3). Aging is now viewed as an extremely complex multifactorial process 
with interaction of various pathways to differing degrees and effect (4). 
Age is not a contraindication to anesthesia and surgery; however, peri-
operative morbidity and mortality are greater in elderly than younger 
surgical patients. Anesthetic risk correlates much better with the pres-
ence of coexisting disease than chronological age. Therefore, preanes-
thetic evaluation should concentrate on the identification of age-related 
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diseases and an estimation of physiological reserve. Age-
related cardiovascular changes are leading factors impact-
ing perioperative outcomes among elderly patients, de-
spite advances in perioperative care cardiac morbidity and 
mortality remain high ranging from 2-15% depending 
from the study (5). 
case report 
A 87-year-old female patient, with 150 cm of height 
and 50 kg of weight, was hospitalized under diagnosis of 
fractured left femur neck, left elbow dislocation and frac-
tured left forearm with open wound on the left wrist after 
she had fallen at home. Indication for revision of wound 
of left wrist and reposition and immobilization of left 
forearm and elbow was set.
Her previous medical records revealed that she arte-
rial hypertension, chronic atrial fibrillation with dilated 
cardiomyopathy and chronic kidney disease, stage II. She 
was on treatment with amiodarone, trandolapril, metil-
digoxine and furosemide. 
After admission, the patient’s initial laboratory reports 
were: random blood glucose of 7.9 mmol/L, urea 17.4 
mmol/L, creatinine 162 µmol/L, sodium 140 mmol/L, 
potassium 3.8 mmol/L, hemoglobin 132 g/l, hematocrit 
42.2%, CRP 80.5 mg/L, and blood coagulation were 
normal. Her chest X-ray revealed enlarged cardiac borders 
and clear lung fields [Figure 1].
On preanaesthetic examination her heart rate was ir-
regular, presented as atrial fibrillation with an average 
ventricular response of 80 beats per minute. Systolic and 
diastolic blood pressures were 150 mmHg and 90 mmHg, 
respectively. Her respiratory rate was accelerated with 
jugular retraction and usage of accessory respiration mus-
cles. She was given ASA IVE status on preoperative ex-
amination.
After reviewing medical records and patient examina-
tion, a supraclavicular brachial plexus block was chosen 
because it produces minimal effects on the heart rate, 
blood pressure and contractility of the heart. It was con-
sidered as appropriate form of anesthesia according to the 
planned surgical treatment and subsequent pain treat-
ment. Before the beginning of the procedure, venous access 
and standard monitoring was established (pulse oximetry, 
electrocardiography and noninvasive arterial blood pres-
sure monitoring). After aseptic preparations and under 
ultrasound guidance brachial plexus was identified and 
20ml of 0.75% ropivacaine were administered slowly in 
2ml increments with gentle aspiration between doses. 
After completion of the procedure, sensory (warm, cold, 
touch, pain) and motor (absence of foot mobility) block-
ade were evaluated in 10 minutes intervals. Visual ana-
logue scale (VAS) was used for pain score recording. A 
paralysis of the left arm and VAS score 0 was recorded 
after 40 minutes and complete block was achieved. 
Figure 1. Chest X-ray at the admission in hospital.
Figure 2. Control chest X-ray at the admission in ICU.
Figure 3. Control chest X-ray after interval of 6 hours from admis-
sion in ICU.
After that patient was taken to operation theatre and 
positioned supine. During the treatment patient had a fall 
of heart rate to 50/min and atropine 0.5mg was adminis-
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tered after what heart rate revert to 80/min. There was no 
oscillation in blood pressure. The total duration of the 
surgery interventions were approximately 30 min. At the 
end of treatment patient become somnolent and respira-
tory insufficient and was intubated with cuffed endotra-
cheal tube 7.5 mm ID (Internal Diameter). She was ad-
mitted to ICU and connected to respirator. Until that 
moment, from admission in hospital (interval of 6 hours), 
she received 700ml crystalloid solution.
First few hours after admission patient was hemody-
namically unstable and continuous norepinephrine infu-
sion was started in the dose required to attain normoten-
sion. Later during that day her neurological condition 
improved, in the evening she regained consciousness and 
became communicative. Thereafter, she was switched 
from SIMV mode to CPAP mode of respiration.
We investigated possible causes of such outcome. Since 
the peripheral nerve block was performed, two control chest 
X-rays were done (immediately after the surgery when she 
was admitted in the ICU, and 6 hours later) [Fig. 2 and 3]. 
A pneumothorax and iatrogenic paresis of phrenic nerve 
were excluded, and cardiac decompensation as a cause of 
patient’s respiratory insufficiency and somnolence was sus-
pected. Acute congestive heart failure was confirmed by 
combination of X-ray and increased proBNP 6781 g/L (nor-
mal value for patients over 75 years is under 450g/L).
During the next day patient’s respiratory function im-
proved and she was disconnected from respirator and 
extubated. A motor function of the left recovered within 
14 hours after the local anesthetic injection. The patient 
reported that sensory block was present for 4 more hours 
after that (overall 18 hours). On the day after, she was 
discharged to surgical ward with normal blood pressure 
and respiratory function. The later was confirmed by 
blood gas analysis.
On the same day, in the afternoon, patient was read-
mitted to ICU because of repeated episode of respiratory 
insufficiency. Her saturation as measured by pulse oxim-
etry, with 6L of 100% oxygen applied was 82%. She was 
intubated and assisted ventilation was continued. The 
control chest X-ray that was done has confirmed repeated 
congestive heart failure. In the laboratory reports an in-
creased value of CRP (192.1 mg/L) was registered, the rest 
of findings didn’t show any significant deviations. A tra-
cheal aspirate for analysis was taken, and Enterobacter 
species was confirmed. A specific antibiotic therapy ac-
cording to antibiogram was started. Despite all supportive 
measures, her physical condition deteriorated and she 
died on 19th day of hospitalization.
discussion
Anesthetic management of patients with cardiomy-
opathy, with reduced systolic function, is challenging and 
it may be associated with high mortality. It is commonly 
complicated by congestive heart failure and malignant 
arrhythmias. Dilated cardiomyopathy is defined as a de-
terioration of the function of the myocardium, either 
caused by left ventricular or biventricular dilatation or 
due to impaired systolic function of one or both ventricles, 
with impaired ventricular contractility. The anesthesiolo-
gist should have a thorough knowledge on its pathophys-
iology, clinical features, diagnostic evaluations and the 
treatment modalities. This has to be accompanied by a 
careful planning to provide safe anesthesia. Choice of 
anesthesia should be planned and it should be aimed to 
reduce hemodynamic fluctuations (6). The use of periph-
eral nerve blocks in the elderly is a rational approach for 
appropriate surgery as it has minimal influence on hemo-
dynamics (7).
All investigation that we took in our patient to define 
cause of respiratory insufficiency suggested that it was 
caused by acute congestive heart failure as a complication 
of severe cardiomyopathy. Our suspicion was supported 
with the fact that it occurred again shortly after discharge 
from ICU. 
Studies show that overall mortality and morbidity is 
higher in emergency anesthesia than in elective anesthesia 
and that ASA physical status correlates with overall mor-
tality and morbidity, regardless of etiology, as well. For 
the patients with ASA IVE physical status the incidence 
of all critical events totally attributable to anesthesia is 
14.85% and the overall mortality rate totally attributable 
to anesthesia is 6.60% (8). 
This case confirms that despite all the measures and 
precautions that were taken, with choosing anesthesia 
aimed to reduce haemodynamic fluctuations, with careful 
planning and balancing hydration of patient, we still may 
have unwanted complications.
conclusion
The elderly population is the fastest growing part of the 
population in the developed world. Aging increases the 
probability of a person to undergo surgery. It alters both 
pharmacokinetic and pharmacodynamic aspects of anes-
thetic management (9). Anesthesia planning, preoperative 
assessment, optimizing cardiac status and medical manage-
ment, formulating the good anesthetic plans and postop-
erative monitoring, prompt diagnosis and management of 
complications have to be considered to minimize the inci-
dence of critical events and the mortality rate.
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Paravertebral block: review of the literature
Abstract 
Background: Paravertebral Block (PVB) is an established regional an-
esthetic technique. It is technically easy to perform and is being used increas-
ingly for intra-operative and post-operative analgesia. This popularity is 
mainly due to the ease of the technique and fewer complications. 
Materials and Methods: This is quantitative systematic review of li-
terature database with the aim to assess the efficacy and safety of Paraverte-
bral block in thoracic, abdominal and breast surgery.
Results: Six randomised control trials that included 386 patients were 
reviewed. Authors of reviewed articles reported 100% success in block effec-
tivenes and low incidence of complications. 
Conclusion: Paravertebral block is effectiv anesthetic/analgetic tech-
nique with very few complications
introduction
Paravertebral Block (PVB) is an established regional anesthetic tech-nique. The injection of local anesthetic in a space immediately lat-
eral to where the spinal nerves emerge from the intervertebral foramina 
produces unilateral, segmental, somatic, and sympathetic nerve block-
ade which is effective for anesthesia and in treating acute and chronic 
pain of unilateral origin from the chest and abdomen.
PVBs are highly adaptable and, except for thoracotomy, may serve 
as the primary anesthetic for breast surgery, chest trauma, hernia repair, 
soft tissue mass excisions, and /or as a useful adjunct in laparoscopic 
surgery, cholecystectomy, nephrectomy, or other abdominal and tho-
racic surgery (1).
mAteriAl And methods
The aim of this quantitative systematic review of literature database 
was to assess the efficacy and safety of PVB in thoracic, abdominal and 
breast surgery. The systematic search was conducted in the Central re-
gister of controlled trials of the Cochrane Library ,MEDLINE and EM-
BASE according to the current recommendations of the CochraneCo-
llaboration (2).The search strategy consisted of a combination of free text 
words and Medical Subject Headings (MeSH) terms: ‘paravertebral’, 
’thoracic surgery’, ’abdomina surgery’ and ‘breast surgery’
The authors scanned the avaliable articles by the initial search to 
exclude irrelevant studies. 
Study eligibility was determined by reading the title and abstracts 
and obviously irrelevant trials were excluded at this stage. 
The six studies that are included in review are in Table 1 (3, 4, 5, 6, 
7, 8).
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3  Childrens ś Hospital Zagreb, 
Department of Anesthesiology,  
Reanimatology and Intensive Care
Correspondence: 
Maja Karaman Ili} 
Sveti Duh Univesity Hospital  
Department of Anesthesiology,  
Reanimatology and Intensive Care 
E-mail: majakilic1@gmail.com
abbreviations: 
PVB  – Paravertebral Block 
MeSH – Medical Subject Headings  
LA – Local Anesthetic 
RCT – Randomised Control Trial 







Received May 5, 2015.
Maja Karaman Ilić et al. Paravertebral block
316 Period biol, Vol 117, No 2, 2015.
results
The studies included in the reviw were randomised, 
control trials(RCT).Hadžić, Naja,Pusch and Klein repor-
ted 100% success in block effectivenes. The failure rate 
associated with PVB is not > 9%.Inadvertent vascular pun-
cture (5,2%), hypotension (6%), epidural spread of Local 
Anesthetic (LA) (1,8%), inadvent pleural punction (1.8%) 
and pneumothorax (0.5%) were the recorded complicati-
ons. Complicatins were  higher in bilateral compared to 
unilateral block. Postoperative nausea and vomiting are 
significantly lower in patients given PVB compared to GA.
discussion
First PVB was performed in 1905 as an alternative to 
neuraxial block for obstetric procedures and became a 
popular technique for the provision of analgesia in the 
early part of the twentieth century (9,10). 
The technique however remained neglected till the late 
1970s. Renaissance for PVB began 1979 due to efforts 
from Eason and Wyatt who presented a reappraisal on 
Thoracic Paravertebral Block (TPVB) (11). 
PVB is technically easy to learn with a high success 
rate, and is being used increasingly for not only intra-
operative and post-operative analgesia but also as a sole 
anesthetic technique for carrying out various procedures. 
This popularity is mainly due to the ease of the technique 
and fewer complications. 
Post-operative pain control is one of the major concerns 
in the post-operative care of patients undergoing thoracic 
surgery, especially when thoracotomy is required. In thora-
cic surgery PVB is placed at the level of the surgical thoracic 
incision,in most of the cases it is a unilateral block (12).
The injection of LA in the paravertebral space produces 
analgesia because of direct contact of LA with the spinal 
nerve roots before they emerge from the intervertebral 
foramina. 
The pain associated with thoracotomy surgery can be 
severe (13).
Pain stimuli arising from skin and muscles incision as 
well as from ribs are spread and conducted by intercostal 
nerves that are also important for the transition from 
acute to chronic pain from nociceptive to neurogenic and 
neurophatic pain. 
The paravertebral block has also been used extensively 
for anaesthesia and analgesia for abdominal surgery, es-
pecially for ambulatory inguinal hernia repair (4, 14). 
The injection of LA into the paravertebral space avoids 
the severe autonomic dysfunction seen with neuraxial 
techniques and allows the patient to mobilise earlier.
The paravertebral approach to analgesia after inguinal 
herniorrhaphy can provide analgesia that is superior to 
oral analgesia or  local field blocks.
Breast surgery under the PVB showed satisfactory pain 
control with no need for supplementation of analgetics. 
Postoperative pain is effectively controlled and patients 
rated the experience as very satisfactory (15).
From the retrived papers,with eception of reviwed ar-
ticles, additinal posibility for PVB application is observed.
Paravertebral blocks have been used less frequently for 
other abdominal procedures. A series of ten patients un-
dergoing abdominal vascular surgical procedures was 
reported. Cardiovascular stability was noted upon inci-
sion, clamping of the aorta and throughout surgery in all 
patients (16).
No further intra-operative opioids or neuromuscular 
blocking drugs were required and postoperative analgesia 
was excellent. 
The paravertebral block has also been used success-
fully as rescue analgesia for visceral pain after failure of 
Table 1
Studies included in review.
Trial No of patients Type of surgery Type Details 
Naja and colleagues  (3) 60 Breast surgery MPVB Lidocaine 1%, bupivacaine 0.5%, fentanyl, clonidine, epinephrine
Wassef et al.(4) 30 Heniorraphy MPVB 2%lidocain,epinephrin
Klein and colleagues (5) 60 Breast surgery MPVB Bupivacaine 0.5%, epinephrine
Richardson et al.(6) 100 Thoracic surgery SPVB 0,5% bupivacain
Hadžić et al (7) 50 heniorraphy SPVB 0,75% ropivacain
Pusch and colleagues(8) 86 Breast surgery SPVB Bupivacaine 0.5%
MPVB – multiple paravertebral block 
SPVB – single paravertebral block
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systemic analgesics for renal colic in an obstetric patient.
Described experiences with liver surgery-pain control fol-
lowing radiofrequency ablation of liver mass (17) as well 
for percutaneous transhepatic biliary drainage were satis-
factory(18). 
The effect of PVB examined on the pain-relief and 
perioperative stress response in patients scheduled for 
open cholecystectomy showed less pain scores and less 
requirements on supplemental analgesics for three days 
postoperatively.A significant reduction in circulatory and 
hormonal response to stress was also seen (19).
In conclusion, based on the current evidence, PVBs for 
surgical anesthesia at the level of the thoracic and lumbar 
vertebrae are associated with less pain during the immedi-
ate postoperative period, as well as less postoperative nau-
sea and vomiting, and greater patient satisfaction com-
pared with GA. A modern approach to pain control 
should consider that reduction or elimination of pain, 
reduction of  morbidity, length of stay and hospital costs.
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dAy 1: fridAy, June 12, 2015 
HALL Ban Josip Jelačić, Hotel Dubrovnik
12:00 –   REGISTRATION
Registration desk
14:30 – 18:30 SESSION 1
HIGHLIGHTS IN REGIONAL ANAESTHESIA & PAIN MEDICINE
Chair: J. De Andrés (Spain), S. Gligorijevic (Switzerland) 
14:30 – 15:00 Genetics and pain
D. Primorac, Zagreb, Croatia
15:00 – 15:30 Pain medicine - medical management of acute and chronic pain
J. De Andrés, Valencia, Spain
15:30 – 16:00   POSTER PRESENTATIONS  
Chair: V. Nesek Adam (Zagreb), D. Bandić Pavlović (Zagreb), J. Pavičić Šarić (Zagreb)
15:30 – 16:00 Coffee break
16:00 – 16:30 Status of Regional anesthesia & Pain medicine in undergraduate and postgraduate study – today 
and tomorrow
M. Van de Velde, Leuven, Belgium
16:30 – 17:00     What is new in Education and Teaching in Regional anaesthesia?
V. Paver Eržen, Ljubljana, Slovenia
17:00 – 17:30     Adverse events and regional anaesthesia: Preventing the preventable
S. Gligorijevic, Zuerich, Switzerland                   
17:30 – 18:00     Spinal anaesthesia and stress response in hip trauma
K. Šakić, Zagreb, Croatia
18:00 – 18:30 Discussion
20:00 – 22:00 WELCOME RECEPTION, Hotel Dubrovnik, 1st floor
CSRAA 2015 Best Poster Award
Musical act: M. Barišin and Pavao Markovac, Music School String Quintet
dAy 2: sAturdAy, June 13, 2015 
HALL Ban Josip Jelačić, Hotel Dubrovnik
08:00 – 10:30 SYMPOSIUM I
REGIONAL ANAESTHESIA AND ANALGESIA
Chair: M. Van de Velde (Belgium), K. Šakić (Croatia)
08:00 – 08:40 Update in obstetric Regional Anesthesia  
Anesthetic management of the severly preeclamptic parturient
M. Van de Velde, Leuven, Belgium
08:40 – 09:10     Perioperative Analgesia for thoracic surgery
V. Novak Jankovič, Ljubljana, Slovenia 
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09:10 – 09:40 Update in orthopaedic Regional Anesthesia: state of the art practice  
B. Tripković, Zagreb, Croatia   
09:40 – 10:10     Ultrasound use for nerve blocks and management strategies in outpatient surgery 
K. Oremuš, Zagreb, Croatia                         
10:10 – 10:30 Discussion       
10:30 – 11:00 POSTER PRESENTATIONS 
Chair:  Chair: S. Kvolik (Osijek),  J. Peršec (Zagreb)
10:30 – 11:00 Coffee break
11:00 – 13:00 SYMPOSIUM II   
PAIN MEDICINE 
Chair: J. De Andrés (Spain), I. Radoš (Croatia)
11:00 – 11:20 Anatomy and Physiology of nociception and centrally-mediated pain states 
Z. Petanjek, Zagreb, Croatia
11:20 – 12:00 Invasive procedures for chronic pain
J De Andrés, Valencia, Spain  
12:00 – 12:20 Neurosurgical procedures for chronic pain treatment
D. Chudy, Zagreb, Croatia 
12:20 – 12:40 Postoperative Neurological Sequelae – Management, early Diagnosis and treatment of Neurologic 
complications after regional anaesthesia 
V. Bašić Kes, Zagreb, Croatia
12:40 – 13:00 Discussion 
13:00 – 14:00 Lunch break 
Hotel restaurant
14:00 – 16:00 SYMPOSIUM III 
CLINICAL RESEARCH IN REGIONAL ANAESTHESIA 
Chair: D. Tonković (Croatia), S. Kvolik (Croatia)
14:00 – 14:20 Effect of age on onset time and duration of sensory blockade in regional anaesthesia    
J. Pavičić Šarić, Zagreb, Croatia
14:20 – 14:40     Attenuation of systemic inflammatory stress response after 
preoperative analgesia with clonidine compared to levobupivacaine 
J. Peršec, Zagreb, Croatia
14:40 – 15:00   Upper extremity blocks or general anaesthesia
S. Baranović, Zagreb, Croatia
15:00 – 15:20     Paravertebral blocks in high risk thoracic surgery
J. Špiček Macan, Zagreb, Croatia 
15:20 – 15:40     Neuropathic Orofacial pain – diagnostic and therapeutic challenges
I. Šklebar, Zagreb, Croatia
15:40 – 16:00     Discussion
16:00 – 16:30 POSTER PRESENTATIONS (P17–P24)
Chair: V. Golubović (Rijeka), T. Šimurina (Zadar), L. Kalagac Fabris (Pula)
16:00 – 16:30 Coffee break
16:30 – 17:30
SYMPOSIUM IV
MISCELLANEOUS TOPICS  IN REGIONAL ANAESTHESIA 
Chair: I. Suljević (Bosnia and Herzegovina), V. Nesek Adam (Croatia)
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16:30 – 16:45     Anaesthetic procedures and pain relief for child delivery in Bosnia and HerzegovinaI. Suljević, Sarajevo, BIH
16:45 – 17:00     Regional anesthesia in cancer surgery: updateG. Brozović, Zagreb, Croatia
17:00 – 17:15     Perioperative pain management in ICU patientsV.Nesek Adam, Zagreb, Croatia
17:15 – 17:30     Regional anesthesia in children: indications and limitationsA. Hasani, Pristhina, Kosovo
17:30 – 17:45    Radiofrequency denervation of lumbar facet joints in the treatment of chronic low back painI. Radoš, Osijek, Croatia
17:40 – 18:20 WORKSHOPS – PART 1
Hall A W 01 Nerve location for peripheral nerve blocks: ultrasound and nerve stimulation 
Upper extremity blocks
Brachial plexus – Proximal approaches: interscalene, infraclavicular
Distal approaches: nerve blocks at elbow and wrist level 
Demonstrators/speakers: K. Oremuš, Croatia
Hall B W 02 Nerve location for peripheral nerve blocks: ultrasound and nerve stimulation 
Lower extremity blocks
Proximal approaches: psoas compartment, femoral and sciatic nerve blocks. 
Distal nerve blocks: sciatic and saphenous nerve block at the knee and ankle level
Demonstrators/speakers: S. Huterer, Austria
Hall C   W 03 Paravertebral, sympathetic, and other blocks
Demonstrators/speakers: J. Ažman, I. Skok, Croatia
Hall D   W 04 Airway management, Topical anaesthesia of the airway
Ganglion stelatum block Sympathetic block, and other blocks
Demonstrators/speakers: V. Frković, T. Goranović, Croatia
18:20 – 19:00 WORKSHOPS – PART 2
Hall A W 01 Nerve location for peripheral nerve blocks: ultrasound and nerve stimulation 
Upper extremity blocks
Brachial plexus - Proximal approaches: interscalene, infraclavicular
Distal approaches: nerve blocks at elbow and wrist level 
Demonstrators/speakers:  K. Oremuš, Croatia
Hall B W 02 Nerve location for peripheral nerve blocks: ultrasound and nerve stimulation 
Lower extremity blocks
Proximal approaches: psoas compartment, femoral and sciatic nerve blocks. 
Distal nerve blocks: sciatic and saphenous nerve block at the knee and ankle level 
Demonstrators/speakers: S. Huterer, Austria
Hall C   W 03 Sympathetic trunk (Ganglion stelatum, plexus celiacus  and other blocks)
Demonstrators/speakers: J. Ažman, I. Skok, Croatia
Hall D   W 04 Airway management, Topical anaesthesia and upper airway blocks
Paravertebral  and other blocks
Demonstrators/speakers: V. Frković, T. Goranović, Croatia
19:10 – 21:00 CLOSING CEREMONY
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poster presentAtion schedule 
 
fridAy, June 12, 2015
15:30 – 16:00   POSTER PRESENTATIONS (P 1 – P8)  
D. Bandić Pavlović(Zagreb), J. Pavičić Šarić (Zagreb)
P 1   PATIENTS’ SATISFACTION WITH SPINAL ANESTHESIA IN PATIENTS UNDERGOING INGUINAL HERNIA 
REPAIR 
Daniela Bandić Pavlović, Sanja Sakan, Željka Martinović, Igor Virag, Klaudija Prlić, Dinko Tonković, Mladen Perić
P 2   FACTORS ASSOCIATED WITH SUCCESSFUL PERFORMANCE OF UNILATERAL SPINAL ANESTHESIA FOR 
VARICOSE VEIN SURGERY 
Kristina Medved, Damira Vukičević, Marko Oreški
P 3   INFLUENCE OF UNILATERAL SPINAL BLOCk ON HAEMODYNAMIC PROFILE IN DIABETIC AND  
NON-DIABETIC PATIENTS 
Petra Ožegović, Vanja Vončina, Jelena Zenko, Jadranka Pavičić Šarić
P 4   SPINAL ANAESTHESIA AND IT´S COMPLICATIONS – EVALUATION OF EXPECTATIONS, IMPRESSIONS 
AND EXPERIENCES AMONG PATIENTS 
Sonja Krofak, Višnja Nesek Adam, Petra Matković, Maja Karaman – Ilić, Žarko Rašić, Livija Šakić 
P 5   EPIDURAL ANESTHESIA IN PATIENT WITH DBS – OUR FIRST CASE 
Marin Knez, Nikolina Narančić Knez, Ante Tolić, Marina Nekić Borčilo, Alfio Poropat, Milica Komšo, Anamarija Mrđen, 
Orijana Džepina
P 6   SPINAL ANESTHESIA FOR LUMBAR SPINE SURGERY IN UNIVERSITY CLINICAL HOSPITAL MOSTAR 
Dajana Vladić, Mirko Mihalj, Anita Kosjerina, Zoran Karlović, Vesna Golubović
P 7   SUPRACLAVICULAR NERVE BLOCK: DOES KIDNEY TRANSPLANTATION MAKE A DIFFERENCE? 
Katarina Tomulić Brusich, Ivana Acan, Vesna Kovačić Vicić, Nataša Višković Filipčić
P 8   ULTRASOUND-GUIDED TRANSVERSUS ABDOMINIS PLANE BLOCK IN COMBINATION WITH  
ILIOINGUINAL AND ILIOHYPOGASTRIC BLOCk IN A HIGH RISk CARDIAC PATIENT FOR INGUINAL 
HERNIA REPAIR: A CASE REPORT 
Stjepan Barišin, Viktor Đuzel, Livija Šakić
sAturdAy, June 13, 2015
10:30 – 11:00 POSTER PRESENTATIONS (P 9 – P 16 )
Chair: I. Matić (Slavonski Brod),  J. Peršec (Zagreb), I. Škeblar (Zagreb) 
P 9   ARTERIAL PRESSURE AND HEART RATE CHANGES IN PATIENTS DURING „BEACH CHAIR POSITION“ 
FOR SHOULDER SURGERY: COMPARISON OF THE REGIONAL AND GENERAL ANESTHESIA TECHNIQUES 
Ivana Haršanji Drenjančević, Domagoj Drenjančević, Danijela Gulam, Slavica Kvolik, Tomislav Ružman,  Gordana Kristek
P 10   FEMORAL NERVE BLOCk IN A HIGH RISk CARDIAC PATIENT. CASE REPORT. 
Verica Mikecin, Miroslav Župčić, Sandra Graf Župčić, Sanja Peremin, Viktor Đuzel, Ana Briški, Ino Husedžinović
P 11  THE USE OF AN ULTRASOUND-GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCk IN A HIGH RISk 
PATIENT WITH CARDIOMYOPATHY  
Barbara Palković, Ivana Haršanji Drenjančević, Dubravka Ivić, Slavica Kvolik
P 12   COMPARISON OF MINIMUM EFFECTIVE VOLUME OF LOCAL ANESTHETIC FOR ULTRASOUND GUIDED 
SUPRACLAVICULAR BLOCk (MEAV95) IN ELDERLY AND MIDDLE AGED PATIENTS
Jadranka Pavičić Šarić, Vinko Vidjak, Jelena Zenko, Matea Bogdanović Dvorščak, Vanja Vončina, Nataša Paklar
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P 13   SCALP BLOCk FOR HEMODYNAMIC STABILITY DURING NEUROSURGERY 
Dinko Tonković, Vasilije Stambolija, Marin Lozić, Petar Martinović, Daniela Bandić Pavlović, Ante Sekulić, Robert Baronica, 
Mladen Perić
P 14   PARAVERTEBRAL BLOCK: REVIEW OF LITERATURE 
Maja Karaman – Ilić, Višnja Nesek Adam, Martina Matolić, Jana Kogler, Dijana Butković 
P 15  THE APPLICATION OF PARAVERTEBRAL BLOCk IN HIGH-RISk PATIENTS WITH CARDIORESPIRATORY, 
LIVER AND kIDNEY PROBLEMS: A CASE REPORT  
Miroslav Župčić, Sandra Graf Župčić, Ana Brundula, Iva Korečić Zrinšćak, Jasminka Peršec, Ino Husedžinović
P 16   TRENDS IN OBSTETRIC REGIONAL ANESTHESIA AND ANALGESIA AT SVETI DUH UNIVERSITY HOSPITAL 
Ivan Šklebar, Tino Klancir, Livija Šakić, Luka Djulabić
 
16:00 – 16:30 POSTER PRESENTATIONS (P 17 – P 24)
Chair: V. Golubović (Rijeka), T. Šimurina (Zadar), L. Kalagac Fabris
P 17   SATISFACTION WITH REGIONAL ANESTHESIA IN PARTURIENTS UNDERGONE CAESAREAN SECTION  
Sonja Škiljić, Dubravka Ivić, Gordana Kristek
P 18   PATIENT SATISFACTION WITH REGIONAL ANESTHESIA IN ORTHOPEDIC SURGERY 
Tomislav Ružman, Nataša Ružman, Ivana Haršanji Drenjančević, Gordana Kristek, Danijela Gulam, Slavica Kvolik
P 19  INFLUENCE OF DEXAMETHASONE ADMINISTRATION IN SPINAL ANESTHESIA FOR FEMUR FRACTURE 
ON POSTOPERATIVE COGNITIVE DYSFUNCTION
Livija Šakić, Dinko Tonković, Borna Josip Godan, Katarina Šakić 
P 20   LUMBAR SPINAL STENOSIS: METHODS OF TREATMENT WITH EMPHASIS ON EPIDURAL STEROID 
INJECTIONS 
Neven Elezović, Dragica Kopić, Sanda Stojanovic Stipić,  Ana Šarić, Anela Elezović, Tomislav Ljubičić
P 21   PROLONGED RELIEF OF HEAD AND FACE NEURALGIA AFTER REGIONAL NERVE BLOCkS 
Lada Kalagac Fabris, Maša Biberić 
P 22   TEMPOROMANDIBULAR JOINT DISORDER AND HEADACHE – ONE-YEAR-FOLLOW-UP 
Iva Klarić, Tomislav Badel, Vanja Bašić Kes, Samir Ćimić, Dijana Zadravec
P 23   LOCAL ANALGESIA IN PAIN MANAGEMENT AFTER CARDIAC SURGERY 
Anita Kosjerina, Zoran Karlović, Vesna Golubović, Dajana Vladić
P 24   DOES ROTATION THROMBELASTOMETRY (ROTEM®) IMPROVE EARLY PREDICTION OF COAGULOPATHY 
IN (BENIGN AND MALIGNANT) BREAST TUMOR? 
Dinko Bagatin, Katarina Šakić, Tomica Bagatin, Deana Šturm, Milan Milošević
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A1, P1: Patients’ satisfaction with spinal anesthesia  
in patients undergoing inguinal hernia repair 
DANIELA BANDIC PAVLOVIC1, SANJA SAKAN2, ZELJKA MARTINOVIC3, IGOR VIRAG2, KLAUDIJA PRLIC2, DINKO TONKOVIC1, MLADEN PERIC1
1 School of Medicine,  University of Zagreb, Clinical Hospital Center Zagreb, Croatia
2 Clinical Hospital Center Zagreb, Croatia
3  Ministry of Labour and Pension System, Medical Assessors Department, Croatia
(daniela.bandic.pavlovic@mef.hr)
Background and goal: The aim of the study was to assess patients satisfaction,  postoperative complication and hospital stay with SA.
Materials and methods: This observational, retrospective study included 27 patients in Clinical hospital center Zagreb 
in six months period. Patients were interviewed by phone for satisfaction by Likert scale from one (very unsatisfied) to five 
(very satisfied) for anesthesia, for pain by VAS (1 to 10), presence of PONV, headache and urinary retention. Following data 
were collected from medical documentation (age, sex, BMI, ASA, hospital stay). 
Results:  In spinal group median age was 65 years (range 23-82), BMI was normal in 17 patients and increased in 10 
patients, 18 patients were ASA 1 and 2, seven were ASA 3 and 2 were ASA 4. From complication, two patients had a head-
ache, two vomiting and five patients had urinary retention. 20 patients assess satisfaction with anesthesia in spinal group 
as very satisfied, 3 as satisfied, 1 as neutral, 1 as unsatisfied and 2 as very unsatisfied. Satisfaction in postoperative period of 
this group was as follows: 13 were very satisfied, 10 were satisfied, 1 was neutral, nobody was unsatisfied and 3 were very 
unsatisfied. All four patients marked their satisfaction as unsatisfied or very unsatisfied due to development of urinary reten-
tion. Median of hospital stay was three days. 
Conclusion: From patients point of view, for scheduled inguinal hernia repair high degree of satisfaction provides SA. 
While urinary retention was the reason of patients’ unsatisfaction, other complication patients have not been related with 
dissatisfaction.
 
a2, P2: Factors associated with successful 
performance of unilateral spinal anesthesia  
for varicose vein surgery
KRISTINA MEDVED, DAMIRA VUKI^EVI], MARKO ORE[KI
Department of Anesthesiology and Intensive Care, University Hospital Merkur, Zagreb, Croatia  
(kristinamedved1@gmail.com)
Background and purpose: Unilateral spinal anesthesia provides excellent surgical anesthesia and postoperative analge-sia with minimal effect on motor limb blockade. This enhances patient recovery and hospital discharge. Single center 
retrospective study was conducted to determine factors associated with unilateral spinal block performance.
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Materials and methods: Medical records of patient undergoing varicose vein surgery at University Hospital Merkur, 
between February 2014 and February 2015 were reviewed. All patients underwent unilateral spinal anesthesia with hyper-
baric anesthetic solution (0.5% levobupivacaine 10 mg, fentanyl 25 mg and 0.5 mL of 40% glucose). Patients were divided 
according to age (young <35 years, mean 35-65 years, older >65 years), body mass index (BMI kg/m2; <25, 25-30, >30) and 
presence of musculoskeletal system pathology. 
Results: A total of 97 patients gave written consent for unilateral spinal block performance - 35 males (36.1%) and 62 
females (63.9%). Successful rate performance for surgical anesthesia was 86.6%. Thirteen patients (13.4 %) had to be con-
verted to general anesthesia. Patient factors were analyzed using linear regression model. Failure of adequate anesthesia was 
not associated with age (p <0.05) and BMI (p <0.05). However, presence of musculoskeletal lumbar pathology had signifi-
cant impact on the unilateral spinal block success (p <0.01). 
Conclusion: Failure of unilateral spinal anesthesia is associated with musculoskeletal lumbar pathology and not with 
age or BMI.
 
a3, P3: Influence of unilateral spinal block  
on haemodynamic profile in diabetic and non-diabetic  
patients
PETRA O@EGOVI], VANJA VON^INA, JELENA ZENKO, JADRANKA PAVI^I] [ARI]
Department of Anaesthesiology, Reanimatology and Intensive Care, University hospital Merkur, Zagreb, Croatia 
(petra.oze@gmail.com)
Background and purpose: Patients with diabetes mellitus (DM) are at higher risks of haemodynamic instability during anaesthetic procedures, including spinal anaesthesia. A hyperbaric solution of local anaesthetics (LA) for spinal anaes-
thesia allows for a reduction in dose, hence decreasing side effects while ensuring an adequate sensory block. We analyzed 
hypotension following the establishment of unilateral block in two groups of patients, diabetic and non-diabetic.
Materials and methods: In our retrospective clinical study we collected data for 44 patients who underwent lower limb 
surgery, 22 diabetic and 22 non-diabetic. Patients were comparable in terms of age, ASA status, pre-procedural volume 
therapy, premedication and dose of administered LA. Following a successful unilateral spinal block, arterial blood pressure 
(BP) was measured every 5 minutes during surgical procedure. The lowest BP in the first 30 minutes was taken in calcula-
tion. Administration of vasoactive drugs was noted.
Results: Even though both systolic and median arterial pressure on average decreased more in the diabetic group than 
in the non-diabetic (23.6 % versus 21.9 and 24.2 versus 20.7, respectively) none of these differences were statistically signi-
ficant. Furthermore, only two diabetic patients had hypotension that warranted administration of vasopressors, but the 
occurrence of such clinically relevant hypotension was not statistically significantly different from the non-diabetic group.
Conclusion: Our results showed no difference in hypotension in diabetic patients compared to non-diabetic patients. 
Therefore, unilateral block with low doses of local anesthetic is a safe form of anesthesia that guarantees haemodynamic 
stability even in such a distinctive group of patients.
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a4, P4: Spinal anaesthesia and it’s complications 
– evaluation of expectations, impressions  
and experiences among patients
SONJA KROFAK¹, VI[NJA NESEK ADAM¹, PETRA MATKOVI]³, MAJA KARAMAN – ILI]¹, @ARKO RA[I]², LIVIJA [AKI]1
1 University Department of Anaesthesiology, Resuscitation and Intensive care, Sveti Duh Clinical Hospital, Zagreb
2 University Department of Surgery, Sveti Duh Clinical Hospital, Zagreb
3  Counceling and Pshychotherapy Centre, Zagreb
(sonja.krofak@gmail.com)
Background and purpose: Every surgical procedure, together with anaesthesia is stressful for a patient. In order to introduce patients’ personal impressions of spinal anaesthesia, our aim was to analyse their expectations, fears and 
other emotions. We compared those emotions to objective measures to estimate the success of spinal anaesthesia.
Materials and methods: Prospective study included 30 patients aged 18 – 65, ASA I - III status, who are native or 
proficient in Croatian language and are undergoing an elective surgical procedure. Exclusion criteria were patient́ s refusal, 
allergy to local anaesthetics, coagulopathy, severe spine deformation, failed or inadequate spinal block, history of alcohol 
or narcotic abuse, and psychiatric history. We developed our own structural questionnaire in order to investigate patient’s 
emotions before spinal anaesthesia performance and during the operation itself and the day after. It contained 33 questions 
based on Likert́ s method. As objective measures to estimate the success of spinal anaesthesia, we focused on providing a 
regional block in an expected time and presence of complications and side-effects of spinal anaesthesia. 
Results and conclusion: Although our questionnaire hasǹ t been validated, it helped us to understand the dominating 
emotions among patients undergoing spinal anaesthesia and to recognize the connection between patient́ s personal expec-
tations and objective outcome of spinal anaesthesia experience. Total patient satisfaction with spinal anaesthesia and willing-
ness to undergo an operation in spinal anaesthesia again if neccessary, were more expressive among patients who showed 
positive emotions before spinal anaesthesia performance. Since this research showed some interesting trends, a space for 
further questions and upgrading the research opened.
 
a5, P5: epidural anesthesia in patient with deep brain 
stimulation – our first case
MARIN KNEZ, NIKOLINA NARAN^I] KNEZ, ANTE TOLI], MARINA NEKI] BOR^ILO, ALFIO POROPAT, MILICA KOM[O,  
ANAMARIJA MR\EN, ORIJANA D@EPINA
Orthopedic Hospital, Biograd na moru, Croatia 
General Hospital Zadar, Department of Neurology, Croatia 
(marinknez@net.hr)
We present a case of a 69-year-old male patient with an essential tremor and deep brain stimulator (DBS) implanted in his left thalamus 2 years ago in Department of Neurosurgery, University hospital Dubrava, Zagreb. 
The patient’s left leg has been amputated after war trauma and TEP implanted in his right knee. He has oesophagitis of 
Barret, chronic prostatitis, and underwent surgery of baseocellular carcinoma of face and lumbar spine stenosis. Both pro-
cedures were before DBS implantation. Last year in May he had surgery in general anesthesia of chronic dacrocystitis of 
left eye. After that the twitches (jerks) of the head and left arm appeared and were characterized as thalamic bursts in tha-
lamic stimulated patient.
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Now, the same patient needs a surgery of right knee because of gonarthrosis and he needs implantation of reTEP. Team 
of medical specialist (neurologist, cardiolologist and anesthesiologist) made preoperative examinations. In neurological 
status patient had tremor of both hands, more in left one. Our cardiologist needed to make heart ultrasound; she could not 
make ECG regularly because of DBS. Preoperative laboratory findings of blood and urine and X-ray of heart and chest were 
normal. 
Because of the side effects after general anesthesia during surgery few months ago, our anesthesiologist decided to make 
this operation in epidural anesthesia. They were not able to switch off DBS before surgery. 
Before surgery, anesthesiologist inserted epidural catheter between L2 and L3 vertebra and applicated mixture of local 
anesthetic 0.5% levobupivacaine (10 ml) and fentanyl (1ml) diluted in saline in 1:1 ratio, in 3 boluses of 5 ml, total 15 ml. 
After that he applicated another bolus of 5 ml just before the end of surgery. During the surgery patient was haemodinamic 
stable, with normal vital functions and partly preserved motor skills of legs. 
After the procedure we continued with epidural analgesia (the same mixture in lower ratio) without using other analge-
sics. Patient didn’t have new neurological symptoms and he felt good. Sixth day after the surgery he was transfered in De-
partment of physical therapy. 
 
a6, P6: Spinal anesthesia for lumbar spine surgery 
in University Clinical Hospital Mostar
DAJANA VLADI]1, MIRKO MIHALJ1, ANITA KOSJERINA1, ZORAN KARLOVI]1, VESNA GOLUBOVI]2
1 Department of Anesthesiology, Reanimation and Intensive Therapy, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
2  Medical Faculty Rijeka, University of Rijeka, Rijeka, Croatia
(daki.vladic@hotmail.com)
Until 2012 in the University Clinical Hospital (UCH) Mostar lumbar spine surgical procedures were performed in general anesthesia using standard anesthetic procedure. The first lumbar spine surgery under spinal or subarahnoidal 
anesthesia was performed on the 23rd of May 2012. Since then spinal anesthesia for lumbar spine surgery was considered 
as a standard anesthetic technique in UCH Mostar.
The mixture of anesthetic drugs was applied in subarachnoidal space two intervertebral spaces above the intervertebral 
space that was planned to be operated. Considering the needed distance between the punctated intervertebral space and 
planned operative field, spinal anesthesia for lumbar spine surgery can be applied only for surgery from fourth lumbar 
vertebra bellow. In UCH Mostar, we use it for L4/L5 and L5/S1 discectomies. Spinal puncture is performed with the spinal 
needles with smallest diameter that are available (25-27 Gauge) in sitting or lateral decubitus position. The mixture of local 
anesthetic levobupivacaine 0.5% (cca 2 ml) and opioid drug fentanyl (cca 2,5 mcg) was injected in spinal space and the 
patient was turned in supine position. After clinical confirmation that applied anesthetic mixture has reached adequate 
space, the patient was rolled in prone position adequate for the planned surgery.
Since May of 2012 we have started performing spinal anesthesia for lumbar spine surgery, applying the mixture of local 
anesthetic and opioid drugs. The same year 23 patients were operated in spinal anesthesia and 128 patients underwent 
general anesthesia. In the year 2013, 59 patients underwent lumbar spine surgery in spinal anesthesia, and 83 patients re-
ceived general anesthesia. In 2014, 61 patients were operated in spinal anesthesia comparing to 78 patients operated in 
general anesthesia. Our aim is to improve the quality of anesthetic procedure in our hospital according to ESRA guidelines 
regarding as well patients’ satisfaction and wellbeing during perioperative procedure and hospital stay.
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a7, P7: Supraclavicular nerve block: does kidney
transplantation make a difference?
KATARINA TOMULI] BRUSICH, IVANA ACAN, VESNA KOVA^I] VICI], NATA[A VI[KOVI] FILIP^I]
Department of Anaesthesiology, Reanimatology and Intensive Care, University Hospital Merkur, Zagreb, Croatia
(acan.ivana@gmail.com)
Background and purpose: Number of transplanted patients increased overall. However, clinical research among these patients regarding regional anesthesia is insufficient. Transplanted patients often require upper extremity surgery. Pe-
ripheral nerve blocks became popular anesthetic option due to hemodynamic stability and better postoperative analgesia. 
Single center retrospective study was conducted to determine possible difference among renal transplant patients and non-
transplanted patients regarding block onset and duration for supraclavicular nerve block (SCB) where the same dose of local 
anesthetic was used.
Materials and methods: Medical records of patients with SCB performed for surgical procedures on upper extremities 
at University Hospital Merkur, between May 2009 and March 2013 were reviewed. All SCB performed were ultrasound-
guided. Patients in whom a single-injection of local anesthetic (equal aliquots of lidocaine 2% and levobupivacaine 0.5%) 
was performed for SCB were included in study. Patients were divided in groups: renal transplant recipients (Tx) and non-
transplanted (Non-Tx) patients. 
Results: A total of 57 SCB procedures were performed using lidocaine+levobupivacaine mixture: Tx (n=15) and Non-Tx 
(n=42). Non-Tx patients were older (Tx 51.60+/-9.63 vs Non-Tx 61.45+/-13.19, P=0.0106). However, there was no difference 
regarding sex, ASA status, patient co-morbidities (diabetes mellitus and coronary artery disease). Tx group had higher body 
mass index (Tx 32.4+/-6.18 vs. Non-Tx 25.8+/-4.50, P<0.0001). This did not affect block success. There was no difference 
between total volume of local anesthetic used, time of block onset and block duration. 
Conclusion: There is no difference in duration of SCB in patients after kidney transplantation compared to the general 
surgical population. 
 
a8, P10: Femoral nerve block in a high risk cardiac 
patient. Case report.
VERICA MIKECIN1, MIROSLAV @UP^I]1, SANDRA GRAF @UP^I]2, SANJA PEREMIN1, VIKTOR \UZEL3, ANA BRI[KI1, INO HUSED@INOVI]1
1 Clinical Department of Anesthesiology, Reanimatology and Intensive Care Medicine, University Hospital Dubrava, Zagreb, Croatia
2 The University of Osijek, Sveti Duh University Hospital, Department of Neurology, Zagreb, Croatia
3 Dept of Anaesthesia and Intensive Care, Our Lady of Lourdes Hospital, Drogheda, Co Louth, Ireland
(mikverica@gmail.com)
Background and purpose: Elderly patients admitted to the emergency department usually have concomitant diseases. In risk evaluation for surgery and anesthesia, they usually represent a high risk group. General anesthesia itself could 
have a deleterious effect on hemodynamic stability so regional techniques are usually preferred in this group of patients.
Case report: We present a case of a 69 year old gentleman admitted to hospital with traumatic rupture of the quadriceps 
muscle. In preoperative evaluation it was established that he suffers from coronary artery disease, dilative cardiomyopathy, 
hypothyroidism, hypertension and diabetes mellitus. Due to ASA IV status and high risk of perioperative cardiac complica-
tions, it was decided to apply an ultrasound guided femoral nerve block technique combined with the use of a nerve stimulator. 
A complete sensory block was achieved and the patient was hemodynamically stable during and after the surgical intervention.
Conclusion: Peripheral nerve block is safe and effective in high risk patients with no negative effects on hemodynamic 
stability. A combined nerve stimulator technique with ultrasound guided femoral nerve block eliminates the need for ad-
junctive analgesics.
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a9, P16: Trends in obstetric regional anesthesia and 
analgesia at Sveti Duh University Hospital
IVAN [KLEBAR1, TINO KLANCIR1, LIVIJA [AKI]1, LUKA DJULABI]2
1 Department of Anesthesiology, Reanimatology and Intensive Care, University Hospital “Sveti Duh”, Zagreb, Croatia
2 Department of Anesthesiology, Reanimatology and Intensive Care, University Hospital Center “Sestre  Milosrdnice”, Zagreb, Croatia
(isklebar@kbsd.hr)
Background and purpose: Regional anesthesia and analgesia are the preferred anaesthetic methods recommended for obstetrics. This research examines the frequency and quality of spinal and epidural anesthesia and analgesia used dur-
ing labor and cesarean section in the six year period from 2009 to 2014 at Sveti Duh University Hospital in Zagreb. Qual-
ity is assessed according to the frequency of severe post-dural puncture headache (PDPH), the most common serious 
complication of central regional blocks.
Materials and methods: A retrospective analysis of obstetric anesthetic management for the past six years was con-
ducted using archived hospital records. Use of a blood patch was considered an indicator for the development of severe 
PDPH.
Results: In accordance with the falling birth rates throughout Croatia, the number of births at Sveti Duh hospital de-
creased during the observation period. The use of epidural analgesia for labor increased during the same time period. The 
rate of cesarean sections remained constant at 19-20% of deliveries. The number of cesarean sections performed under 
spinal and epidural anesthesia increased along with a concurrent decrease in the use of general anesthesia. The use of a blood 
patch, indicating the development of severe PDPH, dropped from 27 in 2009 to six in 2013 and 2014. This can be attrib-
uted to the transition to thin, atraumatic spinal needles for spinal blocks along with the increased level of experience of the 
obstetric anesthesiology team.
Conclusions: During the past six years, there was an increasing proportion of births using regional analgesia for labor 
and regional anesthesia for caesarean sections. Meanwhile, PDPH has been drastically reduced.
 
a10, P17: Satisfaction with regional anesthesia 
in parturients undergone caesarean section 
SONJA [KILJI], DUBRAVKA IVI], GORDANA KRISTEK
Departement of Anesthesiology, Reanimatology and Intensive Care Unit, Clinical Hospital Osijek, Osijek, Croatia
(skiljicsonja@gmail.com)
Background and purpose: Regional (RA) and general (GA) anesthesia are used for caesarean sections (CS). Reducing the frequency of GA may serve to reduce maternal complications. Important component of quality of perioperative 
care is patient’s satisfaction with anesthesia service. We investigated the level of satisfaction with anesthetic technique in 
parturients undergone CS and determined factors influencing on it.
Patients and methods: Retrospective survey was conducted by anonymous questionnaire introduced to parturients 
undergone CS. 
Results: Forty-five women participated. Under RA was done 57.8% of CS (64.7% of electives and 36.4% of urgents). 
Most parturients had previous information about anesthetic techniques and 79.4% of them participated in choosing the 
type of anesthesia. High satisfaction with RA revealed 77.8%, while 11.1% of them revealed poor satisfaction, related to 
patchy-block and conversion to GA. All parturients experienced RA, as well as the ones under GA, would choose the same 
technique again.
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Conclusion: More than 50% elective procedures were done in RA while in urgent cases dominates GA. Parturients were 
well informed about anesthetic techniques, mostly by internet and anesthesiologist. Reason for RA was possibility of seeing 
their newborn and for GA fear of awareness. Women who were previously informed, prepaired and participated in choosing 
the type of anesthesia, showed high level of satisfaction. The patient’s previous knowledge as well as participation and ap-
proach of anesthesiologist can influence strongly on choice of anesthetic technique and the level of satisfaction with anes-
thesia in parturients undergone CS. 
 
a11: The comparison of analgesic effect 
of fractionated and continuous epidural analgesia with 
painless childbirth during the first stage of labor
ISMET SULJEVI]1, ISMANA [URKOVI]2, MAIDA SULJEVI]3
1 University Clinical Center Sarajevo, Clinic of Anesthesiology, Bosnia and Herzegovina
2 University Clinical Center Sarajevo, Clinic of Endocrinology, Diabetes and Metabolic Diseases, Bosnia and Herzegovina
3 Faculty of Medicine, Sarajevo, Bosnia and Herzegovina
Background: In this study we point out the difference between the analgesic effect of administered local anesthetic and the analgesic epidural block through the techniques of fractionated applications of analgesia and applications of anal-
gesia with continuous infusion technique, in primiparas during the first stage of labor.
Methods: In group G-I, (n-20) local anesthetic and analgesic techniques were applied with fractional epidural block. In 
group G-II, (n-20) the maintenance of epidural block was administered through the application of infusion. For the test 
application of 3 ml in both groups we used a mixture of Chirocaine 0.25% 20 ml and 100 mcg Fentanyl. In group G-I, 5 
minutes after the application of the test dose there was an application of an additional 7 ml of the same mixture as analge-
sic dose. In group G-II, after the application of the test dose, an additional dose of 7 ml of a mixture of an analgesic, the 
continuous analgesia was maintained at a dose of 10 ml / h of the mixture of 0.125% Chirocaine and 1.5 micrograms / ml 
of fentanyl using Infusomats. Using the VAS scale for pain, the pain was determined before the application test dose and 
at the end of the first stage of labor. 
Results: The average pain intensity before applying the test dose in group G-I was 2.8, and 3.3 in group G-II. At the end of 
the first stage of labor, at the maximum dilatation of the cervix in group G-I, pain intensity was 2.1, and 4.3 in group G-II.
Conclusion: Epidural analgesia with the application of fractional technique is a more favorable option for the reduction 
of pain in pregnant women than the continuous infusion.
 
a12, P21: Prolonged relief of head and face neuralgia 
after regional nerve blocks
LADA KALAGAC FABRIS, MA[A BIBERI] 
Departement of Anesthesiology, ICU and Pain Service, General Hospital Pula, Pula, Croatia
(lada1966@gmail.com)
Background and purpose: The main sensory innervation of the face derives from the cranial nerve V and the upper cervical nerves. Atypical neuralgia is caracterized by unilateral, prominent, constant and severe aching, boring or burn-
ing pain within the affected distribution of the cranial nerve. 
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Patients and methods: 11 patients (7 females/4 males) with facial neuropathic pain (tirgeminal, occipital, frontal-su-
pratrochlear) were forwarded to pain clinic because of complications and side effects of high doses of anticonvulsant and 
antidepressants therapy but still suffering of severe burning pain. All patients, after they signed informed consents, were 
treated with three or four series of minimal invasive techniques of reaching the trigeminal/maxillar/cranial nerves through 
the face without the skin incision. The goal of peripheral levobupivacaine and corticosteroids injections was to block the 
area of the injured nerves to keep it from sending pain signals to the brain. 
Results: All patients experienced an initial total relief of ongoing pain for 8-12 hours. Evoked pain (hyperalgesia or al-
lodynia) was blocked simultaneusly with the spontaneus pain. In all of the patients we achieved a long term decrease of 
anticonvulsant daily therapeutic doses. In one young female patient with trigeminal (V2) neuralgia the nerve blocks reduced 
the incidence of pain apareance but she expressed the side effects of  corticosteroids injections, so after applying the bocks 
twice she gave up.
Conclusions: Prolonged relief of neuralgia after regional blocks my be the result of a central action of local anesthetics 
and corticosteroids at the spinal level after an intra-axonal incorporation and centripetal axoplasmatic transport, and allow 
us to avoid the drug abuse.
 
a13, P23: local analgesia in pain management after 
cardiac surgery
ANITA KOSJERINA1, ZORAN KARLOVI]1, VESNA GOLUBOVI]2, DAJANA VLADI]1
1 Department of Anesthesiology, Reanimation and Intensive Therapy, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
2 Medical Faculty Rijeka, University of Rijeka, Rijeka, Croatia
(daki.vladic@hotmail.com)
Background: Patiens submitted to cardiac surgery under general anesthesia have a lengthened post-operative use of mechanical ventilation, slower recovery, and a longer stay in the Intensive Care Unit (ICU), and have the need for more 
analgetics after the operation. Infusion of levobupivacaine 0.5%, at the median sternotomy site, for 36 h after cardiac surgery 
reduces the need for intravenous opioid analgesics and improves the recovery process. 
Material and methods: Forty-three consenting clinical trial patients undergoing open-heart surgery with a standardized 
general anesthetic technique had two indwelling infusion catheters placed at the median sternotomy incision site at the end 
of surgery. The patients were randomly assigned to receive 1st group opioid analgetics intravenous and 2nd group levobupi-
vacaine 0.5% via an elastomeric infusion pump at the rate of 2-6 ml/h for 36 hours. The patients evaluated their chest pain 
using the Visual Analog Scale (VAS). The VAS were in 1st group (>3), in  levobupivacaine group (=<3). 
Results: Compared with the control group, there was a statistically significant reduction in VAS scores in the levobupi-
vacaine  group, and they need less opioid analgetics later. Patient satisfaction with their pain management was also improved 
in the levobupivacaine group.
Conclusion: A continuous infusion of levobupivacaine 0.5% through infusion catheters was effective for pain manage-
ment, faster weaning from mechanical ventilation, the reduction of stay in the ICU and decreasing the need for opioid 
analgesic medication. 
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